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RÉSUMÉ 
La prévalence croissante des infections bactériennes ayant acquis une résistance aux antibiotiques 
a créé une crise mondiale en terme de santé publique.  Effectivement, l'échec de la médecine 
traditionnelle pour le traitement efficace de ces infections implique un coût sociétal annuel de 35 
milliards de dollars aux États-Unis. Avec les déboires des stratégies conventionnelles de 
traitement, le diagnostic précoce de pathogènes bactériens résistants aux antibiotiques, tel que le 
Staphylococcus aureus résistant à la méthicilline (SARM), devient primordial pour la prévention 
et le traitement rapide et efficace des infections. Cependant, les techniques de détection 
courantes, telles que des tests de culture microbiologiques standards, la réaction en chaîne par 
polymérase (PCR), les dosages immunologiques, les techniques de fluorescence et la 
spectrophotométrie, présentent plusieurs inconvénients; notamment, ces techniques requirent des 
étapes de préenrichissement, un personnel médical hautement qualifié, un temps d'analyse 
relativement long et des coûts élevés. Il y a donc un besoin pressant pour une méthode de 
détection rapide, fiable, sensible, spécifique et à coût modique pour la détection de pathogènes.  
 
Cette dernière décennie a vue l’émergence de plusieurs biocapteurs pour fins biomédicales. 
Cependant, ces capteurs s’appuient majoritairement sur l'utilisation d'anticorps. Ces éléments de 
reconnaissance présentent plusieurs inconvénients (e.g. coûts de production élevés, instabilité 
face aux fluctuations environnementales, etc.).  Dans ce travail, nous favorisons donc une 
approche basée sur les bactériophages, des virus qui reconnaissent spécifiquement leurs hôtes 
bactériens, peuvent distinguer entre les cellules vivantes et les cellules mortes, sont robustes et 
ont de faibles coûts de production. 
 
Dans ce travail pluridisciplinaire, nous combinons la biologie moléculaire, la virologie, la 
microbiologie, la chimie des surfaces, la nanotechnologie et le génie physique afin de façonner 
une méthode innovante, potentiellement miniaturisable, pour la détection clinique d'agents 
pathogènes à l'aide de bactériophages spécifiques comme éléments de reconnaissance. 
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Nous commençons par examiner les principes fondamentaux et les progrès récents des 
technologies utilisant des biocapteurs optiques, électrochimiques et acoustiques pour les 
diagnostics basés sur les phages.  Nous constatons que, malgré un travail notable, une méthode 
optique, spécifique, sensible pour détecter de faibles concentrations d'agents pathogènes en 
quelques minutes, à faibles coûts, n'a pas été établie. Nous concluons que l'amélioration des 
stratégies d'immobilisation des phages ainsi que l’utilisation d’éléments phagiques plus 
appropriés pour une approche utilisant un biocapteur optique SPR (Surface Plasmon Resonance) 
permettrait une détection en temps réel plus sensible.  
 
Nous croyons qu’une meilleure compréhension des caractéristiques d'adsorption des 
monocouches organiques auto-assemblées est nécessaire pour des applications impliquant la 
modification des surfaces de métaux pour la fixation subséquente d'éléments de reconnaissance. 
Notre deuxième article porte donc sur l’étude de la cinétique d’auto-assemblage de monocouches 
de L-cystéine et d'acide 11- mercaptoundécanoïque (MUA) sur l'or en utilisant la SPR [1]. Notre 
but dans l'accomplissement de ces recherches est d'établir la validité et l'applicabilité de chacune 
de ces molécules comme élément de liaison pour une utilisation subséquente dans les biocapteurs 
optiques. Nous constatons que la formation des monocouches de L-cystéine et de MUA n’est 
décrite par l'isotherme de Langmuir qu’à de faibles concentrations seulement. Nos études 
démontrent que dans le cas de la formation de la monocouche de L-cystéine, le groupement  
amine ainsi que le groupement thiol contribuent à la fixation initiale de la molécule, suivie du 
remplacement des complexes amine-or, formés initialement, par des complexes thiol-or plus 
stables. La réorganisation de la L-cystéine crée donc plus d'espace à la surface de l'or, entraînant 
l’adsorption de molécules subséquentes. De plus, la forme zwittérionique de la molécule de L-
cystéine permet la physisorption d'une deuxième couche par des interactions électrostatiques. 
D'autre part, les molécules de MUA s’adsorbent aléatoirement sur la surface de l'or  permettant 
une réorganisation subséquente de la monocouche plusieurs heures après le dépôt initial.   
 
Nous avons ensuite utilisé la résonance plasmonique de surface (SPR) pour effectuer la détection, 
en temps réel, de l'attachement de bactériophages contre le SARM à l'or, en utilisant plusieurs 
différentes stratégies d'immobilisation[2].  Nous avons constaté qu’une monocouche auto-
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assemblée mixte de L-cystéine et de MUA permet une orientation favorable des phages 
lorsqu’immobilisés à l’or.  Ce positionnement orienté des phages préserve leur biofonctionnalité 
et leur capacité de lyse bactérienne. Ceci est dû à la formation de cavités uniformes sur les 
surfaces d'or, permettant une orientation du phage de façon à ce que les protéines caudales, 
responsables de la reconnaissance des épitopes bactériens, soient exposées vers le milieu externe 
contenant leurs hôtes bactériens. 
 
Nous avons ensuite utilisé une plateforme SPR pour détecter E. coli à l’aide de bactériophages T4 
ainsi que des SARMs à l’aide de phages spécifiques BP14[3]. Nous avons constaté que notre 
technique d’immobilisation, combinée à l'utilisation de la SPR, permet la détection sans 
marquage préalable, en temps réel, de façon précise, rapide et peu coûteuse d'agents pathogènes, 
pour des concentrations de 103 colonies/millilitre (CFU/ mL), et ce, en moins de 20 minutes. 
 
Nous avons ensuite porté notre attention sur la détection différentielle de SARM d'origine 
communautaire (CA-SARM), d’origine nosocomiale (HA-SARM ), des S. aureus sensibles à la 
méthicilline (SASM), et des souches ayant une résistance limite à l’oxacilline (BORSA), en 
utilisant SPR[4]. Nous avons étudié deux cent cinquante isolats cliniques de Staphylococcus 
aureus pour déterminer leur sensibilité aux antibiotiques β-lactamines. Un biocapteur SPR a été 
utilisé pour différencier les CA-SARM, des HA-SARM, des BORSA ainsi que des souches de 
SASM en détectant spécifiquement PBP2a, une protéine liant la pénicilline qui a acquérit une 
altération conférant ainsi aux souches de S. aureus une résistance aux antibiotiques β-lactamines. 
Nous avons constaté que le système le permet la détection spécifique des agents pathogènes pour 
des concentrations aussi faibles que 10 CFU/mL, sans avoir recours à la PCR, à un marquage ou 
à un enrichissement préable. Cette approche présente l'avantage d'être simple et rapide, 
permettant l'identification de souches résistantes de Staphylococcus aureus jusqu'à 48 heures plus 
rapidement que les techniques microbiologiques classiques. Cette méthode pourrait avoir un 
impact significatif sur les coûts hospitaliers, le contrôle efficace de l'infection et la mortalité des 
patients. 
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Finalement, nous proposons une nouvelle perspective sur la fixation des phages à des 
nanoparticules d'or[5] pour une meilleure détection SPR. Nous rapportons la synthèse et la 
caractérisation de nanohybrides or-bactériophages multifonctionnels, ayant un grand potentiel 
pour des applications nano-biomédicales telles que la SPR localisée. Les nanoparticules d'or 
(AuNPs) fonctionnalisées au polyéthylène glycol (PEG) et couplées aux phages contre les 
SARMs ont été étudiées par microscopie électronique à transmission (MET) et par la 
spectroscopie de photoélectrons à rayons X (XPS). Le rôle de l'interface ainsi que celui de la 
chimie employée pour fixer les phages aux nanoparticules d'or ont été délimités. L'attachement 
des phages aux AuNPs a été confirmé par la formation de liens peptidiques entre les amines 
primaires des phages et le groupement terminal d'acide carboxylique des nanoparticules pegylées, 
ainsi que par la formation de liens hydrogènes entre les espèces carboxyle et amine. L'utilisation 
de ces nanoparticules hybrides phagiques peut être étendue à une large gamme d'applications 
biotechnologiques. 
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ABSTRACT 
The ever-increasing prevalence of multidrug-resistant infections has created a global public 
health crisis with the failure for conventional medicine to effectively treat patients, resulting in 
prolonged hospital occupency, greater risk of death and annual societal cost reaching over $35 
billion in the United-States alone. With the failure of conventional treatment strategies, early 
diagnosis of drug-resistant bacterial pathogens, such as methicillin-resistant Staphylococcus 
aureus (MRSA), becomes primordial in preventing resultant life-threatening illnesses. 
Conventional detection techniques, such as standard culture-based assays, polymerase chain 
reaction (PCR), immunological assays, fluorescence and spectrophotometry, suffer from several 
drawbacks including the requirement for pre-enrichement steps, lengthy assay times, high costs 
and the necessity for highly-trained medical personnel. There is a need for a rapid, reliable, 
inexpensive, sensitive and specific method for pathogen detection. The past decade has brought 
about the increased use of biosensing technologies, relying on the use of antibodies for 
biomedical purposes.  These recognition elements suffer from several drawbacks including high-
costs and limited shelve-lives. We thus turn our attention to bacteriophages, viruses that 
specifically recognize their bacterial hosts, can distinguish between live and death cells, are 
robust, easy to produce and cost effective. 
 
In this multidisciplinary work, we combine molecular biology, virology, microbiology, surface 
chemistry, nanotechnology and engineering physics to bring about an innovative, potentially 
miniaturizable method for the point of care detection of pathogens using specific bacteriophages 
as a recognition elements.   
 
We start by reviewing the basic principles and recent advances in biosensing technologies using 
optical, electrochemical and acoustic platforms for phage-based diagnostics.  Although much 
notable work has been done, a low cost, specific, sensitive optical method for detecting low 
concentrations of pathogens, in a few minutes, has not been established. We conclude from the 
limited body of work on the subject that improving immobilization strategies and finding more 
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suitable phage recognition elements would allow for a more sensitive approach. Our aim was to 
better describe the attachment process of MRSA specific phages on gold surfaces, and the 
subsequent biodetection of their bacterial hosts by surface plasmon resonance (SPR).  
 
With the knowledge that the adsorption characteristics of thiol-containing molecules are 
necessary for applications involving the attachment of recognition elements to a functionalized 
surface, we start by providing comparative details on the kinetics of self-assembly of L-cysteine 
and 11-mercaptoundecanoic acid (MUA) monolayers on gold using SPR[1]. Our purpose, in 
carrying out these measurements was to establish each molecule’s validity and applicability as a 
linker element for use in biosensing. We find that monolayer formation, for both L-cysteine and 
MUA, is described by the Langmuir isotherm at low concentrations only. For L-cysteine, both 
the amine and thiol groups contribute to the initial attachment of the molecule, followed by the 
replacement of the amine-gold complexes initially formed with more stable thiol-gold complexes. 
The reorganization of L-cysteine creates more space on the gold surface, and the zwitterionic 
form of the molecule permits the physisorption of a second layer through electrostatic 
interactions.  On the other hand, MUA deposits randomly onto the surface of gold as a SAM and 
slowly reorganizes into a denser, vertical state. 
 
Surface plasmon resonance was then used for the real-time monitoring of the attachment of 
MRSA bacteriophages to gold, using several immobilization methods[2]. We found that mixed 
self-assembled monolayers (SAMs) of L-cysteine and MUA permitted oriented positioning of the 
phages, thus preserving their biofunctionality and their bacterial lysing efficiency. This was due 
to the formation of uniform cavity islands on the gold surfaces, permitting an oriented positioning 
of the phages, thus better exposing their recognition proteins towards the medium containing the 
bacterial hosts. 
 
T4 bacteriophages were then used to detect E. coli, while a novel, highly specific phage was 
isolated, characterized and used to detect MRSA[3]. We found that our technique, combined with 
the use of SPR permits label-free, real-time, specific, rapid and cost-effective detection of 
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pathogens, for concentrations of 103 colony forming units/milliliter (CFU/mL), in less than 20 
minutes.  
 
We then turned our attention towards the  differential detection of community-acquired MRSA 
(CA-MRSA), hospital-acquired MRSA (HA-MRSA), methicillin susceptible S. aureus (MSSA), 
and borderline resistant oxacillin-resistant S. aureus (BORSA), using SPR[4].  We studied two 
hundred fifty Staphylococcus aureus clinical isolates to determine their susceptibilities to β-
lactam antibiotics. A surface plasmon resonance (SPR) biosensor was used to differentiate among 
CA-MRSA, HA-MRSA, BORSA and MSSA strains by specifically detecting PBP2a, an altered 
penicilling binding proteins that confers resistance to S. aureus strains, on whole bacterial cells, 
without labeling, without recourse to PCR or enrichment steps. We found that the system 
permits, specific detection of pathogens for concentrations as low as 10 CFU/mL.  This approach 
has the advantages of being simple and rapid, allowing for identification of resistant strains of 
Staphylococcus aureus up to 48 hours earlier than conventional microbiological techniques. This 
method could have a significant impact on hospital costs, effective infection control, and patient 
mortality. 
 
Finally, we offer a new perspective on the attachment of phages to gold nanoparticles[5] for 
enhanced SPR detection. We report the synthesis and characterization of gold-bacteriophage 
hybrids multifunctional scaffold with great potential for nanotechnologically-based biomedical 
applications, such as localized SPR. Gold nanoparticles (AuNPs), stabilized (PEGylated) using 
heterobifunctional polyethylene glycol (PEG), were coupled to methicillin-resistant S. aureus-
specific phagesand studied by transmission electron microscopy (TEM) and X-ray photoelectron 
spectroscopy (XPS). The role of the interface, and the covalent coupling chemistry employed to 
attach the phages to the gold nanoparticles, have been delineated and successful attachment of 
phages to AuNPs was confirmed by the presence of amide between the primary amines of the 
phage and the carboxylic acid terminal groups of the NPs, and by the formation of strong 
intermolecular hydrogen bonds between carboxyl and amine species, as shown by N1s and O1s 
core level shifts. The use of these nanoparticle-phage hybrids can be extended to the targeted 
separation of specific bacteria from heterogeneous samples, as well as a wide range of 
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biotechnological applications, such as labels for enhanced fluorescence and dark-field 
microscopy, and surface-enhanced Raman scattering detection[6].
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CONDENSÉ EN FRANÇAIS 
Bien que l’avènement d'antibiotiques se distingue comme l'une des innovations médicales les 
plus importantes du 20e siècle, la prévalence croissante d’infections microbiennes  
multirésistantes aux antibiotiques engendre actuellement une crise mondiale en matière de santé 
publique[7]. Aux États-Unis, l'excès de coûts générés par le milieu hospitalier,  attribuables aux 
infections résistantes aux antibiotiques, atteint 20 milliards de dollars, avec 8 millions de jours 
supplémentaires d’occupation en hôpital et 35 milliards de dollars en coûts sociaux annuellement 
[8]. Bien que des efforts considérables soient orientées vers la production de produits 
antibiotiques dérivés et de produits non-antibiotiques, tels que les vaccins antibactériens, la 
thérapie phagiques et la formulation d’adjuvants, les méthodes actuellement utilisés en clinique 
pour l'identification bactérienne demeurent les tests traditionnels de culture microbiennes,  qui 
requièrent de longues périodes d’incubation ainsi que des protocoles laborieux. D'autres 
techniques conventionnelles, telle que l’amplification en chaîne par polymérase (ACP), les 
dosages d’immunoabsorption par enzyme liée, les tests de bioluminescence et les méthodes de 
spectrophotométrie, présentent plusieurs inconvénients. Ils sont lents, coûteux, laborieux et 
nécessitent des étapes d'enrichissement ainsi qu’un personnel hautement qualifié. Il y a donc une 
demande croissante pour des méthodes qui éliminent le besoin de culture microbienne, réduisent 
le temps de diagnostic et augmentent la sensibilité et la spécificité de la détection. 
 
L'avènement de biocapteurs a permis des avancées majeures dans la détection microbienne. 
Ceux-ci sont  habituellement classés en fonction de leurs éléments de transduction et peuvent être 
optiques, électrochimiques ou acoustiques. En outre, ils peuvent être classés en diverses autres 
catégories en fonction de leurs éléments de bioreconnaissance. La plupart des biocapteurs 
reposent sur l'utilisation d'anticorps. Cependant, l'utilisation d'anticorps présente des 
inconvénients majeurs, telle que leur instabilité relative aux fluctuations environnementales, ce 
qui peut limiter leur stockage à long terme ainsi que leur applicabilité sur le terrain. De plus, leur 
production est longue et coûteuse. Par ailleurs, les anticorps polyclonaux ne sont pas 
extrêmement spécifiques puisqu’ils peuvent reconnaître différents épitopes sur un même 
organisme, ces épitopes pouvant également être présents dans les organismes connexes non 
pathogènes[9].  
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Nous portons donc notre attention sur les bactériophages, qui sont les principaux régulateurs de 
l'équilibre microbien sur la planète, dépassant en nombre leurs hôtes bactériens par un facteur de 
dix.  Les phages se lient spécifiquement à leur hôte et sont optimisés de façon à être des outils 
idéaux pour la détection de bactéries pathogènes. En effet, ils sont capables de faire la distinction 
entre les cellules vivantes et mortes, sont robustes, extrêmement spécifiques, facile à produire et 
peu coûteux.  
 
Cette thèse a, donc, pour but de décrire une méthode optimale pour l’immobilisation, 
l’intégration et l’utilisation de bactériophages sur une plateforme de biodétection conçue pour 
surmonter les nombreuses limites des méthodes analytiques classiques. Par ailleurs, nous venons 
éliminer les étapes d’enrichissements préalables et la nécessité de personnel hautement qualifié, 
réduire considérablement les coûts de production et le temps d’analyse requis, tout en permettant 
une détection sélective, sensible et rapide.  
 
Dans un premier temps, nous faisons une revue de la littérature des techniques de biodétection 
exploitant la capacité de liaison spécifique des bactériophages. Il s'agit notamment de tests 
d'amplification, de l'utilisation de phages rapporteurs, de la détection de composantes 
intracellulaires libérées par la bactérie suite à leur lyse, du marquage des phages par fluorescence, 
et des biocapteurs utilisant des bactériophages comme éléments de reconnaissance. Nous notons 
que, bien que ces dernières années ont vu une augmentation considérable du nombre de nouveaux 
biocapteurs dédiés à la détection de pathogènes, un nombre minime de ces technologies intègrent  
des éléments phagiques et peu de biocapteurs basés sur l’utilisation de bactériophages sont 
présents dans les domaines clinique, agro-alimentaire et environnemental. Le manque d'attention 
porté aux phages pourrait résulter de la fausse notion que les étudier s’avèrerait trop complexe et  
spécialisé pour la plupart des laboratoires de génie.  
 
Nos recherches nous ont permis de cibler plusieurs lacunes dans les méthodes d’immobilisation 
des bactériophages sur les diverses plateformes de détection. La fixation des molécules à un 
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support a trouvé de nombreuses applications dans l'industrie chimique et les dispositifs 
biocapteurs. En particulier, les monocouches auto-assemblées (SAM), composées d'espèces 
chimisorbées, jouent un rôle fondamental dans la modification des propriétés interfaciales des 
métaux, des polymères et des semi-conducteurs. Notamment,  les caractéristiques d'adsorption de 
molécules contenant des thiols sont nécessaires pour les applications impliquant la fixation 
d'éléments de reconnaissance à une surface fonctionnalisée. Cependant, en dépit des efforts 
considérables pour étudier la formation  des SAM sur l'or, notre connaissance sur leur cinétique 
d'adsorption en temps réel demeure limitée. Sachant que la fonctionalisation préalable des 
surfaces d’or par les SAM vient considérablement influencer l’immobilisation subséquente des 
phages ainsi que la sensibilité de détection de notre plateforme,  nous avons étudié, dans un 
deuxième temps, la formation en temps réel des SAM de L -cystéine et d'acide 11- 
mercaptoundécanoïque (MUA) sur l’or, à différentes concentrations, en utilisant un biocapteur à 
résonance plasmonique de surface (SPR).  Notre but dans l'accomplissement de ces mesures était 
de comparer les caractéristiques de liaison de la L-cysteine et de l’MUA afin d'établir la validité 
et l'applicabilité de chacune de ces molécules comme un élément de liaison pour une utilisation 
ultérieures dans les biocapteurs SPR. Nous avons démontré que l'auto-assemblage de la L-
cystéine diffère de celle de MUA. En effet, le processus de dépôt de la L-cystéine implique non 
seulement des contributions des atomes de soufre, mais aussi celles d'autres groupes fonctionnels 
existants. En effet le groupement amine ainsi que les groupes thiol contribuent à la fixation 
initiale de la L-cystéine, suivie du remplacement graduel des complexes amine-or, préalablement 
formés, par des complexes thiol-or plus stable. De plus, la réorganisation de la L-cystéine crée 
plus d'espace sur la surface d'or, permettant le dépôt d’une quantité accrue de L-cysteine, suivie 
de la physisorption d’une deuxième couche, rendue possible par la forme zwittérionique de la 
molécule. Contrairement à la L-cysteine, les molécules de MUA se déposent au hasard, de façon 
désorientée, sur la surface d'or et se réorganisent lentement pour former une SAM dense. 
 
Nous avons donc utilisé ces nouvelles connaissances en matière de SAM afin d’améliorer les 
stratégies d’immobilisation des phages sur les plateformes d’or en vue de leur utilisation 
subséquente pour la détection de pathogènes à l’aide d’une plateforme SPR.   Le troisième article 
a pour but d’optimiser les conditions initiales permettant une détection plus sensible et plus 
spécifique de bactéries S. aureus résistants à la méthicilline  (SARM) sur l’or. En premier lieu, 
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nos travaux nous ont permis d’identifier un phage spécifique aux souches de S. aureus ayant une 
acquis une résistance aux antibiotiques, et permettant une détection SPR accrue des espèces 
bactériennes. En effet, puisque l'onde évanescente de la SPR ne s’étend que jusqu'à environ 300 
nm dans la direction perpendiculaire à la surface de détection, une partie seulement de la bactérie 
va générer une réponse SPR. Il importe donc de minimiser la grandeur de l’élément de 
reconnaissance. La première partie de l’article décrit l’isolation et la caractérisation d’un phage 
podoviridea de 60 nm de diamètre, idéal pour la détection des SARMs par SPR.  Dans la 
deuxième partie de l’article, les méthodes de SPR, de microscopie électronique à balayage (MEB 
) et de microscopie à force atomique (AFM) ont été utilisés pour l’étude, en temps réel, de la 
fixation des phages à la plateforme d’or, en utilisant diverses méthodes d'immobilisation. Nous 
avons déterminé que l'immobilisation des phages par l'intermédiaire d'une monocouche auto-
assemblée mixte de L-cystéine et de MUA conduit à la formation de liaisons covalentes entre les 
phages et la surface d'or. Les phages immobilisés de cette façon conservent leur pouvoir 
infectieux, suggérant une liaison de la capside du phage au substrat, permettant l’orientation des 
fibres de la queue vers le milieu et, par le fait même, l’accessibilité des protéines caudales pour la 
reconnaissance d’antigènes présents à la surface bactérienne. Les résultats AFM corroborent 
davantage cette affirmation. En effet, les images topographiques indiquent clairement que les 
phages se lient préférentiellement dans les cavités uniformes formées par la monocouche auto-
assemblée mixte de L-cystéine et de MUA.  
 
Ayant décrit une méthode optimale pour l’immobilisation des phages sur une plateforme d’or, 
nous avons porté nos efforts vers la détection pathogènes par SPR.  Bien que quelques groupes 
aient récemment été impliqués dans le développement de capteurs à base de bactériophages pour 
la détection bactérienne, une méthode optique spécifique, sensible, ayant un faible coût pour 
détecter de faibles concentrations d' agents pathogènes, en quelques minutes n'a pas été établie. 
Dans le quatrième article présenté dans cette thèse, nous utilisons un capteur impédometrique 
(PDS , Biophage Pharma) afin de démontrer la spécificité du bactériophage aux SARMs. Afin de 
surmonter les limitations du détecteur ampérométrique, nous avons utilisé un appareil SPR pour 
la détection bactérienne. Nous démontrons la possibilité de détecter des concentrations de 103 
colonies bactériennes par millilitre, sans marquage préalable ou étapes d'enrichissement, en 
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moins de 20 minutes. Nous avons démontré l’applicabilité de cette méthode pour la détection de 
SARM, ainsi que pour E. coli. 
 
Ayant raisonnablement atteint notre objectif, nous avons orienté nos chercherches vers le futur.  
Le cinquième article présenté dans cette thèse porte sur l’applicabilité du système SPR pour la 
détection clinique de 250 différentes souches cliniques de S. aureus. La méthicilline est un 
membre d’une large classe d’antibiotiques appelée β –lactame, dont l’effet est de perturber la 
synthèse de la paroi cellulaire bactérienne. Les β–lactames sont les antibiotiques les plus 
largement prescrits en raison de leur spécificité et de leur effet non-toxique sur les cellules hôtes. 
Cependant, les SARMs ont développé une résistance à ces antibiotiques en produisant des 
protéines altérées liants la pénicilline (PLP), codées par le gène MecA, et ayant une faible affinité 
pour les β –lactames. Les SARMs sont défini comme ayant une concentration inhibitrice 
minimale de l'oxacilline (CIM) ≥ 4µg/ml. Cependant, l'expression hétérogène de résistance à 
l'oxacilline dans plusieurs souches de S. aureus a compliqué l'identification du SARM via des 
procédures microbiologiques classiques. Les souches d'un très faible niveau de résistance à la 
méthicilline sont sensibles à la plupart des antibiotiques non - β -lactames, et les tests de routine 
peuvent conduire à des résultats faussement positifs. Par exemple, certaines souches de S. aureus 
présentent une résistance limite à l’oxacilline (BORSA) avec un CIM d’environ ≥ 2µg/ml. Par 
contre, ces souches ne possèdent pas le gène mecA. Les conditions optimales pour l'identification 
des BORSA et leur différenciation par rapport à SARM n'ont pas été déterminées. Par ailleurs, un 
nouveau gène codant pour la résistance à la méthicilline a récemment été identifié dans les isolats 
cliniques de S. aureus. Ces souches, qui ont un profil de résistance variable à l'oxacilline, ne 
peuvent pas être détectées par des techniques moléculaires classiques, telles que la PCR et des 
tests d'agglutination sur lame, et sont ainsi identifiés à tort comme étant BORSA. Ainsi, notre 
objectif est de répondre au besoin pressant pour le développement d'une méthode de détection 
rapide et sensible afin de détecter spécifiquement les SARM et les différencier des souches 
BORSA ainsi que des souches sensibles à la méthicilline. De plus, nous visons à réduire le temps 
de diagnostic, qui est crucial un traitement efficace ainsi qu’une réduction de la mortalitité et la 
prévention de la propagation de la maladie. Nous avons donc utilisé notre biocapteur SPR pour 
pour différencier les souche SARM  des souches BORSA et des souches sensibles à la 
méthicilline en détectant spécifiquement les protéines altérées liants la pénicilline sur les cellules 
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bactériennes, sans avoir recours à une technique d’étiquetage, à la PCR ou à des étapes 
d'enrichissement préliminaires. La limite de détection du biocapeur est de  10 colonies par mL, en 
moins de 15 minutes.  Ainsi, cette approche présente l'avantage d'être simple et rapide, 
permettant l'identification de souches résistantes de Staphylococcus aureus jusqu'à 48 heures plus 
tôt que les techniques microbiologiques classiques. Cette méthode pourrait avoir un impact 
significatif sur les coûts hospitaliers, le contrôle efficace de l'infection et la mortalité des patients. 
 
Le sixième et le dernier article rapporte la synthèse et la caractérisation des hybrides or 
bactériophages en vue de pouvoir utiliser les principes de résonance plasmonique de surface 
localisée (LSPR) pour permettre une amplification du signal de détection, et donc, une meilleure 
sensibilité de detection. Dans le cas de LSPR pour la détection des bactéries, des études récentes 
montrent que la zone de contact entre une cellule bactérienne et une seule NP peut être trop faible 
pour entraîner un changement détectable. Cela nous a incités à étudier la possibilité de fixer de 
nombreuses nanoparticules à une seule cellule bactérienne, en exploitant la spécificité des 
interactions bactériophages des bactéries. Nous avons démontré qu’il est possible de 
fonctionnaliser des nanoparticules d’or avec un polyéthylène glycol (PEG) hétérobifonctionnel 
possédant un groupement thiol permettant son attache à l’or et un groupement carboxylique 
permettant une attache subséquente du bactériophage. Nous avons utilisé la spectroscopie par 
photoélectrons induits par des rayons X (XPS) pour caractériser chimiquement les surfaces des 
nanoparticules d’or fonctionalisées avec le PEG hétérobifonctionnel, des bactériophages, et des 
hybrides NP d’or-phages. Le rôle de l'interface, et la chimie de couplage covalent employées 
pour fixer les phages à des nanoparticules d'or, ont été délimités. Les nanoparticules d'or, 
fonctionnalisés avec un PEG hétérobifonctionnel, ont été couplés avec succès aux bactériophages 
lytiques spécifiques aux SARMs, via une chimie carbodiimide. Ceci fut démontré par la 
formation de liaisons amide entre les amines primaires du phage et des groupes terminaux d'acide 
carboxylique des NPs fonctionnalisées, ainsi que par la formation de fortes liaisons hydrogène 
entre les espèces carboxylique des NPs et amine des phages. Nous concluons que l'utilisation de 
ces hybrides peut être utilisée pour la LSPR, et peut être étendue ainsi à une large gamme 
d'applications biotechnologiques, telle que la séparation ciblée des bactéries spécifiques à partir 
d'échantillons hétérogènes. 
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INTRODUCTION 
Antibiotic treatment has been at the forefront of therapeutic intervention since the discovery of 
penicillin by Alexander Flemming in 1928. However, the over- and misuse of antibiotics has had 
adverse consequences, such as the evolution and spread of bacterial resistance, becoming an 
alarming threat to public health. The increasing prevalence of antibiotic resistance in many 
bacterial species, combined with the failures of antibiotic therapy, causes hundreds of thousands 
of deaths annually. The development of novel antibiotics to combat this crisis has come to a 
standstill, with the US Food and Drug Administration (FDA) approving only seven new drugs in 
the last decade [10]. Moreover, pathogens continuously evolve resistance to novel antibiotics, 
further hindering pharmaceutical efforts to address this problem.  Knowing that the use of 
antibiotics will inevitably promote resistance, it becomes important to develop novel diagnostic 
and treatment strategies to prevent the inadequate use of these drugs.  To address this problem, 
researchers are turning their attention to the bacterium’s natural enemies: bacteriophages. These 
viruses were discovered a century ago, in 1915, by Frederick Twort, and almost simultaneously, 
in 1917, by Félix d’Hérelle. D’Hérelle termed these viruses bacteria-eaters, and tested phage 
therapy in livestock and humans. The reason for the newfound interest is that phages and bacteria 
are both locked in a constant evolutionary battle, where bacteria constantly produce new defense 
mechanisms to proliferate in adverse environments (e.g. antibiotic-rich environments), and 
phages develop counter-strategies to respond to their ever-evolving hosts. Thus, it is not 
surprising that the idea of using phages as a weapon against multidrug-resistant infections has 
made a comeback:  there is plenty of market opportunity, with phage-products having the 
potential to become a billion-plus dollar industry[10]. Although phage therapy is a very exciting 
prospect, one cannot offer effective treatment without a proper diagnosis. Because of this, we 
posed the following question: ‘‘Is it possible to use these ultra-specific viruses, combined with a 
biodetection platform, to recognize their bacterial host in a rapid, reliable and inexpensive 
fashion?’’ In the following chapters, we will offer guidance through our thought processes, 
describing the chemical functionalization of gold sensing platforms, phage immobilization 
strategies, the screening process for a phage candidate suitable for SPR sensing, and the phage-
based detection of E. coli and multiple strains of S. aureus. We will then compare the use of 
phages against antibodies, before turning our attention to the future, where phage-detection is 
combined with nanotechnology for potential new ways of detecting pathogens. 
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CHAPTER 1 GOING VIRAL : THESIS OBJECTIVES AND 
ORGANISATION 
1.1 Objectives 
This work aims at developing a phage-based biosensing SPR system, suited to the specific and 
sensitive detection of bacterial pathogens in a rapid and inexpensive fashion. Our aim is to better 
describe the attachment process of MRSA-specific phages on gold surfaces, and the subsequent 
biodetection of their bacterial hosts by SPR. The objectives of the present work can be 
summarized as follows :  
1.1.1  1st objective: Understand the surface characteristics of the 
functionalized gold sensing platform and its effects on bacteriophage 
immobilization 
The attachment of molecules to a support, resulting in reduced mobility of the target molecule, 
has found multiple applications in industrial chemistry and in biosensing devices.   However, this 
immobilization can result in the partial or total loss of activity of the recognition element.  This is 
due to the fact that phages that are randomly oriented when immobilized on a surface can have an 
altered structural conformation, as well as the inability to recognize their target hosts due to the 
unavailability of their caudal proteins to the external environment. It is, thus, important to 
understand and characterize the functional surface, to derive better strategies for the oriented 
immobilization of the phages to the gold sensing platform.  
1.1.2 2nd objective: Detect bacterial pathogens using an phage-based SPR 
biosensor 
 
The second objective concerns the development and optimization of the SPR methodology for 
the detection of large biological objects, such as living cells and bacteria. While providing 
excellent sensitivity to thin surface biofilms, SPR shows certain limitations to thicknesses larger 
than the evanescent wave penetration depth. Because the evanescent wave of the SPR is limited 
to 300 nm in the direction perpendicular to the surface of detection (for visible light), only a 
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portion of the bacterium will generate a response by interfering with it. We hypothesize that it is 
possible to detect low concentrations of bacteria in real time, if surface immobilization 
chemistries and bacteriophage candidates are optimized for SPR detection. Our initial objective 
was to detect bacterial concentrations of less than 104 CFU/mL in 20 minutes, without prior 
labeling or enrichment steps. 
1.1.3 3rd objective: Compare phage-based detection with antibody-strategies 
for the SPR detection of clinical strains of S. aureus 
Despite rapid progress in biosensor development for pathogen detection, applications of 
biosensors in a clinical setup are still rare, with the exception of glucose monitoring. In order to 
achieve point-of-care testing, it is necessary to meet the sensitivity and selectivity requirements 
for nosocomial pathogens.  The latter is a major barrier for technology transfer to a clinical setup, 
as clinical samples differ greatly from homogeneous laboratory ones. As a result, it is essential to 
develop a biosensing tool that can effectively differentiate between strains of bacteria displaying 
a large spectrum of resistance. Because phages specific to different resistant strains of S. aureus 
are not yet isolated, we effectively modified the SPR sensing plateform to differentiate between 
250 clinical strains of S. aureus displaying different antibiotic resistance patterns.  
1.1.4 4th objective: Develop methodologies for nanoparticle-phage hybrids for 
enhanced biodetection applications such as LSPR. 
Combining phages to nanoparticles can improve the sensitivity of biodectection as well as extend 
their use to a wide range of biotechnological applications, such as the targeted separation of 
specific bacteria from heterogeneous samples, labels for enhanced fluorescence and dark-field 
microscopy, and surface-enhanced Raman scattering. 
 
1.2 Thesis organization 
 
This thesis consists of one introductory chapter, six articles and one final chapter. While the first 
chapter outlines our objectives, the second, comprising the first article, is a review describing the 
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various antimicrobial approaches to treat bacterial infections, and why these conventional 
treatments are failing. We describe the leading emerging pathogens that are problematic in 
today’s society. We then focus on bacteriophages and their mechanisms of action, and review the 
techniques that have been developed to exploit the specific binding ability of phages, including 
phage-based assays and biosensors. Finally, we outline the basic principles and recent advances 
in optical, electrochemical and mass sensitive biodetection technologies.    
 
The second article, comprising the third chapter, concerns the real-time adsorption kinetics of 
SAMs at the gold interface, as monitored by SPR. Thiolated SAMs play a central role in 
biosensing technologies, as these molecules permit the generation of well-defined surfaces with 
chemical functionalities that permit further immobilization of recognition elements. Our goal was 
to compare the binding characteristics of L-cysteine and MUA, in order to establish the validity 
and applicability of each molecule as a linker element for biosensing purposes. Our findings 
allowed for a better understanding of the binding characteristics of SAMs and amino acids, 
permitting the elaboration of better strategies for the attachment of bacteriophages on gold.  
 
In the fourth chapter, the third article discusses the use of SPR to monitor the real time 
attachment of MRSA bacteriophages to gold, using different immobilization approaches, 
including physisorption, the use of gluteraldehyde, L-cysteine, MUA, EDC/NHS or their 
combination. Our aim was to delineate the best strategy for the immobilization of the phages on 
the gold surface, while preserving their biofunctionalities and lytic efficiencies. We found that a 
mixed self-assembled monolayer of L-cysteine and MUA (in article 2) encouraged the oriented 
positioning of the phages with their caudal recognition proteins being exposed to the bacteria-
containing medium.   
The fourth article, in Chapter 5, integrates the findings of the previous articles and focuses on the 
phage-based detection of two pathogens by SPR, E. coli and MRSA. Furthermore, we report on 
the isolation and characterization of a novel phage that is highly specific for MRSA, and whose 
morphological characteristics make it more suitable for SPR detection.  We find that our 
technique permits a label-free, real time, specific and cost-effective detection of pathogens, for 
concentrations lower than 103 CFU/mL, in less than 20 minutes. This detection scheme is of 
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particular interest for public health, and its applicability can be extended to the military, agro-
food and water industries.  
 
With the goal of proving the validity and transferability of our biodetection system to the clinic, 
we partnered with the Laboratory of Public Health of Québec (Laboratoire de Santé Publique du 
Québec), who provided us with 250 clinical isolates of S. aureus. We first determined the 
susceptibility of these isolates to antibiotics, and found that the strains differed largely in their 
resistance patterns. The fifth article, Chapter 6, reports on the differential detection of 
community-acquired MRSA (CA-MRSA), hospital-acquired MRSA (HA-MRSA), methicillin 
susceptible S. aureus (MSSA), and borderline resistant oxacillin-resistant S. aureus (BORSA), 
using SPR, by specifically detecting PBP2a on whole bacterial cells, but without labeling, PCR 
or enrichment steps. We find that this method significantly impacts hospital costs, treatment, and 
infection control. 
 
The sixth article, in Chapter 7, concerns the attachment and characterization of phages to 
heterobifonctional gold nanoparticles for nanotechnologically-based biomedical applications, 
such as enhanced SPR detection. We delineate the role of the interface, and the covalent coupling 
chemistry employed for the successful attachment of MRSA-specific phages to the gold 
nanoparticles. The applicability of those nano-bio hybrids can be extended to the targeted 
separation of specific bacteria from heterogeneous samples, labels for enhanced fluorescence and 
dark-field microscopy, and surface-enhanced Raman scattering detection.  
The final chapter is devoted to critical discussions of the previous results, and presents our final 
recommendations. 
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CHAPTER 2 ARTICLE 1: BACTERIOPHAGES : POWERFUL TOOLS 
FOR MICROBIAL BIOSENSING 
This chapter is a comprehensive literature review, concerning phage-based analytical and 
biosensing methods. We begin this review by concisely informing the reader of bacterial-host 
evasion mechanisms, as well as different types of antibiotics presently available on the market to 
combat bacterial infections.  We discuss the problem of resistance and its societal costs, and 
delineate the clinically relevant bacterial pathogens, of worldwide concern, that are targeted by 
today’s biodection research and development efforts. We then describe bacteriophages, their 
mechanism of action, and their relevance in theranostics. We discuss and review phage-based 
assays, notably phage amplification, reporter phage, phage lysis, and bioluminescence assays for 
the detection of bacterial species. We finally thoroughly review phage-based biosensors, 
including optical (comprising SPR sensors and fiber optic assays), electrochemical (comprising 
amperometric, potentiometric, and impedimetric sensors), acoustic wave and magnetoelastic 
sensors.  
 
This chapter will pave the way for a better comprehension of the articles to follow, devoted to 
phage-based biosensing strategies for the detection of bacterial pathogens, and more specifically, 
Staphylococcus aureus. 
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2.1. Abstract 
 
Pathogen detection is of utmost importance in many sectors, such as in the food industry, 
environmental quality control, clinical diagnostics, bio-defence and counter-terrorism. Failure to 
appropriately, and specifically, detect pathogenic bacteria can lead to serious consequences, and 
may ultimately be lethal. Public safety, new legislation, recent outbreaks in food contamination, 
and the ever-increasing prevalence of multidrug-resistant infections have fostered a worldwide 
research effort targeting novel biosensing strategies. This review concerns phage-based analytical 
and biosensing methods targeted towards theranostic applications. We discuss and review phage-
based assays, notably phage amplification, reporter phage, phage lysis, and bioluminescence 
assays for the detection of bacterial species, as well as phage-based biosensors, including optical 
(comprising SPR sensors and fiber optic assays), electrochemical (comprising amperometric, 
potentiometric, and impedimetric sensors), acoustic wave and magnetoelastic sensors. 
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2.2. Introduction to virulent pathogenic bacteria 
 
 
Bacterial pathogens have developed several mechanisms that aid in circumventing the host 
defences.  The pathogenicity and virulence of a microorganism are highly complex and are 
governed by the bacterium-host interactions. Classical bacterial virulence factors include toxins 
and molecules essential for adhering and invading the host, as well as evading the host’s  
detection mechanisms and immune response.  
 
Classically, these virulent bacteria have been treated with antibiotics since the discovery of 
penicillin in 1928 [11]. Major mechanisms of antibiotic action include the inhibition of the 
synthesis of DNA (quinolones), RNA (rifamycins), and cell walls (β-lactams and glycopeptides) 
or proteins (macrolides, lincosamides, streptogramins, amphenicols, oxazolidinones, 
tetracyclines, aminocyclitols and aminoglycosides) [12].  Quinolones interfere with DNA 
replication by introducing DNA breaks and trapping topoisomerase II (for Gram-negative 
bacteria) and topoisomerase IV (primarily in Gram-positive bacteria) at the cleavage stage, thus 
compromising strand rejoining[12]. Similarly, rifamycins inhibit DNA transcription by binding to 
the β-subunit of an active RNA polymerase. Additionally, bactericidal activity can be achieved 
by inhibition of cell wall synthesis.   
 
Bacterial cell walls are composed of peptidoglycan layers that are extended by transglycosylases 
and cross-linked by penicillin-binding proteins (PBPs) [13]. β-lactams bind to the active site of 
PBP and inhibit the formation of the peptide bond that cross-links peptidoglycan subunits, 
inducing changes in cell-wall morphology and subsequent bacterial death. Moreover, a broad-
range of drugs inhibits protein synthesis by affecting either the 50S or the 30S ribonucleoprotein 
subunits. Drugs that inhibit the 50S ribosome subunit either block the initiation of protein 
transcription or the elongation of the nascent peptide chain. Furthermore, 30S inhibitors either 
prevent aminoacyl tRNA from binding to the ribosome or induce tRNA mismatching, either of 
which result in protein mistranslation[12].   
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Although the development of antibiotics stands as one of the most substantial medical 
innovations, the ever-increasing prevalence of multidrug-resistant infections has created a global 
public health crisis [7]. In the United States, excess health costs attributable to antibiotic-resistant 
infections annually reach $20 billion, with 8 million days of additional hospital occupancy, and 
$35 billion in societal costs [8].  
 
Antibiotic resistance can be acquired through several mechanisms including mutations due to 
selective pressure and horizontal transfer of genetic material through transformation, conjugation 
and transduction. These genes include a variety of enzymes and efflux pumps that are detrimental 
to the antibacterial agent. Moreover, these genes can alter the metabolic pathway resulting in the 
production of altered cell-wall proteins that evade antibiotic targeting.  
 
Although substantial efforts are directed toward producing antibiotic and non-antibiotic 
derivatives, such as antibacterial vaccines, phage therapy, immunostimulants, adjuvants, 
probiotics, and antivirulence therapies, the gold standard for bacterial detection persists to be 
traditional culture-based assays, which are cumbersome and time-consuming.  Other 
conventional techniques, such as the polymerase chain reaction (PCR), immunological assays, 
fluorescence and spectrophotometry, suffer from several drawbacks:  they are time-consuming, 
expensive, laborious, and require enrichment steps and highly trained personnel. There is, 
therefore, a increasing need for methods that eliminate the necessity for microbial cultures, 
reduce the time of diagnosis, and increase the sensitivity and specificity of detection.  
 
The advent of biosensors has permitted major advancements in microbial detection.  Depending 
on their transduction elements, these can be classified as optical, electrochemical or acoustic. 
Moreover, they can be classified according to their biorecognition elements.  Most biosensors 
rely on the use of antibodies. However, polyclonal antibodies suffer from high costs of 
production and environmental instability, thus limiting their shelf-life, storage and applicability 
in non-regulated environments such as humid and high temperature climates. Moreover, 
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polyclonal antibodies have the ability to recognize different epitopes present on the same 
pathogen or on related non-pathogenic organisms, thus hindering their selectivity [9]. On the 
other hand, monoclonal antibodies can be produced more rapidly, and are selective, but their 
production is still costly and they are fragile to environmental fluctuations, such as temperature, 
pH, ionic strength, and cross-reactivity.   
 
We now turn our attention to bacteriophages, which are a key factor in microbial homeostasis on 
Earth, outnumbering their bacterial hosts tenfold. Throughout history, bacterial pathogens have 
developed multiple strategies to combat viruses, which were circumvented by phages’ ability to 
evolve and survive in adverse environments. Bacteriophages’ specificity to their bacterial hosts, 
robustness, low-cost and ease of production make them ideal recognition elements for bacterial 
biodetection purposes.  
 
Here we delineate the clinically relevant bacterial pathogens, of worldwide concern, that are 
targeted by today’s biodetection research and development efforts. We then describe 
bacteriophages, their mechanisms of action, and relevance in therapeutics and diagnostics. We 
finally review phage-based analytical and biosensing methods, notably phage-amplification, 
reporter phage, phage lysis, bioluminescence assays, as well as the novel optical, electrochemical 
and mass-sensitive biosensor technologies using bacteriophages as a recognition element.   
 
 
2.2. Clinically relevant bacterial pathogens 
 
Microorganisms are an intrinsic part of our environment, and play a fundamental role in human 
hemostasis. Problems arise when immunocompromised patients come into contact with certain 
pathogens that have developed resistance to antimicrobial agent in our health care system. The 
most predominant nosocomial agents are Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumanni, Pseudomonas aeruginosa, and Enterobacter 
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species, commonly known as “the ESKAPE bugs”[14]. In the following section, we briefly 
describe some of these bacteria, as well as other virulent bacteria that cause major problems in 
hospitals in the developed and developing countries. Most of these bacteria have been targeted in 
biosensing technologies depicted in this review. 
 
2.2.1. Staphylococcus aureus: the case of the golden killer bacterium 
 
S. aureus is a ubiquitous Gram-positive microorganism that colonizes the nasal passages and skin 
of approximately 50% of healthy individuals [15]. S. aureus can cause a broad spectrum of 
infections, ranging from common skin infections to sepsis.  It is the leading cause of nosocomial 
pneumonia, bloodstream infection, and infections caused by surgical wounds and prosthetic 
implants [16, 17]. S. aureus has quickly acquired resistance against β-lactam antibiotics by 
producing a specific penicillinase enzyme [18] encoded by a plasmid. This prompted the 
introduction, in 1959, of methicillin, a modified penicillin that was unaffected by the 
staphylococcal penicillinase [17]. Its success was, unfortunately, short-lived.  β-lactams, are 
substrate analogs of a penicillin-binding protein, which, as previously mentioned, catalyzes the 
formation of peptide crosslinks between glycan chains of the bacterial cell wall. This time, S. 
aureus acquired a mecA gene that encodes PBP2a , that confers a broad spectrum of resistance 
against methicillin, as well as all other β-lactams (i.e. synthetic penicillins, cephalosporins and 
carbapenems) [18]. Recently, strains resistant to glycopeptides, such as vancomycin, have 
immerged and acquired a vanA gene cluster [19]. These strains are very hard to detect and are 
often associated with therapeutic failure. MRSA has become an increasingly alarming problem, 
as it is no longer contained in hospital settings, but has emerged into the community, and is now 
pandemic. According the Centers for Disease Control and Prevention (CDC), more patients died 
from MRSA-related infections in the United States, in 2005 [20],  than did from acquired 
immunodeficiency syndrome (AIDS) complications [21]. 
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2.2.2. Y. Pestis: from ‘‘black death’’ to biological warfare 
 
Yersinia pestis is the causative organism of plague, which is often thought about as an ancient 
disease, but which is, to this day, endemic in parts of Asia, Africa, and America, causing a 
reported three thousand deaths annually [22]. Y. pestis is a Gram-negative bacterium of the 
Enterobacteriaceae family. It infects human macrophages, which are transported to draining 
lymph nodes. It becomes extracellular upon apoptosis of the infected host macrophage, 
colonizing major organs and causing systemic failure, leading to death [23]. The lack of proper 
diagnostic tools that can effectively and rapidly detect this pathogen has contributed to 
underreporting of cases and major shortcomings in case-management and surveillance [22].  
 
2.2.3.  E. coli O157:H7: an emerging lethal food-borne pathogen 
 
Enterohemorrhagic E. coli is a zoonotic life-threatening bacterium that was first described in 
1982, and leads to diarrhea, hemorrhagic colitis and hemolytic-uremic syndrome in humans. 
O157:H7 is a pathogenic subset of the Shiga toxin-producing E. coli (STEC) that is mainly 
transmitted by consumption of undercooked meat, unpasteurized dairy products, and produce 
contaminated with bovine faeces.  Detection and control of these pathogens represent a 
challenging problem, with regard to their high virulence and the extremely low infectious dose 
required to induce disease [24]. 
 
2.2.4. Salmonella: a non-negligible threat 
 
Salmonella bacterium colonize a broad spectrum of host organisms, efficiently infecting both 
animals and plants.  Among the Salmonella species, Salmonella enterica is the primary cause of 
food-borne poisoning in humans, contaminating a wide range of produce, such as pre-cut meats, 
poultry, eggs, vine vegetables, fruits, nuts, sprouts, leafy greens, roots and beans [25]. The CDC 
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reports that approximately 15% of United States citizens will become infected with food-borne 
pathogens, with salmonellosis ultimately responsible for the largest number of hospitalizations 
and related deaths [26].  
 
2.2.5. Listeria monocytogenes: an emerging pathogen 
 
L. monocytogenes is a Gram-positive rod responsible for listeriosis, a flu-like disease, 
gastroenteritis and fever in healthy individuals.  However, listeriosis can be deadly, with 
symptoms ranging from septicemia, meningitis or spontaneous abortion, in immune-
compromised patients, children, the elderly, and pregnant women [27]. Listeria is one of the 
leading emerging pathogens associated with food-borne diseases, with an estimated 1600 cases 
yearly in the United States[28]. 
 
2.2.6. M. tuberculosis: the modern ‘‘white plague’’  
 
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis, and is one of the most 
destructive bacterial diseases to afflict humans. The World Health Organization reports that 
approximately 33% of mankind is latently infected with TB, with 1.8 million annual deaths and 
9.8 new infections every year.  
 
Following the inhalation of the bacilli, the bacteria deposit in the lung alveolar space, and 
multiply in the alveolar macrophages.  They are then carried to the lymph nodes by dendritic cells 
(DCs), which undergo programmed cell death and release mycobacterial antigenic peptides.  
These antigens activate T-cells that will proliferate and become effector T cells, which go back to 
the lungs to fight the infection. This is followed by the generation of granuloma, that can 
ultimately contain the infection.  Many factors, such as a poor diet, immunosuppression, steroid 
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use, and HIV therapy, can reactivate the latent state of the infection and cause bacteria to become 
metabolically active and reactivate the disease.   
 
Drug-susceptible TB can be successfully treated by daily administrating a regimen of drugs to the 
patient, for an initial treatment phase of two months, followed by a continuation phase ranging 
from four to seven months [29]. However, major complications arose following the emergence of 
multidrug-resistant and extensively drug-resistant strains, around the world. As with MRSA, 
there are very few compounds in clinical development for anti-TB drugs; thus, fast detection 
becomes paramount for a better management of the disease. 
 
 
2.3. The potent bacteriophage 
 
Bacteriophages serve as the natural counterbalance to bacteria, and have become the most 
ubiquitous source of life on earth (1030 - 1032 phage species). They are commonly found in human 
intestines, having been consumed by humans via foods (e.g., ground beef, pork sausage, chicken, 
farmed freshwater fish, oil sardines, raw skim milk, cheese, and drinking water) [30], and are 
vastly distributed in our ecosystem.  
 
Modern phage research was initiated by Frederick W. Twort 1915 [30, 31] and carried on by 
Félix d’Herelle, in 1917 [32] who uncovered the phages’ natural ability to combat bacterial 
pathogens and prevent infections [33],[34],[35]. Bacteriophages are viruses that infect both Gram-
negative and -positive bacteria by using their pili as receptors. Phages are parasites that use their 
bacterial host machinery to direct their replication. Each phage particle is constituted of genomic 
material enclosed in a protein or lipoprotein coat, called a capsid [30].  Phages are subdivided in 
multiple genera, based on their morphology, nucleic acid homology, and serology, and two 
groups, based on their life cycles, replication, and propagation [36]. Lytic bacteriophages are 
virulent phages that specifically recognize and infect their host bacterium, use the bacterial 
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machinery to replicate its genome, produce and assemble their structural components, and 
ultimately lyse and kill the bacterium to release the newly assembled virions. 
 
Temperate phages differ from lytic phages as they are capable of of both lytic and lysogenic 
propagation. These phages have the capacity of incorporating their genomic material into 
bacterial chromosomes and assuming a quiescent state (prophage), which will allow both the 
bacterium and the prophage to co-exist for a period of time without lysis [36], shielding the host 
bacterium from further phagic infection, and introducing novel genetic material such as reistance 
genes and restriction systems [30]. 
 
Curently, phages are grouped in nineteen families, of which two possess an RNA genome and 
five are enveloped. Tailed phages of the order of the Caudovirales accounts for approximately 
95% of present-day isolated bacteriophages. The virions are constituted of an isocahedral head 
composed of repeating units of one or two proteins, which enclose the phage’s genomic double-
stranded DNA [30].  Tailed phages are grouped according to their morphology: phages 
possessing a long flexible tail belong to the Siphoviridae, while the Myoviridae comprise phages 
with contractile tails, and the Podovidrea being phages with very small non-contractile tail [30].   
 
Ten more families account for a vast variety of tailless phages which are polymorphic in shape, 
may have a lipid coat, differ in their genomic material with the nucleocapsid containing either 
ssDNA, dsDNA or RNA. Moreover, these phages can differ on the basis of their means of 
propagation, and by whether they are segmented or not [30].  The difference between tailed and 
tailless phages is of major importance for host recognition and adsorption. The interaction 
between the phage and the receptor of the bacteria is an on-and-off process, ultimately followed 
by the irreversible binding of the phage to its host [37].  Tailed-phages specifically recognize 
their bacterial hosts through the interaction of a single central fibre called adhesin, or a cluster of 
3,6 or 12 fibers found on their caudal extremity. These caudal proteins will recognise and adhere 
to specific epitopes on their host membrane and achieve irreversible binding through the 
interaction of a secondary tail protein to another bacterial membrane receptor. 
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Some types of bacteriophages, such as P22, have short tail fibers, called tail spike proteins, which 
recognize and bind the host bacteria. Furthermore, the phage tail often exhibits enzymatic activity 
capable of locally breaking down the cell wall. Filamentous phages, on the other hand, consist of 
a long structure made of repeating pVIII proteins.  The length of the phage is proportional to the 
number of nucleotides in its genome (there are 0.435 pVIII proteins per nucleotide, which 
corresponds to 0.1435 nm per nucleotide) [38]. Figure 2-1 shows a transmission electron 
microscope (TEM) photomicrograph of bacteriophages specifically interacting with a MRSA 
bacterium.   
 
 
 
 
Figure 2-1: TEM photomicrograph of bacteriophages adhering specifically to the MRSA 
bacterium 
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Bacteriophages’ specificity, ability to persist in a vast range of environmental conditions, and 
their ease of production in suitable hosts, make them a critical vehicle for the coevolution and 
horizontal gene transfer between different bacterial species[30]. Moreover, the many 
advantageous properties of bacteriophages make them an important tool for the diagnosis and the 
control (prevention and therapy) of bacterial diseases. 
 
The therapeutic potential of bacteriophages for the treatment of bacterial infections in humans 
was recognized in the early 1920s with the pioneering work of d’Herelle who successfully treated 
patients infected with the bubonic plague while stationed in Egypt, and patients suffering from 
cholera in India[30]. However, phage research came to a standstill with the advent of antibiotics 
and their mass-production during World War II. Recent interest in bacteriophages was brought 
about by the alarming incidence of multi-drug resistant pathogens. Today, the commercial and 
medical opportunities of phage-based products are vast owing to their beneficial properties. 
Characterization of novel phages targeting specific bacterial pathogens is achieved much faster 
and at a lesser cost than antibiotics. Moreover, bacteriophages’ specificity allow for a targeted 
action against host whit minimal effects on the otherwise desirable microbial flora, and target 
problematic bacterial states such as biofilms and persister cells[39, 40]. Phage’s ability of to 
distinguish between live and death cells aid in overcoming major limitations of routinely used 
techniques for microbial diagnostics such as PCR and hybridization-based assays.  Finally, 
bioengineered phages with novel functionalities [41, 42] and phage-functionalized nanoparticles 
[43] can be used for sensing as well as other relevant techniques, such as molecular imaging.  
2.4. Phage-based assays 
 
Since their discovery by Twort and d’Hérelle, bacteriophages have been extensively exploited to 
specifically target and identify bacteria. To this day, phage typing is used to differentiate between 
diverse strains of particular species of bacteria. Phage typing exploits phages’ ability to 
specifically recognize, infect, and ultimately lyse their host. However, characterization and 
epidemiological identification of bacteria, using this method, requires the maintenance of a large 
phage library, thus restricting its use to a limited number of reference laboratories. Therefore, 
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there is a paramount need for phage-based technologies that can be used for the detection of 
pathogenic bacteria in a clinical setting. Three main methods exploiting bacteriophages are used 
to detect clinically relevant bacterial pathogens: (1) bacterial amplification of phages followed by 
the detection of progeny phages, (2) detection of light produced by reporter phages or fluorescent 
reporter phages following infection of bacteria, and (3) detection of intracellular components 
following infection and lysis of the bacterial host.   
2.4.1. Phage amplification assays 
 
Lytic phage propagation consists of adhesion to the bacterial host, transfection and replication of 
the phage genome, followed by the assembly of the virion structural components. This 
culminates in the release of the progeny phages as a result of bacterial cell lysis. The increased 
number of phages in the solution can be used as a marker of the specific infection and and phage 
lytic propagation in a target bacterium. In the past, this technique has been hampered by the 
necessity of a large bacterial titer, as well as the cost and complexity of identifying the progeny 
phages with high-performance liquid chromatography (HPLC).  Novel advances in phage 
amplification assays have obviated the need for complicated instruments and require a low 
abundance of initial target pathogens. Phages are incubated with their target bacteria, and 
phagicidal reagent is added before lysis can occur to inactivate free phages. The virucide is then 
neutralized and helper cells, susceptible to be infected by the progeny phages, are added to the 
solution and plated onto a soft agar overlay. The phages are allowed to replicate within the 
previously infected bactrerial pathogens and can, in turn, infect the helper cells, resulting in the 
formation of lysis plaques. This technique has the advantages of being able to detect initially low 
concentrations of bacteria, as well as target bacteria in a heterogeneous bacterial sample. 
Diagnostic kits and novel assays based on phage amplification are available for M. tuberculosis 
[44-49], Staphylococcus aureus [50-52], and Yersinia Pestis [45, 53]. Table 2.1 lists phage-based 
amplification assays for the detection of a large number of bacterial species. Phage amplification 
assays, combined with the addition of antibiotics, can help distinguish between resistant and 
susceptible strains, such as antibiotic resistant M. tuberculosis [54-57] and MRSA [58]. 
Moreover, phage typing is often combined with other techniques, such as PCR [59, 60], mass 
spectrometry [51, 53] and competitive ELISA [61].  
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Table 2.1:Phage-based amplification assays for the detection of bacterial species  
 
Bacterial Species Phage Time of 
detection 
Sensitivity References 
E. coli O157:H7 LG1 23 h 2 CFU/25 g [62, 63] 
E. coli O157:H7 AR1 3.5 h 1 CFU/mL [63, 64] 
E. coli MS2 2 h  104 CFU/mL [65] 
Salmonella P22 4 h 104 CFU/g [66] 
Salmonella SJ2 20 h 3 CFU/25 g [62] 
Salmonella enterica SJ2 5 h 104 CFU/mL [67] 
Mycobacterium avium 
paratuberculosis 
D29 48 h 10 CFU/mL [68] 
M. tuberculosis D29 48 h 102 CFU/mL [68] 
Y. pestis ΦA1122 5 h 106 CFU/mL [69] 
Y. pestis ΦA1122 4 h 103 CFU/mL [69] 
Y. pestis L-413 C 4 h 105 CFU/mL [45] 
Pseudomonas aeruginosa NCIMB 10116 4 h 10 CFU/mL [50] 
Salmonella Felix-01 4 h  102 CFU/mL [50] 
 
S. aureus N-15 5 h 105 CFU/mL [51] 
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2.4.2. Reporter phage assays 
 
It is possible to engineer recombinant phages for pathogen detection.  This can be done by 
inserting the reporter gene into the target cell and monitoring the production of the protein 
encoded by the inserted genomic material.  The method of gene insertion into the phage varies 
considerably. Cloning can only be used with somewhat small phage genomes and is made 
difficult by the need of customized genetic manipulation, systems and nucleic acid packaging.  
An easier, more efficient and cost-effective method is the insertion of the reporter gene into the 
intergenic parts of the phage genome, resulting in multiple and diverse particles that can later be 
selected, depending on the desired properties. Cloning of the reporter phage into a plasmid is 
another method of insertion.  The introduction of a plasmid into a phage host will result into 
double-crossover homologous recombination between the plasmid and the phage DNA, and the 
introduction of the plasmid into the phage genome.  Again, the expression of the reporter gene in 
the host cell will result in a measurable signal.  The use of a reporter phage provides an economic 
and timesaving method of detection of pathogenic bacteria. A variety of reporter genes, such as 
firefly luciferase (Lux), green fluorescent protein (GFP), and yellow fluorescent protein 
(ZsYellow), have been incserted into non-coding regions of a phage and were subsequently used 
for bacterial detection (Table 2.2). 
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Table 2.2:Reporter phage assays for the detection of bacterial species  
 
Reporter 
gene 
Bacterial specie Phage Time of 
detection 
Sensitivity Refs 
luxI and luxR E. coli λ 10 h 1 CFU/mL [70] 
luxI and luxR E. coli O157:H7 PP01 22 h 1 CFU/mL [71] 
luxI and luxR E. coli O157:H7 PP01 6 h 1 CFU/mL [71] 
luxI and luxR E. coli O157:H7 PP01 12.5 h 1 CFU/mL [71] 
luxAB E. coli O157:H7 AR1 3 h 10 CFU/mL [64] 
luxAB Y. Pestis ΦA1122 30 min. 106 
CFU/mL 
[72] 
luxAB Salmonella enteritidis P22 24 h 63 CFU/mL [73] 
luxAB Salmonella 
Typhimurium 
P22 16 h 106 
CFU/mL 
[74] 
luxAB Salmonella enterica P22 6 h 10 CFU/mL [73] 
luxAB L. monocytogenes A511 20 h 1 CFU/g [75] 
luxAB Enteric bacteria Cocktail 5 h 10 cells/g [76] 
luxAB B. anthracis Wβ 1 h 103 
CFU/mL 
[72] 
lacZ E. coli T4 8 h 10 CFU/mL [77] 
inaW Salmonella P22 2 h 10 CFU/mL [78] 
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luc M. tuberculosis phAE142 1-2 weeks 103 
CFU/mL 
[79] 
luc M. tuberculosis Che/phAETRC16 24 h 108 
CFU/mL 
[80] 
GFP E. coli IP008e-/2xGFP 6 h Not 
reported 
[81] 
GFP E. coli λ 6 h 102 
CFU/mL 
[82] 
GFP M. tuberculosis TM4 4 h 100 cells [83] 
 
2.4.3. Phage lysis assays 
The lytic propagation of bacteriophages results in the lysis and the release of bacterial 
intracellular components, as well as the liberation of progeny virions into the extracellular 
environment. Phages’ lytic properties are attributed to two phagic proteins implicated in the 
break-down of the bacterial cell wall.   The first functions as a holing protein, forming small 
pores in the bacterial cytoplasmic membrane, while the second protein, an endolysin, degrades 
peptidoglycans, resulting in the release of a multiple intracellular markers that can be easily 
detected [84]. Table 2.3 lists phage-mediated cell lysis assays. The most popular method is the 
measurement of bacterial intracellular adenosine triphosphate (ATP).  The amount of ATP 
metabolized by a bacterium declines quickly following cell death. The firefly luciferase/luciferin 
enzyme system allow for the detection and enumeriation of viable bacterial cells by sensing 
intracellular ATP [85]. The enzyme system allows for the production of light that can be measured 
by a small hand-held luminometers and is directly proportional to the quantity of ATP in the 
assay.  However, this system is limited by the fact that detection of specific pathogens is not 
possible.  The specificity can only be achieved by specific cell lysis, which can be accomplished 
by phages [84]. Therefore, pathogen-specific phages and ADP are added to the sample, where the 
phage will only infect the target bacteria and not interact with other microorganisms that may be 
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present in the sample. The sensitivity of this assay can be improved by measuring the amount of 
released adenylate kinase (AK). Similarly, intracellular AK will be released after phage lysis. 
When ADP is present in excess, the equilibrium of the reaction shifts toward the creation of ATP, 
and the overall quantity of fluorescent light emitted from a firefly luciferase will be proportional 
to the number of viable cells in the sample.  Table 2.4 lists bioluminescence assays, including 
those utilizing AK. So as to further improve the sensitivity of the assay, AK is combined with an 
immunomagnetic separation (IMS) step, where the pathogens of interest can be captured on 
antibody-coated magnetic beads [84].  Another method for the identification and quantification of 
bacterial pathogens relies on the amperometric detection of enzymatic activity induced by 
intracellular bacterial enzymes liberated following phage-induced lysis. Betagalactosidase and 
endolysins can also be monitored. 
 
Table 2.3: Phage-mediated cell lysis assays for the detection of bacterial species  
 
Bacterial Specie Phage Time of detection Sensitivity Refs 
E. coli O157:H7 CSLO157 10 h 10 cells/25 g [86] 
E. coli PhiX174 2 h  105 cfu/mL [87] 
E. coli NCIMB 10359 1 h 104 cfu/mL [88] 
E. coli AT-20 2 h  103 cfu/mL [89] 
E. coli T4 2 h 103 cfu/mL [90] 
E. coli λ 6 h 102 cfu/mL [91] 
B. cereus B1-7064 8 h 10 CFU/mL [92] 
Salmonella SJ2 2 h  103 cfu/mL [89] 
Salmonella newport Felix-01 and Newport 2 h 104 cfu/mL [88] 
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Table 2.4:Bioluminescence assays for the detection of bacterial species 
 
 
Assay type Bacterial specie Phage Time of 
detection 
Sensitivity Refs 
Adenylate kinase 
assay 
E. coli E. coli phage 1h 103 cfu/mL [88] 
YOYO-1 fluorescent 
dye 
E. coli O157:H7 LG1 6 h 2 CFU/g [63] 
DAPI fluorescent dye E. coli T4 6 h Not 
reported 
[93] 
Adenylate kinase 
assay 
Salmonella 
Newport 
Newport 
phage 
2h 103 cfu/mL [88] 
Adenylate kinase 
assay 
Salmonella 
enteritidis  
SJ2 2h 103 cfu/mL [89] 
Adenylate kinase 
assay 
E. coli G2-2 AT20 2h 103 cfu/mL [89] 
Bioluminescent 
phage 
Bacillus anthracis Wβ:luxAB 60 min 103 cfu/mL [72] 
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2.5. Phage-based biosensors 
 
Recent years have seen the increased use of biosensors as a novel method for pathogen detection. 
These new systems are designed to overcome the many limitations of conventional detection 
platforms, such as reverse transcriptase PCR (RT-PCR) and enzyme-linked immunosorbent 
assays (ELISA).  Although RT-PCR and ELISA are popular, and prove effective in detecting the 
presence of pathogens, they still require an enrichment step prior to analysis, as well as highly 
trained personnel. On the other hand, biosensors are selective, sensitive, cost-effective, rapid and 
portable alternatives to conventional analytical methods. Various recognition elements, such as 
nucleic acids and antibodies, can be used in pathogen detection.  There are, however, very few 
biosensing technologies using bacteriophages in the clinical, agro-food or environmental fields.  
The lack of attention paid to phages may result from the misconception that their study is too 
specialized an undertaking for most engineering laboratories. However, viral diversity and 
novelty are astounding, and including them in sensing platforms has several benefits. Here we 
outline the basic principles and recent advances in biosensing technologies using optical, 
electrochemical and mass monitoring for phage-based diagnostics. 
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Figure 2-2: Schematic representation of phage-based biosensing techniques for the detection of 
bacterial pathogens using (a) optical, (b) electrochemical, and (c) mass monitoring techniques. 
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2.5.1. Optical biosensors 
 
Optical biosensors have been extensively investigated as a means of detecting pathogens, due to 
their well-known selectivity and sensitivity. Of the various optical techniques used for the 
detection of pathogens, surface plasmon resonance and evanescent field optical fiber systems 
dominate the industry (e.g. Biacore, Biosensing Instruments, Inc. and Research International). 
 
 
2.5.1.1. Surface plasmon resonance biosensors 
 
Surface plasmon resonance (SPR) is a method that can be suitably modified for bacterial 
detection, as it is designed for the real-time monitoring of all dynamic processes, without labeling 
and complex sample preparation.  Therefore, adsorption rate, association and dissociation 
kinetics, as well as affinity constants and ligand interactions, can be easily and rapidly examined 
[94].   
 
In 1902, Wood observed slender, dark bands when illuminating a metallic diffraction grating 
with polychromatic light, which he called anomalies [95].   Later, Fano came to the conclusion 
that the excitation of electromagnetic surface waves on the diffraction grating caused these 
anomalies [96]. Moreover, while illuminating thin metal films on a substrate in 1958, Turbadar 
noticed a decrease in reflectivity [97].  A decade later, Otto explained these results and 
demonstrated that this drop in reflectivity is due to the excitation of surface plasmons observed in 
attenuated total reflection (ATR) [98].  This phenomena was also reported the same year by 
Kretschmann and Raether, while using another ATR configuration[99]. 
 
A surface plasmon is a specific mode of the electromagnetic field (i.e. a longitudinal charge 
density wave) that propagates at the interface between a metal and a dielectric [100]. Surface 
  
32 
plasmons are characterized by a field distribution and a complex propagating constant which is 
highly sensitive to changes in the refractive index distribution [100]. It is important to use the 
right kind of metal, as this metal must fulfill certain requirements.  The metal of choice must 
exhibit free electron behavior:  the metal must follow the free electron model and its permittivity 
component, in the visible and near infrared regions of the spectrum, must be negative [100].  This 
is due to the fact that a surface plasmon exists at the metal-dielectric interface only at 
wavelengths longer than a certain critical wavelength.  This critical wavelength is contingent on 
the plasma frequency, and is specific to the metal. Metals, such as gold, silver and aluminum, are 
all suited for surface plasmon resonance because their critical wavelengths lie in the UV or 
visible region of the spectrum. Gold is one metal of choice because of its stability, and silver, 
because it provides a sharp SPR resonance peak.  
 
Surface plasmons are excited by light waves, using 1) prism coupling and attenuated total 
reflection, 2) diffraction on a metal diffraction grating, and 3) coupling among parallel optical 
waveguides [100].  
 
An SPR optical sensor generally comprises an optical system, a transducing medium and an 
electronic system permitting data processing. Analysis is performed by capturing a recognition 
element on the sensor surface, and by injecting the analyte over the sensor surface.  A measurable 
signal will be generated in the event of analyte binding to the immobilized ligand on the sensor 
surface, resulting from a refractive index change in the evanescent field, shifting the SPR angle. 
Figure 2-2 is a schematic representation of the SPR direct detection of captured bacteria, via 
immobilized bacteriophages, on a gold sensing platform. 
 
Current instruments have a detection limit of 10-7 refractive index units (RIU), corresponding to 
0.1 pg mm-2 of molecules gathering on the sensor surface [101]. When applied to pathogen 
detection, the current detection limit is about 105 CFU/mL for Listeria monocytogenes [102], E. 
coli O157:H7[103], Campylobacter jejuni [103], S. typhimirium [103], and S. aureus [104], using 
different recognition elements.  Balasubramanian et al. showed that it was possible to specifically 
detect Staphylococcus aureus, using a Spreeta biosensor, by physically adsorbing bacteriophages 
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on the gold surface.  However, the surface coverage of the platform by bacteriophages did not 
have a significant effect on the sensitivity of detection [105].  The authors assumed that the non-
favorable orientation of the phages resulted in blocking the bacterial adhesion sites.  Moreover, 
their results showed that it was difficult to detect bacteria in solution, due to the size of the 
bacterium cell (0.5-1µm).  Because the evanescent wave of the SPR is limited to 300 nm in the z-
direction, only a portion of the bacterium will generate a response by interfering with the 
evanescent wave. Improving immobilization strategies and phage recognition elements allowed 
for a more sensitive approach (i.e. detection limit ranging from 102-103 CFU/mL) for the 
detection of S. aureus [3, 106, 107] and E. coli [3]. Table 2.5 compiles recent advances in phage-
based SPR detection of pathogens. 
 
Table 2.5:Phage-based SPR assays for the detection of bacterial species 
 
Species Phage Time of detection Sensitivity Refs. 
E. coli K12 T4 20 min. 7 x 102 cfu/mL [108] 
E. coli K12 T4 15 min. 103 cfu/mL [3] 
MRSA BP14 15min. 103 cfu/mL [3] 
Salmonella P22 phage TSP 30 min. 103 cfu/mL [109] 
C. jejuni Phage NTC 12673 TSP 25 min. 102 cfu/mL [110] 
S. aureus Phage 12600 40 min. 104 cfu/mL [111] 
S. aureus Phage 12600 10 min.  106 cfu/mL [112] 
L. monocytogenes Phage Lm P4:A8 2 h 106 cfu/mL [113] 
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2.5.1.2. Fiber optic biosensors 
 
As with SPR biosensors, fiber optic sensors react to changes in the evanescent field due to 
modifications of the refractive index at the sensor surface following analyte binding. [114]. In 
general, fiber-optic sensors utilize lasers to generate evanescent waves that excite fluorescently 
labeled pathogens present on the surface of the waveguide [115].  This generates fluorescent 
signals that can be detected in real time.  Fluorescein isothiocyanate (FITC) is the most 
consistently used fluorescent marker.  Fiber optic sensors can be couple to PCR and ELISA 
assays for the detection of multiple pathogens, such as staphylococcal enterotoxin type-B (SEB), 
Francisella tularensis LVS, Bacillus anthracis Sterne, ricin, Yersinia pestis F1 antigen, MS2 
bacteriophage, cholera toxin, and Salmonella typhimurium [116].  Phage-based fiber optic 
sensors have been reported in the literature [117-119] (Table 2.6).  
 
Table 2.6:Fiber optic assays for the detection of bacterial species 
 
Species Phage Time of detection Sensitivity Refs. 
E. coli T4 25 min.  104 CFU/mL [117] 
E. coli T4 20 min. 108 CFU/mL [118] 
E. coli T4 20 min. 103 CFU/mL [119] 
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2.5.2. Electrochemical biosensors 
 
Electrochemical sensors measure the changes in current or in potential due to interactions 
occurring at the electrode/matrix interface. Significant advantages of these types of sensors, such 
as their potential for miniaturization, their compatibility with turbid media and their simplicity, 
have rendered them very popular in research laboratories. Electrochemical sensors are classified 
with regard to the transducer used, and can thus be amperometric, potentiometric, or 
impedimetric. Phage-based electrochemical biosensing of bacterial pathogens are found in Table 
2.7. 
 
 
2.5.2.1. Amperometric sensors 
 
Amperometric biosensors are composed of a reference electrode, and a working electrode that 
measure changes in current generated by either enzyme-catalyzed redox reactions or bioaffinity 
reactions between the analyte and the recognition element. This current change will dependent on 
the ionic concentration of the surrounding medium.  Moreover, signal amplification can be 
achieved by an enzyme complex that catalyzes an electoactive  product that will, in turn, enhance 
the detected current. Applications, for amperometric sensors used for the detection of various 
pathogens, have been reported in the literature [120]. Amperometric sensors integrating phages 
have been reported to successfully detect bacterial species [91, 121, 122], based on the principle 
that bacterial lysis, induced by phage infection, leads to the release of bacterial cell contents, such 
as enzymes, intracellular adenosine triphosphate (ATP), or β-D-galactosidase, into the 
surrounding medium, which can then be measured, using a specific substrate. ATP is the most 
common marker, and can be measured with a firefly luciferase-based bioluminescent assay[73, 
74].  
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Table 2.7:Phage-based electrochemical biosensing for the detection of bacterial species 
 
Transducer Species Phage Time of detection Sensitivity Refs. 
Amperometric E. coli EK12 λ 6 h  103 CFU/mL [91] 
 E. coli T4 5 h 104 CFU/mL [121] 
 E. coli M13K07 3h 1 CFU/mL [122] 
 B. cereus B1-7064 8 h  10 CFU/mL [92] 
 L. monocytogenes Listeria scFvs 5 min. 500 CFU/mL [123] 
 
 M. smegmatis D29 8 h 10 CFU/mL [92] 
Impedimetric E. coli EK12 T4 20 min  104 CFU/mL [124] 
 E. coli T4 6 h 104 CFU/mL [125] 
 E. coli T4 30 min. 104 CFU/mL [126] 
 S. Newport GIII 2 h  103 CFU/mL [127] 
 
2.5.2.2.Potentiometric sensors 
 
Phage-based potentiometric sensors have found limited use in applications concerning pathogen 
detection [128]. These sensors usually consist of a selective outer layer and a bioactive element 
that will catalyze reactions to either generate or consume chemical species [114]. Pathogen 
detection is possible through the detection of pH or ionic fluctuations.  
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2.5.2.3. Impedimetric sensors 
 
Impedimetric sensors are based on electrical impedence spectroscopy (EIS), where low voltage is 
applied to an electrochemical cell at various frequencies.  The resulting impedance is determined 
by measuring the current. The rationality behind phage-based EIS is that bacterial growth will 
result in a change of the composition of the medium, i.e., the transformation of uncharged 
metabolites, such as carbohydrates, into charged products, mainly acids, causing an increase in 
medium conductivity. The lysis of host bacteria by phages reduces microbial growth.  The 
conductances of phage-treated and untreated samples are then compared. Limitations of direct 
impedimetric detection include the necessity of optimizing the medium for electrical 
measurements, as well as selecting microorganisms that produce sufficient amounts  of ionized 
metabolites to permit their detection [129]. Successful phage-base impedimetric detections of E. 
coli, MRSA and Salmonella have been reported in the literature [124, 126, 130-132]. 
 
2.5.3. Phage-based mass biosensors 
2.5.3.1.Acoustic wave biosensors 
Acoustic wave biosensors are mass-sensitive detectors, using quartz-crystal resonators.  These 
oscillating crystals resonate at a frequency that depends on their geometry.  There is a direct 
relationship between the mass adsorbed on the surface of the crystal and its resonant frequency in 
air. Most acoustic biosensors use piezoelectric transducers that generate and transmit acoustic 
waves with a vibrating crystal, which resonates in a frequency-dependent manner. Of the acoustic 
wave sensors using a piezoelectric transducer, the quartz crystal microbalance (QCM) is largely 
used for pathogen detection. Applying an electrical field to electrodes situated on each side of the 
crystal creates a potential difference across the two sides.  This produces a mechanical oscillation 
with a  characteristic vibrational frequency, and is sensitive to mass. Olsen et al. reported the 
detection of Salmonella typhimurium, using specific bacteriophage, with a detection limit of 102 
CFU/mL[133]. 
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2.5.3.2.Magnetoelastic sensors  
 
Magnetoelastic sensors are composed of a magneto-restrictive material that contracts or lengthens 
when exposed to an external magnetic field. The resonant frequency is dependent on the mass 
bound to the surface of the resonator. The phage-based detection of Salmonella typhimurium and 
Bacillus anthracis has been reported with a detection limit in the range of 103 CFU/mL[134-144] 
(Table 2.8).  
Table 2.8:Phage-based magnetoelastic biosensing for the detection of bacterial species 
 
Species Phage Time of 
detection 
Sensitivity Refs. 
B. anthracis  JRB-7 30 min. 103 CFU/mL [144] 
B. anthracis Filamentous landscape 
phage 
1 h 1 cell per spore [138] 
B. anthracis JRB-7 2 h 104 CFU/mL [134] 
S. typhimurium Filamentous phage 20 min. 103 CFU/mL [139] 
S. typhimurium JRB-7 30 min. 103 CFU/mL [145] 
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2.6. Concluding remarks  
 
Novel diagnostic technologies are of primordial importance for the control of drug-resistant 
pathogens. Rapid, specific, and sensitive sensors should aim at facilitating the diagnosis and 
enabling an accurate and efficient decision-making in individual point-of-care settings. The 
selectivity, specificity, robustness, and low production cost of phages make them ideal 
recognition elements for bacterial detection. However, despite efforts in commercializing phage-
based diagnostic devices, traditional microbiological methods remain the gold standard for 
diagnosis in a clinical setting. Although vast efforts have reduced identification times from days 
to hours when using modern molecular techniques, such as PCR, most assays still require an 
amplification period to increase the bacterial load of the specimen to be tested. There is, 
therefore, a requirement for biosensing technologies with sensitivities allowing for the detection 
of concentrations below 102 CFU/mL. Moreover, future research efforts should be aimed at 
detecting bacteria within complex matrices, in order to effectively move phage diagnostics from 
the laboratory to the clinic. 
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CHAPTER 3 .ARTICLE 2: SURFACE PLASMON RESONANCE 
DETERMINATION OF THE BINDING MECHANISMS OF L-
CYSTEINE AND MERCAPTOUNDECANOIC ACID ON GOLD 
 
The high selectivity of biological sensing elements, such as antibodies or bacteriophages is 
exploited in biosensors by capturing the biomolecule on the surface of the transducer. As a 
consequence, immobilization strategies are of paramount importance for the preservation of the 
biomolecule’s biological activity. The strategies used typically involve the adhesion of SAMs of 
thiolated molecules to a gold surface. Although the physical and structural characterizations of 
alkanethiol SAMs have been extensively reviewed, little is known about their real time 
adsorption kinetics.  Moreover, insufficient information exists about the assembly of amino acids, 
such as L-cysteine, on gold.  
In this article, SPR was used to study the formation of SAMS of L-cysteine and MUA on gold.  
Comparative details of the kinetics of assembly of both molecules are provided, and numerical 
models are introduced to describe their adhesion at lower and higher concentrations.  
Understanding the differences in the adlayer formation of L-cysteine and MUA on gold is an 
important issue for biosensing purposes, and paves the way for a more effective immobilization 
strategy for bacteriophages on gold. Figure 3-1 depicts L-cysteine and 11-MUA structures 
 
a)    b) 
 
Figure 3-1: Schematic representation of (a) L-cysteine, and (b) 11-MUA 
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3.1 Abstract 
Surface plasmon resonance was used for the real-time monitoring of the formation of self-
assembled monolayers of L-cysteine and 11-mercaptoundecanoic acid (MUA) on gold 
surfaces. We provide comparative details on the kinetics of the assembly of short thiols 
with multiple functional groups, as opposed to longer alkanethiols with fewer functional 
groups. Our results indicate that the adsorption of L-cysteine is a rapid process, involving 
both amino- and thiol-Au interactions, followed by the exchange of amino-Au to thiol-Au 
species and the physisorption of a second cysteine layer. The formation of MUA is also 
rapid, followed by a slower structural rearrangement of the monolayer. We find that 
monolayer formation, for both L-cysteine and MUA, is described by the Langmuir 
isotherm at low concentrations only. Numerical models are introduced to describe the 
assembly of both higher and lower concentrations of thiolated molecules on gold.   
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3.2 Introduction 
 
The attachment of molecules to a support, resulting in their immobilization, has found multiple 
applications in industrial chemistry and biosensing devices. Self-assembled monolayers (SAMs), 
composed of chemisorbed species, play a fundamental role in altering the interfacial properties of 
metals, polymers and semiconductors. Notably, the affinity of thiols for gold permits the 
generation of well-defined surfaces with various desirable chemical functionalities and optical 
properties. Currently, thiols are the most utilized form of organic thin-film material. 
The physical and structural characterizations of SAMs have been extensively reviewed in the 
literature[146, 147]. However, despite considerable efforts to study their formation on gold, little 
is known about their real-time adsorption kinetics[148]. Although the chemistry appears to be 
straightforward, the details of the assembly at the interface are still approximated qualitatively by 
a Langmuir absorption model[149]. Originally, SAM formation was thought to occur by the 
activation of the S-H bond at the surface[146]. Alternative interpretations, such as a two-stage 
adsorption process for longer chains, have been reported, where the surface coverage reaches 
60%-90% of its maximum in the first few minutes, followed by a slower period of several hours, 
before which maximum coverage is attained[150, 151].  Some authors have shown that the 
dynamics of this adsorption follows a simple Langmuir rate model[152], whereas others have 
shown that a diffusion-controlled Langmuir model is a better fit at low concentrations[153]. Such 
contradictory results could, in part, be attributed to one or more of several sources, such as the 
presence of contaminants on the gold surface, the effects of the concentrations of solvent and 
thiol, and the sensitivity of the method used[152]. Previous studies, using atomic force 
microscopy[154], ellipsometry[155, 156] and contact angle measurements[157], were limited in 
time resolution,  which is why we chose to use surface plasmon resonance (SPR), making real-
time adsorption analysis possible. This article describes the real-time formation of SAMs of L-
cysteine and 11-mercaptoundecanoic acid (MUA) at different concentrations, on a gold sensor 
platform using SPR and evaluation by numerical methods. Our purpose, in carrying out these 
measurements with both L-cysteine and MUA, was to compare the binding characteristics of both 
molecules and establish each molecule’s validity and applicability as a linker element for use in 
biosensing.  
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3.3 Experimental Section 
3.3.1 Preparation of Au surfaces  
Biacore Platypus biosensor chips, to be described below, were used as the gold surface. Prior to 
modification, they were placed in freshly prepared “Piranha” solution, a 7:3 mixture of 
concentrated H2SO4 and 30% H2O2 (Caution: piranha solution reacts vigorously with organics 
and can splatter), at room temperature for 30 min, then rinsed thoroughly with MilliQ water 
(Millipore, Mississauga, Ont.), ultrasonicated in water for 15 min, and dried in a  nitrogen flow.  
3.3.2 Chemicals 
L-cysteine, MUA, sodium chloride, magnesium sulfate and phosphate buffered saline (PBS) were 
purchased from Sigma-Aldrich.  
3.3.3 Surface plasmon resonance apparatus 
Superluminescent light-emitting diode (SLED), emitting at 650 nm, was used as the light source. 
An achromatic lens produced a collimated beam, which passed through a polarizer. The linearly 
p-polarized light was focused by a lens and then used to excite surface plasmons on the sensing 
surface, situated on top of a coupling prism. A commercial sensing surface (Platypus 
Technologies), consisting of a glass microscope slide (BK7) covered by an adhesion layer of 5 
nm of titanium and a sensing layer of 50 nm of gold, was placed in oil immersion contact 
(Cargille Laboratories) on the top of the coupling prism. For the real-time tests, a flow injection 
double channel-measuring cell, with a 12 µL volume, was developed. The entire system was 
placed on a goniometer stage, with 2-D linear translation for exact beam angle and position, 
permitting surface plasmon excitation at the gold/adjacent medium interface. The spatial 
distribution of the reflected light intensity was recorded by a CCD camera (Hamamatsu C4742-
95), and examined by an appropriate software image treatment. A more detailed description of 
the system can be found in reference [3]. 
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3.3.4 SPR detection L-cysteine and MUA adsorption to gold 
 
 The cleaned gold slides were placed on the SPR coupling prism, using a refractive index-
matching immersion liquid (Cargille Laboratories). Prior to L-cysteine injection, MilliQ water 
was injected at a flow rate of 111 µL/min, controlled by a peristaltic pump, to obtain a baseline. 
Solutions of different concentrations of L-cysteine in MilliQ water were subsequently pumped 
into the SPR apparatus at the same flow rate. This was followed by a washing step with MilliQ 
water.  
In the case of water-insoluble MUA, ethanol was first injected onto the chip, followed by 
injection of different concentrations of freshly prepared solutions of MUA in ethanol, and ethanol 
was used for the washing step.   
 
3.4 Results and Discussion 
3.4.1 L-Cysteine 
 
Planar gold was used to characterize the attachment of L-cysteine and MUA, because of the ease 
of preparation of such substrates and their compatibility with surface plasmon resonance 
spectroscopy.  
L-Cysteine is a neutral amino acid with hydrophilic properties. It is reported to bind to gold via its 
thiol group. However, it has two other terminal groups that are chemically active, -NH2 and -
COOH, which, depending on the pH, may play a role in the formation and organization of the 
monolayer. 
The Langmuir adsorption isotherm is based on the fraction of available sites that have already 
reacted. Thus, the rate of adsorption is expected to follow Langmuir adsorption kinetics 
          (1) Θ−Θ−=Θ da kckdt
d )1(
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where Θ is the fraction of the gold surface that is covered, (1-Θ) is the uncovered fraction, ka is 
the association constant, kd is the dissociation constant, and c is the concentration of the thiol 
solution.  
We have examined L-cysteine adsorption kinetics at several concentrations. The raw data are a 
direct result of the refractive index change induced by L-cysteine adsorption onto the gold 
surface.  
 
 
Figure 3-2: Relationship between physisorption and chemisorption of L-cysteine on gold. A 
baseline was created by flowing MilliQ water for 10 min over the sensor surface. Following this, 
a solution of 1 mg of L-cysteine per mL of MilliQ water was injected for varying periods of time 
(10, 20, 30 and 60 min), each followed by a washing step of 10 min duration. The first 30 min 
shows a negative slope, whereas there is a positive shift of the plasmon response within 30 min 
after the initial injection of L-cysteine.  The physisorption and chemisorption components 
responsible for the plasmon shift reach equilibrium 30 min after L-cysteine injection. 
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Figure 3-2 provides insight into the relationship among physisorption, chemisorption, 
concentration and time. In this experiment, MilliQ water was first injected for 10 min, to create a 
baseline, after which 1 mg/mL of L-cysteine was injected for a period of 10 min, followed by a 
10 min washing step.  The same solution of L-cysteine was further injected for longer periods of 
time (20, 30 and 60 min), each separated by a washing step of 10 min to remove the loosely 
bound, physisorbed L-cysteine molecules. Our results show that the slope is negative for the first 
30 min, but goes from negative to positive over a longer time period (between 30 and 180 min).  
The equilibrium between chemisorption (SPR signal following washing) and physisorption (SPR 
signal after further injection of 1mg/mL of L-cysteine) is attained in > 30 minutes after initial 
injection, as is shown by the identical slopes of both signals.  Moreover, it can be seen that the 
rearrangement of the adsorbed thiol is a very slow process, taking hours. Because the strength of 
the -SH chemisorption bond is large (125-167 kJ/mol)[158, 159], any desorption of the adsorbed 
thiol is assumed to be negligible.  This leads us to believe that the loss of plasmon response units, 
on washing, is due to the removal of a second, loosely bound layer. This is corroborated by other 
studies, showing the prevalence of a double layer configuration of L-cysteine[160]. Moreover, in 
an XPS study on self-assembled films, Cavaleleri et al. reported that for L-cysteine a physisorbed 
layer forms on top of the chemisorbed monolayer and that the analysis of the N1s spectrum 
indicated the prevalence of a zwitterionic state[161].  It has also been reported that molecules 
tend to adopt conformations that allow high degrees of van der Walls interactions and hydrogen 
bonding to minimize the free energy of the organic layer[162, 163]. The washing away of 
physisorbed L-cysteine molecules, electrostatically attached to the chemisorbed monolayer, 
appears to explain the loss of surface plasmon response after the washing step. This is supported 
by Abraham et al., where solid-state NMR spectroscopy showed that cysteine adsorbs to gold via 
the formation of a two-layer boundary, in which a second layer of L-cysteine molecules interact 
with the cysteine molecules chemisorbed on gold through hydrogen bonding between the charged 
groups of the zwitterions[164]. 
 Moreover, because physi- and chemisorption quickly reach equilibrium, we conclude that 
reaching a steady state condition is a consequence of the ordering and rearrangement of the 
monolayer chains alone. 
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Figure 3-3: SPR sensogram of the adsorption of different concentrations of L-cysteine on gold.  
A baseline was created by injecting MilliQ water on the sensor surface for a period of 10 min.  
This was followed by the injection of different concentrations of L-cysteine (0.001, 0.01 and 0.1 
mg/mL).  Subsequently, a washing step was performed, in which MilliQ water was injected on 
the sensor surface for another 10 min. 
 
 
Figure 3-3 shows the real-time adsorption of several concentrations of L-cysteine on gold at 
295K.  Lower concentrations of L-cysteine (0.001 and 0.01 mg/mL) appear to follow simple 
Langmuir adsorption kinetics while the higher concentration (0.1 mg/mL) does not. From the 
SPR data for lower concentrations, we determine the kinetic parameters using equation 1, ka = 
3.87 L mol-1 s-1 and kd = 0.00266 s-1, making Keq = 1.455 x 103 L mol-1 and ΔGads = -17.9 kJ mol-1 
. Thus, desorption does not play an important role in the formation of the chemisorbed layer and 
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that most of the adsorption sites on the surface are occupied. Because mass transfer is central to 
exploring biochemical reactions in a surface-based detection system, we wish to ensure that the 
SPR signal is indeed reaction-limited; that is, the diffusion time of the analyte to the surface is 
much smaller than the binding time.  To verify this property, we use the expressions for the 
convective/diffusive length, ζ=LWD/Qh, and the Damköler number, Da=kaCs0d(h)/D, for a first-
order surface reaction;  L is the length of the reactive zone, W is the channel width, D is the 
diffusivity of the analyte, Q is the flow rate, and d(h) =h*ζ1/3  is the characteristic thickness of the 
diffusive boundary layer as a function of channel height. Cs0, the initial surface concentration of 
binding sites, was found to be of a typical densely packed thiol monolayer (~7.47 x 10-6 
mol/m2)[163]. We find that for both L-cysteine and MUA ζ<<1 (~10-5), suggesting that mass 
transfer occurs through a thin boundary layer of characteristic thickness d ≈ 1 µm, greatly 
speeding up diffusion. Furthermore, the Damköler number is of the order of 10-3, indicating that 
the transport is limited by the process on the surface and that a constant concentration profile can 
be expected across the channel[165]. Therefore, the diffusive effects are negligible.  
 
 
Figure 3-4 models the adsorption of L-cysteine on gold. The rapid response in the first few 
minutes is attributed to the chemisorption of the L-cysteine via both amine and thiol groups.  The 
subsequent negative slope is attributed to the reorientation of that fraction of the L-cysteine, 
initially adsorbed via its amine end, to a more stable Au-S bound species.  This is in agreement 
with Kuhnle et al. [166], where L-cysteine is shown to be bound by both sulphur-gold and amino-
gold bonds. L-Cysteine molecules can exist in either neutral or zwitterionic forms, depending on 
the pH of the solution. It is believed that at low coverage, the neutral form of L-cysteine is present 
simultaneously with zwitterionic form, whereas the zwitterionic form is dominant at monolayer 
coverage and beyond[161, 167, 168] .  Furthermore, because the L-cysteine solution has a pH of 
4.7, its amine is protonated (NH3+)[169], enabling an additional layer[170], physisorbed by 
electrostatic interactions to the chemisorbed layer. We present a simulation in Figure 3-4b,c that 
qualitatively shows the interaction. The binding kinetics of a surface-immobilized ligand to 
capture an analyte in solution, including the second layer formation, is modeled as a four-step 
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reaction.   For L-cysteine, the net reaction rates of the different concentrations follow Langmuir 
adsorption kinetics, as indicated by the set of equations: 
 
                            (2-a) 
                                                (2-b) 
                                                   (2-c) 
                                                       (2-d) 
For simplicity, we have normalized all terms by a constant, having units of min-1; that is, τ=K0t.  
[L] and [A] represent, respectively, the concentrations of surface ligands and analytes in bulk 
solution. [LA1], [LA2], and [LA2A] represent, respectively, the surface densities of adsorbed 
analyte molecules via thiol group, amine group and second-layer. [A] is assumed to be constant 
with time, whereas [L] is depleted, due to the binding reaction. Φ is the unreacted fraction of the 
gold surface after the reorientation of L-cysteine molecules, (1-Φ) is the reacted fraction, Kai (i=1, 
2, 3) is the normalized association constant, Kdi (i=1, 2, 3) is the normalized dissociation 
constant, and Kr is the normalized reorientation constant. The initial conditions at time t = 0 are 
[L] = 10 and [LA1] = [LA2] = [LA2A] = 0.  In these equations, the positive and negative terms 
show the formation and breaking, respectively, of the ligands and complexes in the system. For 
example, in eq 2-a, the first and second terms represent the breaking of the ligands for a constant 
value of analyte concentration, which leads to the formation of the [LA1] and [LA2] complexes. 
The third and the forth terms represent the formation of ligands by dissociation of the [LA1] and 
[LA2] complexes. Finally, the fifth term represents the formation of ligand by reorientation of the 
[LA2]  complex.    We used a numerical solver, available in the Maple software package 
(Maplesoft, a division of Waterloo Maple, 2012) to solve the coupled differential equation 
system. 
d L[ ]
dτ = −Ka1 A[ ] L[ ]−Ka2 A[ ] L[ ]+Kd1 LA1[ ]+Kd2 LA2[ ]+ΦKr LA2[ ]
d LA1[ ]
dτ = Ka1 A[ ] L[ ]−Kd1 LA1[ ]+ 1−Φ( )Kr LA2[ ]
[ ] [ ][ ] [ ] [ ]22222 LAKLAKLAKd
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rda −−=τ
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τ
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Figure 3-4: Adsorption kinetics of L-cysteine on gold. a) L-Cysteine may attach to gold via its 
thiol or amine groups. The amine-gold interaction is short-lived, and the L-cysteine reorients to 
attach via its thiol group. This is followed by an ordering of the chemisorbed layer and the 
subsequent formation of a second, physisorbed, layer atop the chemisorbed L-cysteine species. b) 
Numerical model for different concentrations of L-cysteine. c) Surface plasmon resonance of 
0.001 mg L-cysteine/mL H2O  profile versus time. The dotted, dash-dotted, dashed, and solid 
curves represent [L], [LA1], [LA2] and [LA2A]+[LA1]+[LA2], respectively. d) Surface plasmon 
resonance of the 0.1 mg L-cysteine/mL H2O  profile versus time. The dotted, dash-dotted, dashed 
and solid curves represent [L], [LA1], [LA2], and [LA2A]+[LA1]+[LA2], respectively.     
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The model applies at both lower (Figure 3-4c) and higher concentrations (Figure 3-4d). It can be 
seen that our model can be simplified to the Langmuir model at low concentrations (Figure 3-4b).  
In the Langmuir model, θ represents the surface occupied by the analyte, which is equivalent to 
[LA] in the previously described model, and the unbound surface (1- θ) is equivalent to (L). 
Thus, although all the terms in the model are necessary at higher concentrations, reactions with 
lower adsorption rates (i.e. [LA2]), become negligible  at lower concentrations and the model is 
simplified to the Langmuir isotherm, using eq 2-b. This is also observed experimentally.   
 
3.4.2 11-MUA 
 
The common protocol for the generation of alkanethiol SAMs involves the immersion of cleaned 
substrates in dilute ethanolic solutions of thiols for several hours at room temperature. Ethanol is 
used because alkanethiols, such as MUA, are not soluble in water. Although the dielectric 
constant of ethanol (24.3) is lower than that of water (78.5), it is still much higher than that of 
non-polar solvents (e.g. εhexane = 1.9) [171]. Figure 3-4 follows the real-time attachment of MUA 
to a gold surface.  Ethanol was first injected for 10 min, to create a baseline, following which 
several concentrations (10-4, 10-3 and 10-2 mol L-1) of MUA in ethanol were injected for 20 min.  
Finally, ethanol was re-injected for the washing step.  Exposure of the gold surface to MUA 
resulted in a rapid increase in the SPR response in the first 30 min, followed by a slow increase 
over the next 2 h (data not shown).  
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Figure 3-5: Various concentrations of MUA adsorbed onto gold. An ethanol baseline was first 
obtained; after 10 min, a solution of MUA was injected for another 20 min, followed by a short 
ethanol washing step.  
 
A rapid coverage of the gold is achieved within the first few minutes, followed by a slower 
increase of the SPR response. The attachment of MUA to the gold surface also follows a two-step 
process but is different than that of L-cysteine (Figure 3-6a). We hypothesize that the chains 
deposit in a random manner, followed by their restructuring into a SAM. The gradual increase in 
plasmon response, over the next few hours, indicates that as expected sites on the gold surface 
slowly become available because this reorientation makes new sites available, permitting further 
adsorption.  Differences in models for low and high concentrations are attributed to a loose, 
horizontal configuration for low-coverage adsorption, whereas a compact, vertical phase is 
observed for higher coverage [172].  Our results are in agreement with recent studies, showing 
that solutions with lower concentrations of SAMs do not have the same physical properties as 
those created from more concentrated solutions[173]. From lower concentrations of MUA, we 
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determine ka = 1.233 L mol-1 s-1 and kd = 8.86 x 10-4 s-1. A value of ΔGads= -17.8 kJ mol-1  was 
obtained, which is similar to the value estimated in the literature [174, 175] .The low value of kd 
tells us that desorption does not play an important role in the formation of the monolayer. 
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Figure 3-6: Model for the attachment of MUA on gold. a) MUA chains first deposit on the 
surface of the gold in a random manner, followed by their rearrangement, which provides more 
sites for further chain attachment to gold.  b) Numerical model for different concentrations of L-
cysteine. c) Surface plasmon resonance profile of 0.01 mol MUA/L of ethanol versus time. The 
dotted, dash-dotted, dashed and solid curves represent [L], [LA1], [LA2] and [LA1]+[LA2], 
respectively. d) Surface plasmon resonance profile of 0.001 mol MUA/L of ethanol versus time. 
As in panel b, the dotted, dash-dotted, dashed and solid curves represent [L], [LA1], [LA2] and 
[LA1]+[LA2], respectively.     
 
For MUA, the net reaction rates of the different concentrations are written as: 
                      (3-a) 
                                              (3-b) 
                                     (3-c) 
In eqs 3-a to 3-c, [LA1] and [LA2] represent the surface densities of MUA chains on the surface 
of the gold in a random (dense random deposition) and aligned manner (filling layer), 
respectively (Figure 3-6a). This is in agreement with multiple studies reporting an intermediate 
low coverage phase arising prior to the nucleation and growth of the upright higher coverage 
phase[176]. Using these equations, we numerically modeled the adsorption of MUA on gold 
(Figure 3-6b). In this process, MUA first deposits on gold in a random fashion ([LA1]), it then 
reorients with a rate of Kr, providing  more space (  [L]) for further MUA attachment to gold 
([LA2]). As with L-cysteine, the model applies to both lower (Figure 3-6c) and higher 
concentrations (Figure 3-6d) of MUA.   The initial conditions for 0.01 mol/L at time t = 0 are [L] 
= 29, and [LA1] = [LA2] = 0. 
 
 
d L[ ]
dτ = −Ka1 A[ ] L[ ]−Ka2 A[ ]Φ L[ ]+Kd1 LA1[ ]+Kd2 LA2[ ]+ΦKr LA1[ ]
[ ] [ ][ ] [ ] [ ]11111 LAKLAKLAKd
LAd
rda −−=τ
d LA2[ ]
dτ = Ka2 A[ ]Φ L[ ]−Kd2 LA2[ ]+ (1−Φ)Kr LA1[ ]
Φ
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3.4.3 Comparison of kinetic profiles of L-cysteine and MUA 
 
Although there is an extensive literature on alkanethiol SAMs, those of amino acids, such as L-
cysteine, have been overlooked in comparison. In the case of L-cysteine, the presence of both the 
carboxy and the amino groups confers broader possibilities for metal-molecule and molecule-
molecule interactions through electrostatic, hydrogen, and peptide bonding.   Understanding the 
differences in the adlayer structure of L-cysteine and MUA on gold surfaces is an important issue 
for biosensing purposes. L-Cysteine is a much smaller molecule and its zwitterionic state results 
in various intermolecular forces that govern its interaction with the metal surface. Thus, even 
though it is believed that the chemical reaction that binds cysteine to gold is similar to that that 
permits the formation of MUA SAMs, we have found that the thiol and amino groups of L-
cysteine first compete for the adsorption on the metal. Our results are in agreement with those of 
various groups whose findings show that cysteine most likely employs multiple functional groups 
in its bonding to gold surfaces[166, 172]. Over a period of time, the thermodynamically more 
stable SH groups replace NH groups on gold, giving additional space on the surface, resulting in 
increased bonding and, ultimately, packing the surface.  This primary rearrangement of the 
groups is not seen with MUA because the primary covalent interaction is due to the thiol group. 
That group is thus more readily attached in the case of MUA, explaining why very little 
desorption is seen when washing the surface compared to L-cysteine.   Moreover, L-cysteine is 
found in a zwitterionic form, and electrostatic interactions expose the amine group, permitting 
possible molecular coordination. Furthermore, the zwitterionic form facilitates the coupling of 
unbound molecules, provoking the formation of a second, physisorbed, layer, a phenomenon not 
seen with MUA. We believe that the zwitterionic character of cysteine is directly linked to its 
ability to form H-bonded molecular networks. This hydrogen-bonded network will affect the 
conformation and the overall packing of the SAM[162].  Moreover, the geometrical structure of 
the H-bonded network was found to be dependent on both layer coverage and temperature[177].  
To that effect, Renzi et al. found that, at room temperature, L-cysteine first-layer deposition was 
quite heterogeneous, and that both weakly and strongly bound molecules coexist. This could 
partially explain the negative slope observed in the first adsorption cycle of L-cysteine. Finally, 
MUA SAMs were found to be more stable than those of L-cysteine because long-chain 
adsorbates are more robust than their shorter counterparts due to contributions of attractive lateral 
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interactions[147] .   It should be noted that studies on the molecular diffusion mechanisms of 
cysteine on gold show that the substrate is central to the formation of the monolayers, a factor not 
accounted for in the model described[178].  New structures not previously reported, such as 
cysteine trimers, molecular rows, or ordered networks, can form due to surface defects. In the 
case of L-cysteine, it has been postulated that the amount of zwitterionic fraction, when compared 
to the acidic fraction, is dependent on the lattice symmetry of the metal surface[168]. Gonella et 
al. believe that the neutral acidic fraction, relevant only at low coverage, is likely related to 
isolated molecules or to the formation of dimers and is possibly related to the surface 
morphology of the substrate. Additional studies clarifying the substrate impact on SAM 
formation are desirable. 
3.5 Conclusion 
The adsorption characteristics of thiol-containing molecules are necessary for applications 
involving the attachment of recognition elements to a functionalized surface. We have considered 
their attachment to gold surfaces for plasmon resonance biosensing applications.  We have shown 
that the self-assembly of L-cysteine differs from that of MUA. It is evident that the deposition 
process involves not only contributions of the sulfur bonds but also those of other existant 
functional groups as well as those of subsequent noncovalent adsorbed molecules. Both the 
amine and thiol groups of L-cysteine contribute to its initial attachment, followed by replacement 
of the amine-gold complex initially formed with the more stable thiol-gold complex. The 
reorganization of L-cysteine creates more space on the gold surface, and the zwitterionic form of 
the molecule permits the physisorption of a second layer through electrostatic interactions.  Such 
a structure has high potential for further biofunctionalization. MUA deposits randomly onto the 
surface of gold as a SAM and slowly reorganizes into a denser, vertical state. 
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CHAPTER 4 ARTICLE 3: STRATEGIES FOR THE 
IMMOBILIZATION OF BACTERIOPHAGES ON GOLD SURFACES, 
MONITORED BY SURFACE PLASMON RESONANCE AND SURFACE 
MORPHOLOGY 
 
 
The immobilization of bacteriophages on an SPR sensing platform requires sophisticated 
approaches to avoid random orientation, as the bacteriophage’s bacterial recognition proteins are 
situated on the phage tail. In the past, researchers have labored to find ways to improve phage 
capture efficiency by immobilizing the phage via its capsid.  These methods span from 
introducing affinity tags to specifically biotinylating fusion proteins. Although these methods 
were proven to be reasonably successful, they are labour-intensive, cumbersome and cannot be 
introduced to all lytic bacteriophages.   
 
In this article, we use SPR, standard microbiological methods, SEM and AFM to investigate 
several phage immobilization strategies, including physisorption, and chemisorptions by L-
cysteine, gluteraldehyde, and MUA. These studies are an important preliminary step for the 
actual phage-based SPR biodetection of live pathogens. 
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4.1 Abstract 
The use of bacteriophages as recognition elements for biosensing techniques has recently 
provoked much interest. Surface plasmon resonance, scanning electron microscopy, and 
atomic force microscopy were used for the real-time monitoring of the attachment of 
methicillin-resistant Staphylococcus aureus (MRSA) bacteriophages to gold using several 
immobilization methods. The MRSA bacterial capture efficiency of phage-functionalized 
surfaces was studied. We found that whereas the physisorption of phages to gold surfaces 
affects their biofunctionality, as expressed by their lysing efficiency of bacteria, phages 
bound via mixed self-assembled monolayers of L-cysteine and 11-mercaptoundecanoic 
acid permitted both the recognition and disruption of bacterial membranes. This is due to 
the formation of uniform islands on the gold surfaces, permitting an oriented positioning of 
the phages, thus better exposing their recognition proteins.  
 
4.2 Introduction 
The attachment of molecules to a support, for use in the immobilization of a target molecule, has 
found multiple applications in industrial chemistry and biosensing devices.  Bacteriophages, a 
group of viruses that attack and lyse specific bacteria, have recently gained much attention as 
recognition elements for biosensing purposes[3, 105, 121, 179, 180]. The many advantages of 
bacteriophages make them an important component for the detection and identification of 
bacterial pathogens as well as potentially excellent vehicles for the diagnostics and therapeutics 
of bacterial disease.  Particular advantages include the specificity of the interaction of this type of 
viruses with their target host cell, their lytic ability, and their capacity to multiply during the 
infection process.  This work has been directed toward investigating the chemical attachment of 
bacteriophages onto gold surfaces using several immobilization methods.   
 
Self-assembled monolayers (SAMs), composed of chemisorbed species, play a fundamental role 
in immobilizing phages on gold.  It was reported that modifying surfaces with cysteine, followed 
by treatment with 2% gluteraldehyde, resulted in a 37-fold improvement of bacteriophage 
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attachment compared with physisorption [180].  Other groups tried to specifically immobilize 
phages by exploiting the high affinity of biotin to streptavidin [101] ;  this strategy involves the 
genetic biotinylation of the capsid heads of the bacteriophages and the natural affinity of the 
biotin/streptavidin system [121]. Gervais  and his collaborators reported a 15-fold increase of the 
attachment densities of bacteriophages over physisorption [121].  However, chemical 
biotinylation of amino groups on the phage had the additional effect of modifying the phage 
groups involved in the recognition and binding to their host cell, resulting in their partial 
inactivation [181]. Sun et al. showed that biotinylated bacteriophages, immobilized on magnetic 
beads coated with streptavidin, captured up to 30% of host cells, which was below the capture 
efficiency reported for antibodies [182]. Tolba et al. used phage display methods to introduce 
affinity tags (biotin carboxyl carrier protein, BCCP, and cellulose binding module, CBM), in the 
head of T4 bacteriophages, to provide a uniform oriented immobilization of the latter on solid 
surfaces [179].  Although the immobilized phages retained infectivity, the authors reported a 
considerably reduced burst size and a longer latent period for both methods of attachment.  
Furthermore, the capture efficiencies of the immobilized phages were significantly different for 
both constructs, as the capture of bacteria by the immobilized CBM-T4 construct was not 
detectable by plate counting [179].   Moreover, these methods are costly, time-consuming, 
require the genetic modification of a given bacteriophage, and cannot be applied to all 
bacteriophages. Arya et al. used dithiobis(succinimidyl propionate) self-assembled monolayer to 
covalently bind T4 phages via their NH2 groups[108]. Although this method of attachment shows 
great promise, the authors report a large decrease in SPR signal after washing the substrate with 
ethanolamine to remove non-specifically adhered T4 phages.  This was attributed to the removal 
of a large number of physically adsorbed T4 phages, which created empty areas on the sensor 
surface. Moreover, there is a lack of systematic investigations of the relationship between the 
immobilization conditions, and the resulting orientation of these adsorbed phages, and their 
bioreactivity. A better understanding of the immobilization process will improve the potential to 
design better bio-sensing platforms. 
 
This article describes the real-time formation of bacteriophage-modified gold surfaces via several 
chemical linkers, using SPR measurements. In addition, the activity, specificity and infectivity of 
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phages towards MRSA were evaluated by standardized microbiological methods and scanning 
electron microscopy (SEM). Finally, a method for immobilizing phages in an oriented manner is 
described and validated by atomic force microscopy (AFM).   
 
 
4.3 Experimental Section 
4.3.1 Preparation of Au surfaces 
 Biacore Platypus biosensor chips, to be described below, were used as the gold surface. Prior to 
modification, they were placed in freshly prepared “Piranha” solution (caution: a 7:3 mixture of 
concentrated H2SO4 and 30% H2O2) at room temperature for 30 min, then rinsed thoroughly with 
MilliQ water (Millipore, Mississauga, Ont.), ultrasonicated in water for 15 min, and dried in a  
nitrogen flow.  
4.3.2 Chemicals 
L-cysteine, 1-(3-dimethylaminopropyl)ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), 11-mercaptoundecanoic acid (MUA), bovine serum albumin, 
gelatin, sodium chloride, magnesium sulfate and phosphate buffer saline (PBS) were purchased 
from Sigma-Aldrich.  Luria-Bertani (LB) medium was purchased from Quelabs (Montreal, 
Quebec, Canada). We dissolved 25 g of LB powder were dissolved in 1 L of distilled water and 
autoclaved.  LB-agar plates were prepared by adding granulated agar (6 g) to LB medium (400 
mL).  LB-agar was also autoclaved, melted, and placed in Petri dishes. SaA4 bacteria, a MRSA 
strain, and BP14, a MRSA-specific bacteriophage, were isolated by Biophage Pharma. 
4.3.3 Bacterial culture 
SaA4 bacteria were grown in an incubator-shaker at 37°C in LB (4mL) broth for 3 h.  The 
bacteria were then centrifuged at 2500 g (Sorvall RT7, 3500 rpm) for 20 min. The supernatant 
was discarded, and the bacteria were resuspended in PBS. This was repeated twice.  The 
concentration of bacteria was determined by plate count and expressed in colony forming units 
per mL (CFU/mL). 
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4.3.4 Bacteriophage preparation 
 Bacteriophages were amplified by pipetting 100 µL of a suspension of 106 plaque forming 
units/mL (PFU/mL) of bacteriophages in a solution containing 1 mL of 106 CFU/mL of freshly 
prepared bacteria. After 15 min of room temperature incubation, the infection mix was added to 
250 ml of LB medium and incubated for 6 hours at 37°C in an incubator-shaker. The infected 
culture was then centrifuged at 2500 g for 20 min, filtered (0.22 µm) and titrated on LB-agar Petri 
dishes to determine the bulk bacteriophage concentration. For the SPR measurements, the 
bacteriophages were further centrifuged for 60 min, following which the supernatant was 
removed and the phages were resuspended in PBS.  
4.3.5 Surface plasmon resonance apparatus 
 A superluminescent light-emitting diode (SLED), operating at 650 nm, was used as the light 
source. An achromatic lens produced a collimated beam, which passed through a polarizer. The 
linearly p-polarized light was focused by a lens and then used to excite surface plasmons on the 
sensing surface, situated on top of a coupling prism. A commercial sensing surface (Platypus 
Technologies), consisting of a glass microscope slide (BK7) covered by an adhesion layer of 5 
nm of titanium and a sensing layer of 50 nm of gold, was placed in oil immersion contact 
(Cargille Labs) on the top of the coupling prism. For the real-time tests, a flow injection, double 
channel measuring cell with a 12 µL volume was developed. The entire system was placed on a 
goniometer stage with 2-D linear translation for exact beam angle and position location, 
permitting surface plasmon excitation at the gold/adjacent medium interface. The spatial 
distribution of the reflected light intensity was recorded by a CCD camera (Hamamatsu C4742-
95) and examined by appropriate software image treatment. 
4.3.6 SPR detection of bacteriophage adsorption to gold 
 The cleaned gold slides were placed on the SPR coupling prism using a refractive index-
matching immersion liquid (Cargille Labs). Prior to bacteriophage injection, PBS was flowed on 
top of a previously functionalized gold surface at a flow rate of 111 µL/min, controlled by a 
peristaltic pump, to obtain a baseline. A solution of 2.2 x 109 PFU/mL of MRSA-specific phages 
was flowed into the SPR chamber. All experiments were carried out at room temperature.  
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4.3.7 SEM 
Phage activity and bacterial adhesion were monitored by field emission scanning electron 
microscopy (FESEM, Hitachi S-4700, operating at 30 kV). Au substrates were cleaned with 
Piranha solution and ultrasonicated for 15 min. BP14 bacteriophages were immobilized with L-
cysteine, MUA, or their mixture. We washed gold surfaces three times with MilliQ H2O and 
exposed them to 109 CFU/mL MRSA bacteria for 20 min.  Gold surfaces were again washed 3 
times and fixed with a drop of 2% gluteraldehyde for 5 min.   
 
4.3.8 AFM 
Tapping-mode AFM measurements were performed with a NanoScope III Dimension 3100 AFM 
(Digital Instruments, Santa Barbara, CA, USA). Etched silicon probes (Digital Instruments), with 
cantilever lengths of 125 µm and resonance frequencies of 200–400 kHz, were used. Images were 
recorded with a scan rate of <1 Hz. 
4.4 Results and Discussion 
4.4.1 Bacteriophage immobilization 
Bacteriophages bind to bacteria via their tail-proteins, which must be free and oriented 
perpendicular to the surface. Figure 4-1 shows the SPR response of bacteriophage attachment 
onto gold, using various chemistries, including physisorption, gluteraldehyde fixation, and L-
cysteine combined with MUA and EDC/NHS.  PBS was first injected into the sensor to create a 
baseline.  After 5 min, a solution of 2.2 x 106 PFU/mL of MRSA-specific phages was injected.  
The bacteriophages were allowed to attach to the functionalized surface.  Phage-treated surfaces 
were not allowed to dry, as drying greatly affects phage binding affinity and lytic properties[183]. 
For all methods except direct gold adsorption, we saw no measurable desorption of the attached 
bacteriophages during the washing step. Physical adsorption results in a low surface coverage and 
dramatically diminishes the sensitivity of the platform. This can lead to a heterogeneous surface 
distribution of adsorbed phages [184]. More importantly, a change in the structural configuration 
of the phage epitopes and orientation is possible, which can lead to a reduction of its activity and 
unavailability of the active site [184]. A higher density of immobilized phages is usually 
  
65 
attributed to an increased bacterial capture. However, the literature reports that a high density of 
phages can result in the aggregation of the phages immobilized on the surface and reduce 
bacterial capture due to the steric hindrance and interaction of neighboring phage tails[108, 109]. 
In our previously characterized SPR biosensor[3], one pixel corresponds to a change of 0.00015 
refractive index units (RIU),  and a change of 0.001 RIU corresponds to 1 ng/mm2 of binding 
protein. Our results show that employing a surface functionalized with mixed self-assembled 
monolayer consisting of L-cysteine and MUA, we obtain a surface density of 19 ng mm-2 for an 
initial bacteriophage solution of 2.2 x 106 PFU/ml. Densities of immobilized phages are all 
reduced when employing L-cysteine (12 ng mm-2), gluteraldehyde (8 ng mm-2) or physisorption 
(8 ng mm-2).  
 
 
Figure 4-1: Immobilization and activity of bacteriophages on gold surfaces using various 
attachment strategies. (a) MRSA-specific bacteriophages were immobilized on gold surfaces via 
physical adsorption, L-cysteine and glutaraldehyde, L-cysteine, MUA, MUA/EDC/NHS and L-
cysteine/MUA/EDC/NHS. SPR response shifts due to the attachment of phages onto gold 
surfaces using the various methods were monitored. (b) PBS was injected for 10 min atop a gold 
slide previously functionalized with L-cysteine and MUA to create a baseline. Phages were then 
injected, and the SPR response was monitored for 60 min.  Loosely bound phages were removed 
by a 10 min washing step with PBS. 
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Covalent attachment of the phages to the gold support is rendered possible by the use of the 
catalysts, EDC and NHS, which can couple carboxylic acid to amine groups to form amide bonds 
[184, 185]. Figure 4-1b shows the EDC/NHS–catalyzed adsorption of bacteriophages onto a gold 
surface previously functionalized with L-cysteine and MUA.  MilliQ water was injected for the 
first 10 min, to create a baseline.  Following this, a solution of 1 mol L-1 EDC was instantly 
mixed with a solution of 0.1 mol L-1 NHS.  The mixture was injected into the biosensor and held 
there for 15 min, followed by a 10 min MilliQ water washing step. Following this, a 109 PFU/mL 
solution of bacteriophages was injected, and held for 60 min, before a final washing step.  
 
To determine whether the activity of phages was affected by the method of immobilization, we 
immobilized rMRSA-specific phages either via physisorption or on gold slides previously coated 
with the following species: (a) L-cysteine, (b) L-cysteine and gluteraldehyde, (c) MUA, (d) MUA 
combined with EDC/NHS, or (e) L-cysteine combined with MUA and EDC/NHS on a gold-
coated microscope slides (Figure 4-2a).  These gold slides were then deposited in vials containing 
40 mL of LB medium to which were added 500 µL of 106 CFU/mL freshly prepared MRSA 
bacteria. If the immobilized bacteriophage was to retain its activity, then it would attach to the 
bacterium and lyse it. If the immobilization process rendered the immobilized bacteriophages 
inactive, then the bacteria would replicate.  As negative and positive controls, we observed both 
the growth of MRSA without bacteriophage and the growth of MRSA with 100 µL of 2.2 x 109 
PFU/mL of phages. After the experiment was terminated (200 min, five lytic cycles), a sample 
was taken from each mixture and titrated on LB-Agar Petri dishes to calculate the final bacterial 
load of the sample (Figure 4-2a). Thus, the generation of progeny phages and ability to freely 
interact with bacteria will have an impact on the final titer, only if the immobilized phages remain 
active on the gold surface.  Physisorbed bacteriophages showed the lowest activity with a final 
bacterial load of 7.1 ± 0.9  x 1010 CFU/mL, compared to the control value of 7.9 ± 0.4 x 1010 
CFU/mL, as the bacteriophages are thought to adsorb preferably via their positively charged tails, 
rendering them inactive [186].  
 
In a recent study 1, the use of sugars improved the binding capacity of bacteriophages to the 
surface by two- to three-fold, whereas modifying the surface with amino acids showed a seven-
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fold improvement compared with physisoption. Nevertheless, the stability and uniformity of the 
coverage was poor. Our results suggest that modifying the gold surface with L-cysteine improved 
the attachment of phages on the surface compared to physisorption; however, the activity of the 
attached phages showed only a two-fold improvement with 4.4 ± 0.1 x 1010 CFU/mL. 
Furthermore, Singh et al. report a 37-fold improvement of bacteriophage adhesion when surfaces 
were treated with cysteine and gluteraldehyde when compared with physisorption[180].  
However, our results show that combining gluteraldehyde and L-cysteine did not significantly 
improve the phage activity (5.2 ± 0.6 x 1010 CFU/mL) nor did attaching phages with MUA alone 
(3.5 ± 0.1 x 1010 CFU/mL). However, a 10-fold improvement, compared to physisorption, can be 
seen when combining MUA and EDC/NHS (4.1 ± 1.1 x 109 CFU/mL). Moreover, the L-
cysteine/MUA/EDC/NHS strategy improved the lysis of bacteria by a factor of 103 (4.3 ± 1.2 x 
107 CFU/mL) when compared to  physisorption.  SEM images of bacterial adherence to 
physisorbed phages on gold (Figure 4-2b), phages adsorbed with L-cysteine (Figure 4-2c), 
phages adsorbed to MUA (Figure 4-2d), and phages adsorbed to a mixed layer of L-cysteine and 
MUA (Figure 4-2e) all corroborate these results.  
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Figure 4-2: Immobilization and activity of bacteriophages on gold surfaces using various 
attachment strategies. MRSA-specific bacteriophages were immobilized on gold surfaces via 
physical adsorption, L-cysteine and glutaraldehyde, L-cysteine, MUA, MUA/EDC/NHS and L-
cysteine/MUA/EDC/NHS. (a) Gold slides were then put in contact with MRSA bacteria, and 
solutions were titrated after 200 min. SEM images show the attachment of bacteria on 
bacteriophages immobilized on gold surfaces through (b) physisorption, (c) L-cysteine, (d) MUA 
and (e) L-cysteine and MUA.  
 
On the basis of these results, the density of immobilized phages cannot solely account for 
increased binding of host bacteria and, ultimately, a better sensitivity of the detection platform. 
This can be demonstrated by the fact that although the surface density of the phages immobilized 
with L-cysteine is higher than those immobilized with gluteraldehyde no significant difference 
can be observed in the bacterial lysis experiments. This implies that although the phages are 
successfully immobilized on the gold surface their activity can still significantly be hindered no 
matter what the surface density. This activity is directly related to their orientation if we assume 
that the treatment itself does not damage the phage tail proteins.  
 
AFM analysis is used to complement SPR by providing further information on the relationships 
between surface topologies and biological interactions.  Figure 4-3 shows representative 
topographic images obtained by tapping-mode AFM. L-Cysteine-modified gold shows atomically 
flat Au grains with ill-defined step edges that are in good agreement with typical AFM images of 
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thiol-modified Au substrates. The exposure of L-cysteine-modified surfaces to MUA produced a 
noticeably different topological image: compact linear bodies are finely distributed, covering the 
substrate surface almost completely. Our findings reveal that roughness of the surface did not 
play an important part in the attachment of the phages to the surfaces (unmodified gold Au (1.10 
nm); L-cysteine (0.998 nm) ; MUA (0.799 nm) and L-cysteine + MUA (0.934 nm)). However, 
modification of the surfaces with structurally different thiols did create vacancy cavities of 
different depths, as shown by the AFM profiles (insets of Figure 4-3). The average length of the 
cavities formed on the surface of bare gold (38 ± 16 nm), L-cysteine modified Au (39 ± 19nm), 
and MUA modified Au (45± 21 nm) varies greatly over the surface. However, the presence of 
both L-cysteine and MUA allow for a more uniform coverage, with vacancy islands of 37 ± 6 nm 
of width, corresponding to the width of the bacteriophage head (36 ± 2 nm),  as measured by 
AFM. We hypothesize that the presence of both L-cysteine and MUA on gold creates cavities 
that fit the heads of the phages, which can explain their increased chemical stabilities and 
activities on gold. The inset to Figure 4-3d clearly shows that the combination of L-cysteine and 
MUA produces a surface having regularly separated depressions. The inset to Figure 4-3e shows 
that many of these depressions are filled with phages projecting above the depressions. The 
phages have been attached through the use of EDC/NHS, which causes binding through the -NH2 
groups available on both the tail and the body of the phages. We expect some differences in the 
orientations of the deposited phages, ranging from tail-up, through horizontal, to tail-down. 
Because lysis can only occur when the phage is in the tail-up position, and our results show 
increased lysis in this case, it appears that there is a preference for tail-up deposition. 
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Figure 4-3: Atomic force micrographs of thiol and phage immobilization on gold. AFM tapping 
mode was used to probe (a) unfunctionalized gold (b) L-cysteine-functionalized gold, (c) MUA-
functionalized gold, (d) L-cysteine- and MUA-functionalized gold, (e) immobilized 
bacteriophages on L-cysteine- and MUA-functionalized gold (500 nm resolution) (f) immobilized 
bacteriophages on L-cysteine- and MUA-functionalized gold (5 µm resolution).   
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The multivalent binding capabilities and high affinities of bacteriophages to host cells make them 
suitable recognition elements for bacterial biosensing. To permit more efficient binding, the tail 
fibers of the phage should face the medium, and thus the phage must be bound to the substrate by 
its head capsid. Alternatively, phages partially oriented with their tail fibers facing the sensor 
surface will not be accessible to bacterial surface antigens. Therefore, the sensitivity of this type 
of biosensor will be strongly dependent on the orientation of the immobilized phages. The 
immobilization of phages via a mixed SAM of L-cysteine and MUA resulted in the formation of  
covalent binding between the phages and the gold surface. L-Cysteine and MUA attached to gold 
through their SH- end group and formed amide bonds between their carboxy-end groups and the 
amines on the phages capsid via EDC-NHS chemistry. Immobilized phages retained their 
infectivity, suggesting that the phages were immobilized, with their tail proteins oriented 
upwards. AFM results further corroborate this claim.  The topographic images clearly indicate 
that the phages preferentially bind in the cavities formed by the mixed SAM of L-cysteine and 
MUA.  This implies that steric hindrance between adjacent molecules plays an important role in 
the immobilization of phages.    We believe that this method of immobilization improves phage 
stability and increases their intrinsic reactivity toward their targeted bacteria by orienting the tail 
fibers toward the incoming medium. Moreover, the use of the mixed SAM provided a more 
uniform surface for the attachment of phages in a more ordered similarly uniform fashion, thus 
improving the detection of bacteria. 
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4.5 Conclusions 
 
We have considered the attachment of bacteriophages to gold surfaces for plasmon resonance 
biosensing applications. It was found that compared to physisorption the covalent chemisorption 
of phages preserves their activity. In particular, the L-cysteine/MUA/EDC/NHS chemisorption 
combination provides a 103-fold improvement in phage activity compared with physisorption due 
to the creation of uniform cavities on the gold surface, whose size is that of the phage head, 
permitting a more uniform distribution and oriented attachment of the phages. The 
characterization of the physical processes of bacteriophage interaction with functionalized Au 
surfaces and the stability of the resulting complexes are of critical importance to biosensor 
applications. 
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CHAPTER 5 ARTICLE 4: SURFACE PLASMON RESONANCE 
DETECTION OF E. COLI AND METHICILLIN-RESISTANT S. 
AUREUS USING BACTERIOPHAGES 
The rapid and specific detection of pathogenic bacteria is important in many areas pertaining to 
human health, such as food safety, air quality, nosocomial and community infection outbreaks, 
and homeland security. Conventional microbiological methods and emerging technologies, such 
as PCR, ELISA, and flow cytometry, require cumbersome sample preparation, highly trained 
personnel, and are costly and time-consuming. Therefore, although these methods are relevant in 
a laboratory setting, they cannot adequately serve the needs of health care practitioners in a 
clinical setting. Phage-based SPR biosensors present a viable solution to these problems, as they 
are specific, sensitive, inexpensive, well adapted to miniaturization, and can, therefore, provide 
disposable chips for field applications.   
 
The present work pertains to the development of a sensitive phage-based SPR biosensor for the 
real time, label-free, rapid detection of whole bacteria in less than 20 minutes. We first describe 
our experimental SPR setup, as well as a novel bacteriophage specific for MRSA, whose 
morphological characteristics are suitable for SPR detection. The specificity of the phage was 
tested via spectrophotometry and impedance sensing. We then present the successful detection of 
E. coli and MRSA for concentrations lower than 103 CFU/mL, without prior labelling or 
enrichment steps in less than 20 minutes. 
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5.1 Abstract  
Early diagnosis and appropriate treatment of Escherichia coli (E. coli) O157:H7 and 
methicillin-resistant Staphylococcus aureus (MRSA) are key elements in preventing 
resultant life-threatening illnesses, such as hemorrhagic colitis, hemolytic uremic 
syndrome, and septicemia. In this report, we describe the use of surface plasmon 
resonance (SPR) for the biodetection of pathogenic bacteria, using bacteriophages as 
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the recognition elements. T4 bacteriophages were used to detect E. coli, while a 
novel, highly specific phage was used to detect MRSA. We found that the system 
permits label-free, real-time, specific, rapid and cost-effective detection of pathogens, 
for concentrations of 103 colony forming units/milliliter, in less than 20 min. This 
system promises to become a diagnostic tool for bacteria that cause major public 
concern for food safety, bioterrorism, and nosocomial infections. 
 
5.2 Introduction 
Nosocomial infection is the leading cause of death for hospitalized patients, affecting more than 2 
million such patients per year, and leading to approximately 90,000 deaths annually [187]. The 
average treatment cost varies between $14,000 and $38,000 per patient, for a total reported cost 
of $4.5 billion annually [188]. Methicillin-resistant staphylococcus aureus (MRSA) is the leading 
cause of nosocomial and community-acquired infections. Reducing the time of diagnosis is 
directly related to reducing morbidity and mortality rates [189]. A non-pathogenic form of  
Escherichia coli was used as a detection model for other harmful bacteria, such as E. coli 
O157:H7, a microorganism that causes severe gastrointestinal diseases in humans, such as bloody 
diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome, reaching a mortality rate of over 
50% in children and seniors [190]. 
 
Conventional culture methods that are predominantly used for bacterial detection are time-
consuming and require enrichment steps in order to visualize colonies on agar plates. Over the 
years, mass spectrometry and biochemical detection systems have been developed to ameliorate 
and increase the speed and sensitivity of culture methods. However, these methods retain 
negative aspects such as high cost and difficulty in handling. PCR and immunoassays are other 
approaches aimed at ameliorating the sensitivity of detection. Nevertheless, routine PCR detects 
the presence of nucleic acid and cannot differentiate between live and dead cells. More 
importantly, PCR techniques still require DNA extractions, which are time-consuming and suffer 
from fidelity of DNA replication. In contrast, immunoassays, such as ELISA, are simple and 
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rapid to use, but they lack suitable sensitivity for pathogen detection. Moreover, assay times vary 
from 24-52 hours for bacteria [191], which can be a decisive factor when treating a patient. 
 
Other major shortcomings of the available biosensors are the use of ligands that cannot 
differentiate between pathogenic and non-pathogenic organisms with sufficiently high sensitivity 
and accuracy. Polyclonal antibodies recognize different epitopes on the same pathogens, which 
can also be present in related non-pathogenic organisms [9]. Major disadvantages of monoclonal 
antibodies are their relative instability to environmental fluctuations, which can limit their long 
term storage and their field applicability.  Furthermore, their production remains time-consuming 
and costly.   
 
Bacteriophages are the main regulators of microbial balance on earth, as they total an estimated 
1032 entities [30]. The many advantages of bacteriophages make them an excellent method for the 
detection and identification of bacterial pathogens. Among these advantages are the specificity of 
the interaction of this type of virus with its target host cell, its lytic ability, and its capacity to 
multiply during the infection process. They are able to distinguish between live and dead cells, 
and they are robust, easy to produce, and cost-effective.  
 
Requirements for pathogenic bacterial detection are rapidity, sensitivity, specificity and cost. 
Recently, many groups have been involved in developing bacteriophage-based sensors for 
bacterial detection [105, 121, 133, 192, 193]. Balasubramanian et al. were able to identify 
Staphylococcus aureus with a detection limit of 104 colony forming units/milliliter (CFU/mL); 
however, detection suffered from the physical adsorption of phages onto the sensor surface [105].  
Moreover, the phages were not directed against methicillin-resistant strains of S. aureus. Oh et al. 
used self-assembled G protein to immobilize antibodies [193], a strategy that cannot be used to 
detect S. aureus. Our group has employed biotinylated T4 bacteriophages to detect E. coli [121], 
but the genetic modification of all phages is not possible.  Although much work has been done, a 
low cost, specific, sensitive optical method for detecting low concentrations of pathogens, in a 
few minutes, has not been established. 
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Our work consists, in part, of creating an accurate and sensitive biosensor for bacterial detection, 
with the potential for miniaturization. We use an already characterized impedometric sensor 
(PDS, Biophage Pharma) [194] to screen for the specificity of the bacteriophage to its target 
bacterium. Direct impedometric detection is limited by the facts that the medium utilized must be 
optimized for electrical measurements, and that not all microorganisms generate an adequate 
amount of ionized metabolites to allow for their detection.   
 
These limitations can be overcome by the use of surface plasmon resonance (SPR). We suitably 
modified an SPR apparatus for bacterial detection. Multiple strategies were used to improve the 
immobilization of recognition elements on sensor surfaces including the physisorption of phages 
and the covalent immobilization of phages via L-cysteine, glutaraldehyde and self-assembled 
monolayers; an article in preparation contains a fuller discussion of the interaction of these 
molecules with gold than is given here, as well as the optimal method for phage immobilization. 
We have isolated and characterized a lytic bacteriophage that can specifically recognize 
methicillin-resistant strains of S. aureus. More importantly, we report on a rapid, specific and 
cost-effective method of detecting 103 CFU of bacteria per mL. 
 
5.3 Materials and methods 
 
5.3.1 Surface Plasmon Resonance 
A schematic diagram of the instrument design is shown in Figure 5-1. A superluminescent light-
emitting diode (SLED), operating at 650 nm, was used as the light source.  This allowed for a 
reduction in speckle patterning and interference fringes as SLEDs present low temporal 
coherence, related to their large spectral bandwidth. This translates in noise reduction, which 
allowed for better signal processing and better sensitivity. An achromatic lens produced a 
collimated beam, which passed through a polarizer. The linear p-polarized light was then 
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focalized by a lens, and excited surface plasmons on the sensing surface, situated on top of a 
coupling prism.  
A commercial sensing surface (Platypus technologies), consisting in a microscope glass slide 
(BK7) covered by an adhesion layer of 5 nm of titanium and a sensing layer of 50 nm of gold, 
was placed in oil immersion contact (Cargille Labs) on the top of the coupling prism (BK7 glass). 
For the real-time tests, a flow injection double channel-measuring cell, with 12 µl volumes, was 
developed. The entire system was placed on a goniometer stage with 2-D linear translation for 
exact beam angle and beam position, permitting surface plasmon excitation on the gold/adjacent 
medium interface. 
The spatial distribution of the reflected light intensity was recorded by a CCD camera 
(Hamamatsu C4742-95), and examined by appropriate software image treatment. The SPR 
resonance dip is usually recorded with a linear CCD detector. In our case, a drastic reduction of 
both signal noise and dispersion, which are due to the non-ideality of the light beam and the 
sensor surface modification, was achieved by using numerical analysis of the acquired SPR 
curves.  Both fourth order polynomial curve fitting and centroid method were used to determine 
accurately the position of the SPR minimum. 
 
Figure 5-1: Experimental CCD camera-based SPR set-up. 
Prior to SPR use, the gold surfaces of the glass slides were cleaned, using freshly prepared 
“piranha” solution (caution: piranha solution is a 3:1 mixture of concentrated H2SO4 and 30% 
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H2O2), at room temperature, for 2 min, then rinsed thoroughly using  MilliQ water, and dried in a  
nitrogen flow. The liquid flow rate (111 µL min−1) was controlled by a peristaltic pump 
(Ismatec). Phages specific for the targeted bacteria were then attached to the gold surface of the 
planar SPR system.  
5.3.2  Impedance Measurements 
 
The impedance measurements were carried out using a PDS Biosensor (Biophage Pharma). The 
PDS biosensor is based on Electric Cell-Substrate Impedance Sensing (ECIS) and is used to 
detect the total live bacterial load of a sample. Small gold electrodes, 250 µm in diameter, were 
placed on the bottom of individual culture wells. The sample, containing the bacteria and culture 
medium, was placed in the culture wells and a 4,000 Hz, 1.5 V, 1 µA current was applied 
between the detecting and the counter electrodes. The bacteria interfere with current flow as they 
occupy the free space immediately above the electrode; the impedance is monitored by a lock-in 
amplifier. Bacteriophages were immobilized on the gold electrode surface, following which, 400 
µL of freshly prepared bacterial solutions were injected into the well containing the gold sensor 
chip. The chip was then placed in an incubator at 37°C. The growth of the bacteria was then 
monitored. 
 
5.3.3  Chemicals 
 
L-cysteine, 1-(3-imethylaminopropyl) ethylcarbodiimide hydrochloride (EDC), NHS, 11-
mercaptoundecanoic acid, bovine serum albumin, sodium chloride, magnesium sulfate, and 
gelatin were purchased from Sigma-Aldrich. Luria-Bertani (LB) medium was purchased from 
Quelabs (Montréal, Québec, Canada); 25 g of LB powder were dissolved in 1 L of distilled water 
and autoclaved. LB-agar plates were prepared by adding 6 g of granulated agar to 400 mL of LB 
media.  The LB-agar was autoclaved, melted and placed in Petri dishes. PBS was purchased from 
Fisher Scientific (Nepean, Ontario, Canada). E. coli K12 (11303) and T4 bacteriophages  (11303-
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B4) were purchased from American Type Culture Collection (ATCC). SaA4 MRSA bacteria and 
BP14 bacteriophages were isolated by Biophage Pharma.  
 
5.3.4  Bacterial culture 
 
EC12 and SaA4 bacteria were grown in an incubator-shaker at 37°C in 4 mL of LB media for 3h. 
The bacteria were then centrifuged at 2500 g (Sorvall RT7, 3500 rpm) for 20 min. The 
supernatant was discarded and the bacteria were resuspended in PBS. This was repeated twice. 
The concentration of bacteria was determined by plate count technique and expressed in colony 
forming units per milliliter (CFU/mL). 
 
5.3.5  Bacteriophage preparation 
 
Bacteriophages were amplified by pipetting 100 µL of a suspension of 106 PFU/mL of 
bacteriophages in a solution containing 1mL of 106 CFU/mL of freshly prepared bacteria. After 
15 minutes of incubation at room temperature, the infection mix was added to an Erlenmeyer 
flask containing 250 mL LB and incubated for 6 hours, at 37°C, in an incubator-shaker.  The 
infected culture was then centrifuged at 2500 g for 20 minutes, then filtered (0.22 µm) and 
titrated. For the SPR measurements, the bacteriophages were further centrifuged for 60 minutes, 
the supernatant was removed and the phages were resuspended in PBS. The concentration of 
bacteriophages was determined by plate count technique and expressed in plaque forming units 
per milliliter (PFU/mL). 
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5.3.6  Optical density measurements 
 
Bacterial suspensions were vortexed. One mL of the suspension was pipette in a disposable 
cuvette (Sarstedt AG & Co., Numbrecht, Germany). Optical density (OD) was monitored at 595 
nm on a Beckman DU-140B spectrophotometer (Beckman Coulter Inc., Fullerton, CA).   
 
5.3.7  Transmission electron microscopy  
 
The TEM used was a Hitachi H-7100, operating at 75 kV. We used copper grids (200 mesh), 
coated with a layer of Formvar and an overlayer of evaporated amorphous carbon. The samples 
were deposited on the grid by the reverse drop method (a drop of sample was deposited on 
Parafilm for 5 min, then the grid was deposited on top of the Parafilm, and excess was wiped up 
with a paper towel.  The grid was then dipped, for 1 minute, in a drop of 3% aqueous 
phosphotungstic acid (PTA) adjusted to a pH of 7; PTA is a negative stain solution, used at 
neutral pH because phages will tend to dissociate at low pH. The grid was allowed to dry before 
the sample was used for TEM analysis.  
 
5.3.8  DNA sequence analysis and bioinformatics 
 
Open reading frame identification was performed using GeneMark.hmm [195]. Similarity 
searches, for nucleotide sequences and for the deduced amino acid sequences, were performed 
using the FASTA [196], BLAST [197], and PARALIGN [198] programs available on the Online 
Analysis Tools website (http://molbio-tools.ca/). 
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5.4 Results and discussion 
 
5.4.1 Specificity of BP14 for MRSA 
 
To facilitate the immobilization and detection processes, bacteriophages should possess 
morphological characteristics, such as small size, and a short tail. For example, the T4 phage has 
a 168.9 kb genome, its head dimension is 110 x 80 nm, while its tail length 98 nm [199, 200]. 
Because the evanescent wave of our SPR travels up to 300 nm into the substrate, only a portion 
of the bacterium will generate a response by interacting with it. Reducing the length of the 
recognition element will increase the SPR response on bacterial attachment. The transmission 
electron microscopic [201] image of BP14 (Figure 5-2a) shows its morphology to be very similar 
to that of the S. aureus 44AHDJ virus, allocated to the order Caudovirales and the family 
Podoviridae. It possesses a short, non-contractile tail measuring 25 nm (black arrow), and a small 
isometric head, measuring 42 nm (white arrow). It has a pre-neck appendage characteristic of the 
ɸ29-like phages, according to the International Committee on Taxonomy of Viruses.  BP14 is 
68% smaller than T4. This observation indicates that a larger portion of the target bacteria (~233 
nm) can be probed by the evanescent field of the SPR, yielding an improved response (Figure 5-
2b).  
 
The complete DNA sequence of BP14 was determined.  The genome of BP14 consists of 17 769 
base pairs (bp), and the total G+C content is 29.6 %. Twenty-two open reading frames (ORFs) 
were identified, with 12 orientated in opposite directions from each other.  The overall DNA 
sequence identity between BP14 and similar phages are 85.7% for Bacteriophage 66, 85.9% for 
S. aureus phage phiP68, 73% for Staphylococcus phage phi44AHJD, and 82% for 
Staphylococcus phage SAP-2. Of the 22 ORFs found, ORF-14 and 15 were identified as major 
and minor tail proteins, respectively, based on the overall similarity to tail proteins of the ɸ29 
phage family. In particular, the sequence coding for the minor tail protein of BP14 differs from 
that of phage phiP68 by 11.2%, of Staphylococcus phage 66 by 9.8%, and of Staphylococcus 
phage SAP-2 by 63.7%.  Our results suggest that phage BP14 is unique and different from other 
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commercially available phages. Bacterial recognition is achieved by tailed-phages through the 
interaction of fibers at their tails.  These fibers will first recognize, and adhere to, the host 
bacterium in a reversible fashion, followed by the irreversible binding of a secondary minor tail 
protein to another receptor molecule on the surface of the bacterium. Having a short, non-
contractile tail, the phage has the advantage of not being able to fold and interact with the gold 
substrate on which it is deposited. Moreover, BP14 has a lesser probability of adhering to the 
gold surface by its tail, compared to phages with larger tail/head ratios. 
 
 
 
 
 
 
Figure 5-2: a) TEM image of bacteriophage BP14, showing an icosahedral head, measuring 42 
nm in diameter (white arrow), and a 25 nm non-contractile tail (black arrow). b)  Comparison 
between T4 and BP14 bacteriophages. The use of a smaller bacteriophage, such as BP14, allows 
for a larger portion of the bacterium to be probed by the evanescent field. 
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Moreover, phages can be further divided into two categories, depending on their life cycles and 
means of propagation [36].  BP14 is a member of the virulent phages, which are only capable of 
lytic propagation, consisting of infection of the host bacterium by the phage, replication of the 
phage genome, production of the phage structural components, and release of the newly 
assembled phages.  More often than not, this process results in bacterial lysis and death. This is 
crucial for cost-effective production. 
 
To establish whether bacteriophage BP14 possesses lytic capabilities, it was exposed to MRSA, 
and the optical density was monitored over time (Figure 5-3a). We found that the optical density 
of BP14+MRSA did not increase over time, indicating that BP14 specifically recognizes MRSA, 
binds to the bacteria and lyses them, ultimately inhibiting their growth. Solutions containing only 
MRSA show an increase in optical density over time, consistent with bacterial growth. 
 
In order to ensure the specificity of the sensor, the non-specific adsorption of entities other than 
the bacterium of interest must be prevented. Moreover, the selected phages should discriminate 
between MRSA and methicillin-sensitive S. aureus (MSSA), which is affected by the use of 
antibiotics. To demonstrate that BP14 can discriminate between different types of bacteria, we 
used an impedance biosensor to detect the total live bacterial load on a sensor chip. Bacteria act 
as insulating particles, by reducing the area that the current reaches and, thus, increasing the 
interface impedance. Because a bacteriophage specifically recognizes a host bacterium and lyses 
it, the microbial growth will be reduced and, therefore, the detection time will increase in the 
wells containing the samples treated with phages.  Here, the gold electrodes were first coated, 
using a solution of bovine serum albumin (BSA), to prevent non-specific binding.  Following 
this, 400 µL of solution was pipetted into each cuvette and placed in an incubator at 37°C for 12 
hours. The LB curve, in figure 5-3b, contains only culture medium and shows that there was no 
contamination present, while the MRSA curve contains only bacteria and shows their unhindered 
growth. Other wells contained bacteriophage BP14, incubated in the presence of various 
solutions of bacteria (EC12, O157:H7, MSSA, and MRSA), at a concentration ration of 1:5. Our 
results indicate that BP14 does not affect the growth of different E. coli strains, such as EC12 and 
O157:H7. Moreover, BP14 does not recognize, or lyse, methicillin-sensitive S. aureus.  However, 
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when in the presence of MRSA, BP14 provokes a delay in the growth of the bacterium. This 
observation signifies that BP14 is able to specifically recognize, adhere to, replicate, and lyse 
MRSA. The impedance decrease that can be observed in the first 30-60 minutes is due to the fact 
that bacteria release molecules to prepare their environment for growth. When bacteria grow in a 
culture medium, they transform uncharged reactants, such as carbohydrates, into charged 
products, mainly carboxylic acids. These molecules render the culture medium more conductive, 
with a resultant decrease in impedance.  
 
 
  
Figure 5-3: Specificity of bacteriophage BP14 to MRSA bacteria. a) Optical density of MRSA 
(positive control), LB (negative control), bacteriophage BP14, and MRSA and BP14 solution.  b) 
MRSA, MSSA, E. coli EC12 and O157:H7 were incubated with BP14 at 37°C. Impedance was 
monitored for 12 h, reflecting bacterial growth. Replications of MSSA, EC12 and O157:H7 were 
not hindered by the presence of BP14. MRSA growth was delayed by the presence of BP14; 
MRSA bacteria are lysed following bacteriophage replication. 
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5.4.2  Detection of E. coli and MRSA 
We used a home-built biosensor, with bacteriophages as specific recognition elements, to detect 
low concentrations of bacteria. Gold was coated with a self-assembled monolayer (SAM) of l-
cysteine overnight at 37°C, washed and subsequently coated with mercaptoundecanoic acid 
(MUA), then treated with 1-(3-dimethylaminopropyl)ethylcarbodiimide hydrochloride (EDC) 
and N-hydroxysuccinimide (NHS). A PBS solution was injected onto the SAM-modified gold 
chip for 10 minutes, followed by the injection of a PBS solution containing 109 PFU/mL phages 
for 50 minutes (Figure 5-4).  PBS was then injected to wash away the unbound phages, and 106 
CFU/mL of the target bacterium was flowed over the sensor for 50 minutes, followed by 
washing.  Because the lytic cycle of the phage is 30 minutes, we chose to follow the initial 20 
minutes of surface plasmon response, following the injection of bacteria (dashed lines).   The 
results are shown in pixels, with one pixel corresponding to 0.005 angle units. 
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Figure 5-4:  SPR response of attachment of phages, followed by specific attachment of bacteria. 
The dashed lines indicate the region of interest for phage assisted detection.   
To determine the sensor detection limit, we coated the gold chips with bacteriophage, using the 
previously described method. Furthermore, the chips were coated with BSA to prevent non-
specific binding, followed by the injection of different concentrations of target bacteria. A 
solution of PBS was injected for the first 10 minutes, to create a baseline, after which a solution 
of E. coli in PBS was injected onto the sensor for another 20 minutes (Figure 5-5). 
Bacteriophages will lyse the bacteria within 20 minutes following their attachment to their hosts. 
A significant change in the surface plasmon response can be seen after 10 minutes. The control 
consists of PBS injected onto a T4-coated gold chip. 
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Figure 5-5: Detection of E. coli, using T4 bacteriophages. T4 bacteriophages were coated onto 
the gold sensor chip. A baseline was created by injecting PBS buffer for 10 minutes. Following 
this, known concentrations of E. coli, diluted in PBS, were flowed over the sensor surface. The 
surface plasmon resonance change was monitored for 20 minutes. A dose-response curve for 
detection of E. coli is shown, in inset, for values taken after 20 minutes following bacterial 
insertion. 
 
The same experiment was repeated to establish the possibility of detecting MRSA bacteria, using 
BP14 combined with SPR (Figure 5-6) All slides were previously coated with BP14 
bacteriophages and BSA, to prevent non-specific adhesion.  The controls consist of PBS injected 
onto a BP14-coated slide, and a solution of 106 CFU/mL of EC12 injected on a BP14-coated 
slide. Because EC12 are E. coli bacteria, and BP14 are not specific to this type of bacteria, we 
saw no significant change in SPR response. Noise was determined to be the surface plasmon 
response difference between the PBS baseline and the non-specific adsorption of E. coli bacteria, 
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corresponding to 0.835 pixels. Using the criterion of S/N ›3, the limit of detection is found to be 
103 CFU/mL. Figure 5-6 demonstrates that the SPR response due to bacterial detection by 
bacteriophages is dose-dependent. All experiments were carried out at room temperature; better 
results are anticipated at 37°C.   
 
 
 
  
Figure 5-6: Detection of MRSA using BP14 bacteriophages. BP14 bacteriophages were 
immobilized on the gold sensor chip. A baseline was created by injecting PBS buffer for 10 
minutes. Following this, known concentrations of MRSA diluted in PBS were flowed onto the 
sensor surface. Surface plasmon resonance change was monitored for 20 minutes.  E. coli, at a 
concentration of 106 CFU/mL, was also tested, and showed the high specificity of the B14 for 
MRSA detection. For detection of MRSA, a dose-response curve is shown, in inset, for values 
taken after 20 minutes. 
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Our results are consistent with those reported by other groups [105, 109]. The interaction 
between the phage and the bacterium receptor is a reversible process, which is ultimately 
followed by irreversible binding, coinciding with the initiation of phage DNA translocation into 
the bacterium.  These two steps are characterized by rapid and slow exponential relaxations [37]. 
Given the geometrical parameters of the phage and the bacterium, the rate of adsorption of phage 
binding can exceed the theoretical limit of adsorption determined by diffusion models [37].  
Moreover, despite the small size of the bacterial receptors and the fact that they are sparingly 
found on the bacterium wall, phage capture of the bacterium occurs on each collision.  
 
 
5.5 Conclusions 
 
Using SPR, we have demonstrated the use of T4 bacteriophage to detect E. coli, as well as the 
use of BP14 to detect MRSA. Our work reveals the specificity of bacteriophage BP14 for MRSA 
bacteria, as none of the other strains of bacteria examined show any interaction with BP14, which 
targets MRSA and interferes with its replication. It was possible to detect concentrations of 103 
CFU/mL, without prior labeling or enrichment steps, in less than 20 minutes. This method of 
detection is of interest not only for public health, but for other phages, which can be used to 
identify and target other types of bacteria, such as anthrax for bioterrorism prevention, and E. coli 
O157:H7 for the food and water industries.  
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CHAPTER 6 ARTICLE 5 : THE DIFFERENTIAL DETECTION OF 
METHICILLIN-RESISTANT, METHICILLIN-SUSCEPTIBLE AND 
BORDERLINE OXACILLIN-RESISTANT STAPHYLOCOCCUS 
AUREUS BY SURFACE PLASMON RESONANCE 
 
The diagnosis and monitoring of various infections necessitate intensive efforts for the routine 
examination of blood samples and other associated tests. Novel diagnostic systems have 
traditionally been developed in response to the needs of the medical community. With the advent 
of nosocomial infection outbreaks, a major challenge for the biomedical engineering community 
is to develop diagnostic tests that can distinguish between the rapidly evolving plethoras of 
resistant bacterial strains. S. aureus infections exemplify this problem with an ever-increasing 
heterogeneous spectrum of resistance. In addition, while substantial efforts have been directed 
towards distinguishing the resistance patterns of highly pathogenic strains from those of 
antibiotically susceptible ones, conventional microbiological and DNA-based genotyping 
techniques have largely failed to address the problem, and to provide adequate treatment to 
patients.  
 
In this fifth article, we characterize 250 different S. aureus clinical isolates provided by the 
LSPQ, and determine their pattern of resistance. We then adapt our SPR biosensor to effectively 
differentiate among MSSA, CA-MRSA, HA-MRSA and BORSA strains. Our proposed assay 
permits the rapid and accurate detection of these strains an less than 20 minutes, for 
concentrations as low as 10 CFU/mL. 
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6.1 Abstract 
Two hundred fifty Staphylococcus aureus clinical isolates were studied to determine 
their susceptibilities to β-lactam antibiotics. Among these isolates, 16 were 
methicillin-sensitive S. aureus (MSSA), 207 were methicillin-resistant S. aureus 
(MRSA) and 27 were borderline oxacillin-resistant S. aureus (BORSA). Currently, 
the reported mechanism of methicillin resistance in S. aureus is the production of a 
distinctive penicillin binding protein 2a (PBP2a), which exhibits low affinity toward 
β-lactams. A surface plasmon resonance biosensor was evaluated for its ability to 
identify MRSA and to distinguish these strains from MSSA and BORSA, by 
specifically detecting PBP2a. We found that the system permits label-free, real-time, 
specific detection of pathogens for concentrations as low as 10 colony forming 
units/milliliter (CFU/mL), in less than 20 min. This system promises to become a 
diagnostic tool for bacteria that cause major public concern in clinical settings. 
 
6.2 Introduction 
 
Nosocomial infections are the primary cause of mortality for hospitalized patients[187]. 
Methicillin-resistant Staphylococcus aureus (MRSA) is the leading cause of nosocomial and 
community-acquired infections worldwide with MRSA accounting for up to 40% of all S. aureus 
isolates[202, 203]. It has been estimated that nearly 50% of adults are carriers of S. aureus[15]. 
Thus, S. aureus ranks amongst the primary causes of skin[204-206] and bloodstream bacterial 
infections[16, 207], as well as nosocomial pneumonia[208-210]. The development of resistance 
to methicillin and vancomycin has been a cause of concern among the medical community. 
MRSA infections have been associated with accelerated deterioration of pulmonary function, 
leading to increased hospitalization, and increased antibiotic usage and mortality[211]. The 
problem resides in the fact that therapeutic options to cure MRSA infections are scarce and that 
MRSA has the ability to acquire resistance to novel antibiotics. 
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Methicillin is a β-lactam, a member of a broad class of antibiotics characterized by the presence 
of a β-lactam ring in their chemical structures, which disrupts bacterial cell wall synthesis. They 
are the most prescribed antibiotics due to their specificity and non-toxicity to host cells. MRSA 
has acquired resistance to such antibiotics due to the production of altered penicillin binding 
proteins (PBPs)[212] that have low affinity for β-lactams, and are encoded by the chromosomal 
mecA gene[211]. 
 
Substantial efforts have been directed at properly distinguishing this resistance pattern from those 
of susceptible strains. Current guidelines call for antibiotic susceptibility testing of S. aureus by 
agar dilution, disk diffusion tests, latex agglutination tests, and molecular methods, such as PCR 
and radio-labeled DNA probes[203, 213]. MRSA is defined as having an oxacillin minimum 
inhibitory concentration (MIC) ≥4µg/ml[214]. However, heterogeneous expression of oxacillin 
resistance in multiple strains of S. aureus[203, 215] has complicated the identification of MRSA 
via conventional microbiological procedures. Strains with extremely low-level methicillin 
resistance are susceptible to most of the non-β-lactam antibiotics[212], and routine tests may lead 
to false positive results. For instance, borderline oxacillin-resistant S. aureus (BORSA) strains 
exhibit oxacillin MICs at, or just above, the susceptibility breakpoint (≥2µg/ml)[215], but lack 
the mecA gene. Optimal conditions for the identification of BORSA and their differentiation from 
MRSA have not been determined[216]. Moreover, a novel gene coding for methicillin resistance 
(mecC) has recently been identified in  S. aureus clinical isolates from humans and animals. 
These strains, which have a variable resistance profile to oxacillin, cannot be detected by 
standard molecular techniques, such as PCR and slide agglutination tests, and are thus falsely 
identified as BORSA[217]. 
 
Rapid assays for detecting methicillin resistance in Staphylococci, such as BD geneOhm 
MRSA[218], Xpert MRSA[218], BBL Crystal MRSA ID[219], Velogene Rapid MRSA 
Identification[220] and MRSA-Screen[221], are commercially available. However, these 
methods lack accuracy for MRSA identification and differentiation from BORSA. For these 
methods, heavy inoculums are still needed, false negative results can still occur[203], and they 
are inappropriate for mecC gene detection. Other DNA-based genotyping techniques, such as 
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polymerase chain reaction (PCR), pulsed-field gel electrophoresis (PFGE) and multi-locus 
sequence typing (MLST), are time-consuming (6h to 3 days) and require highly trained 
personnel. A bioluminescent assay was recently developed, using biotinylated firefly luciferase to 
detect PBP2a[222]. However, the assay suffered from requiring an extraction step, as well as 
having a low sensitivity (0.5 x 106 CFU/mL). Chen et al. recently developed an integrated 
microfluidic system that could effectively differentiate community–acquired MRSA (CA-MRSA) 
from hospital-acquired MRSA (HA-MRSA) in less than 40 min[223]. However, this system 
requires PCR amplification and a labeling step. Similarly, another study demonstrated the 
possibility of detecting the mecA gene by EIS, after PCR has been carried out on genomic DNA 
from bacterial isolates[224]. 
 
Thus, it is our aim to respond to the pressing need for the development of a rapid and sensitive 
biosensing method to specifically detect and differentiate MRSA from both BORSA and 
methicillin susceptible Staphylococcus aureus (MSSA), allowing for a better management of the 
bacterial infection.  Furthermore, we aim to reduce the time of diagnosis, which is crucial for 
effective treatment and the prevention of disease spread[223], and will result in reduced 
morbidity and mortality rates[189]. Here, we studied two hundred fifty Staphylococcus aureus 
clinical isolates to determine their susceptibilities to β-lactam antibiotics. A surface plasmon 
resonance (SPR) biosensor was used to differentiate among CA-MRSA, HA-MRSA, BORSA 
and MSSA strains by specifically detecting PBP2a on whole bacterial cells, without labeling, 
without recourse to PCR or enrichment steps. 
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6.3 Materials and methods 
6.3.1  Bacterial Cultures 
 
Bacteria were either isolated by Biophage Pharma (Saa1 to Saa 29) or provided by the 
Laboratoire National de Santé Publique du Québec (LSPQ) (Saa 30 to Saa 250). At LSPQ, the 
presence of nuc gene to confirm S. aureus was detected using PCR with the following primers: 
SN1 5'-CGAAAGGGCAATACGCAAAG-3' and SN2 5'-ATCAGCGTTGTCTTCGCTCC-3'. 
The presence of mecA genes was detected using PCR as previously described. Susceptibility 
confirmation to oxacillin was done at LSPQ according to the CLSI standards[214]. The presence 
of PVL genes, lukS-PV and lukF-PV, were assessed by PCR amplification as previously 
described[225]. Molecular typing was done by spa typing[226] and epidemic type determination 
was determined according to the guideline for Canadian epidemic type[227]. MRSA, BORSA 
and MSSA bacteria were grown in 4 mL of Luria-Bertani (LB) medium in an incubator-shaker, 
for 3h at 37°C. The bacteria were then centrifuged at 2500 g (Sorvall RT7, 3500 rpm) for 20 min. 
The supernatant was discarded and the bacteria were resuspended in phosphate-buffered saline 
(PBS). This was repeated twice. The concentration of bacteria was determined by plate count 
technique, and expressed as colony forming units per milliliter (CFU/mL). 
 
6.3.2  Chemicals  
 
L-cysteine, 1-(3-dimethylaminopropyl)ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), 11-mercaptoundecanoic acid (MUA), bovine serum albumin (BSA), 
sodium chloride, magnesium sulfate, and gelatin were purchased from Sigma-Aldrich. LB 
medium was purchased from Quelabs (Montréal, Québec, Canada); 25 g of LB powder were 
dissolved in 1 L of distilled water and autoclaved. LB-agar plates were prepared by adding 6 g of 
granulated agar to 400 mL of LB media. The LB-agar was autoclaved, melted and placed in Petri 
dishes. Phosphate buffered saline (PBS) was purchased from Fisher Scientific (Nepéan, Ontario, 
Canada).  
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6.3.3  Extraction of genomic DNA from S. aureus isolates 
 
After centrifugation of 5 ml of cultured bacteria (4000 rpm, 15 min), pellets were resuspended in 
564 µl of TE buffer (10 mM Tric-HCl pH8 / 1 mM EDTA pH8) , frozen at -80°C and thawed at 
45°C. After addition of 6µl of Proteinase K in 30 µl of 10% of sodium dodecyl sulfate (SDS) (2 
hours, 45 °C), 80 µl of CTAB/NaCl (10% hexadecyltrimethyl ammonium bromide/0.7M NaCl) 
(30 min, 65°C), and 750 µl chloroform/iso-amyl alcohol (ratio of 24:1), the mixed solution was 
centrifuged at 15000G for 15 min. The supernatant was then subjected to the addition of 600 µl 
phenol/chloroform/iso-amyl alcohol (25:24:1) and centrifugation (15000 G, 15 min). DNA was 
precipitated, using 600 µl of isopropyl alcohol. After centrifugation, the pellet was allowed to dry 
and, then, resuspended in 20 µl of TE buffer. 
 
6.3.4 Polymerase chain reaction (PCR) 
 
Total Staphylococcus aureus and MRSA DNAs were prepared, as previously described[228]. 
The primer mixes used for the multiplex PCR for SCCmec I, II, II, and IV are listed in Table 6.1. 
The monoplex PCR primers used for SCCmec IV detection are listed in Table 6.2. The PCR was 
carried out with Taq DNA Polymerase (New England Biolabs, Ipswich, MA), using 30 cycles, 
under the following conditions: 30 seconds at 95°C, 30 seconds at 57°C, 90 seconds at 70°C.  
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Table 6.1 Multiplex PCR mixes for SCCmec I, II, III, V and mecA typing 
 Primer Lengt
h 
Forward Reverse 
1 SCCmec 
I 
613 
bp 
GCTTTAAAGAGTGTCGTTACAGG GTTCTCTCATAGTATGACGTCC 
 SCCmec 
II 
287 
bp 
CGTTGAAGATGATGAAGCG CGAAATCAATGGTTAATGGACC 
 
 Sa442 108 
bp 
AATCTTTGTCGGTACACGATATTCTT
CACG 
CGTAATGAGATTTCAGTAGATAATAC
AACA 
2 SCCmec 
V 
325 
bp 
GAACATTGTTACTTAAATGAGCG TGAAAGTTGTACCCTTGACACC 
 MecA 162 
bp 
TCCAGATTACAACTTCACCAGG CCACTTCATATCTTGTAACG 
3 SCCmecI
II 
243 
bp 
CATTTGTGAAACACAGTACG GTTATTGAGACTCCTAAAGC 
 Sa442 108 
bp 
AATCTTTGTCGGTACACGATATTCTT
CACG 
CGTAATGAGATTTCAGTAGATAATAC
AACA 
 
 
Table 6.2: Monoplex PCR primers for SCCmec IV typing 
SCCmec IV type Length Forward Reverse 
IVa 776 bp GCCTTATTCGAAGAAACCG CTACTCTTCTGAAAAGCGTCG 
 
IVb 1000 bp AGTACATTTTATCTTTGCGTA AGTCATCTTCAATATGGAGAAAGTA 
 
IVc 677 bp TCTATTCAATCGTTCTCGTATT TCGTTGTCATTTAATTCTGAACT 
 
IVd 1242 bp AATTCACCCGTACCTGAGAA AGAATGTGGTTATAAGATAGCTA 
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6.3.5 Extraction and isolation of Staphylococcus aureus PBP2a membrane 
protein 
 
A total of 2.0x1010 CFU/mL of cultured bacteria (Saa4, 5, 30, and 226) were used. Membranous 
protein extraction was performed, using a ReadyPrep Protein Extraction kit (Membrane I) 
(BioRad), according to the manufacturer’s protocol. After centrifugation (16000 G, 5 min at 
room temperature), hydrophobic and hydrophilic phases were separated, and the hydrophobic 
protein concentration was determined, using RC DC protein assays (Bio-Rad). Proteins in each 
sample were purified, using ReadyPrep 2-D Cleanup kits (BioRad), following the manufacturer’s 
protocol. Equal amounts of proteins were separated by SDS-PAGE, under reducing conditions, 
and electrophoretically transferred to nitrocellulose membranes. The membranes were blocked 
with 5% BSA and incubated with primary antibody (monoclonal PBP2a antibodies, Fitzgerald) 
overnight at 4°C. After five washes with PBS Tween-20 (PBST), membranes were incubated 
overnight, at 4°C, with secondary antibodies (Cell Signaling, Beverly, MA), conjugated with 
horseradish peroxidase. Immunoreactive proteins were then detected by an Opti-4CN detection 
kit (BioRad). Dried membranes were scanned and densitometric analyses were carried, using the 
Image J software. The following antibody dilutions were used: anti-PBP2a, 1:10 000, anti-IgG 
HRP, 1:3000. 
 
6.3.6  Au Surface Preparation 
 
Biacore Platypus biosensor chips, to be described below, were used as the gold surface. Prior to 
modification, they were placed in freshly prepared “Piranha” solution, a 7:3 (v/v) mixture of 
concentrated H2SO4 and 30% H2O2 (caution: piranha solution reacts vigorously with organics, 
and can splatter), at room temperature, for 30 min, then rinsed thoroughly with MilliQ water 
(Millipore, Mississauga, Ont.), ultrasonicated in water for 15 min and dried in a nitrogen flow. 
The gold substrate was coated with a self-assembled monolayer (SAM) of L-cysteine overnight 
at 37°C, washed with PBS and subsequently coated with mercaptoundecanoic acid (MUA) to 
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create mixed self-assembled monolayers19; these were treated with 1-(3-
dimethylaminopropyl)ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide 
(NHS). Anti-PBP2a antibodies were then exposed to the surface for an hour, followed by BSA 
for 15 min, to prevent non-specific adhesion. 
6.3.7 Surface Plasmon Resonance Apparatus 
 
We used a homemade highly sensitive surface plasmon resonance (SPR) system. Briefly, a 
superluminescent light-emitting diode (SLED), emitting at 650 nm, was used as the light source. 
An achromatic lens produced a collimated beam, which passed through a polarizer. The linearly 
p-polarized light was focused by a lens, and then used to excite surface plasmons on the sensing 
surface, situated on top of a coupling prism. A commercial sensing surface (Platypus 
Technologies), consisting of a glass microscope slide (BK7), covered by an adhesion layer of 5 
nm of titanium and a sensing layer of 50 nm of gold, was placed in oil immersion contact 
(Cargille Labs) on the top of the coupling prism. For the real-time tests, a flow injection double 
channel-measuring cell, with a 12 µl volume, was developed. The entire system was placed on a 
goniometer stage, with 2-D linear translation for exact beam angle and position, permitting 
surface plasmon excitation at the gold/adjacent medium interface. The spatial distribution of the 
reflected light intensity was recorded by a CCD camera (Hamamatsu C4742-95), and examined 
by appropriate software image treatment. A more detailed description of the system can be found 
in references [3, 229].  
 
 
6.3.8 DNA sequence analysis and bioinformatics 
 
Open reading frame identification was performed, using GeneMark.hmm[195]. Similarity 
searches, for nucleotide sequences and for the deduced amino acid sequences, were performed 
using the FASTA[196], BLAST[197], and PARALIGN[198] programs available on the Online 
Analysis Tools website (http://molbio-tools.ca/). 
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6.4 Results and discussion 
 
6.4.1 Characterization of Staphylococcus aureus resistance cassettes 
 
Current methods employed to type bacteria are based on genotypic characteristics of the strains. 
The staphylococcal cassette chromosome, mec (SCCmec), is a mobile genetic element that 
contains the mecA gene, which encodes methicillin resistance in S. aureus. SCCmec typing is 
used to differentiate strains or lineages within the MRSA population. Eleven SCCmec types and 
several variants have been described, with types I to V being the most common[230]. 
From a bacteriological standpoint, CA-MRSA differs from HA-MRSA owing to various 
characteristics. CA-MRSA is typically susceptible to most non-β-lactam antibiotics and 
comprises a SCCmec element of type IV, type V or of the newly described type VII. On the other 
hand, HA-MRSA is usually multidrug-resistant and contains a SCCmec element of type I, II or 
III[230].  
A study by the Society for Healthcare Epidemiology of America [231], surveying both 
community and hospitalized patients in Canada demonstrated the incidence and the changing 
epidemiology of S. aureus infections. This study demonstrates the emergence of CA-MRSA 
strains in Canada and, in particular, the presence of CMRSA-10 (USA300) and CMRSA-7 
(USA400) in the Province of Quebec[231] 
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Table 6.3: Microbiological Characteristics of S. aureus Isolates 
 
Identification 
(nb of 
isolates) 
Oxacillin MIC 
µg/ml (nb of 
isolates) 
mecA 
PCR 
SCCmec 
type 
Epidemiologic  type PVL 
(nb of isolates) 
MRSA (207) ≥ 32 (207) Positive HA-MRSA  
 (55/194) 
CMRSA-1/USA600 (2/184) 
CMRSA-2/USA100/USA800 
(43/184) 
Positive 
(134/196) 
   Negative 
(62/196) 
    
   CA-MRSA 
 (139/194) 
MRSA-7/USA400 (10/184) 
CMRSA-10 /USA 300 
(121/184) 
USA700 (4/184) 
USA1100 (4/184) 
 
    
     
MSSA (16) ≤0.25 (6) Negative - - Negative 
 ≤0.5 (7)     
 ≤1 (3)     
BORSA (27) 1-4 (16) Negative - - Negative 
 4-8 (11)     
 
MRSA infections are endemic in hospitals worldwide.  In recent years, infections have emerged 
in the community and livestock, and thus, MRSA is no longer exclusively considered as a 
healthcare associated problem. Validation of the current SPR platform was carried out on 250 
well-characterized S. aureus strains (82.8% MRSA, 10.8% BORSA, and 6.4% MSSA). S. aureus 
isolates were characterized by multiplex PCR amplification of the Panton-Valentine leukocidin 
(PVL) and mecA genes, staphylococcal cassette chromosome mec (SCCmec) typing and oxacillin 
susceptibility. The results are summarized in Table 6.3. Amongst these isolates, 28.9% were HA-
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MRSA, and 71.1% were CA-MRSA. Further analysis of the LSPQ isolates determined that the 
strains belonged to 6 epidemiologic types, with CMRSA-10 (USA300) accounting for 65.7% of 
isolates, CMRSA-2 (USA100/800) for 23.4%, CMRSA-7 (USA400) for 5.4%, USA700 for 
2.2%, USA1100 for 2.2% and CMRSA-1 (USA600) for 1.1%.   
 
Figure 6-1: a) Multiplexed PCR SCCmec and mecA typing. Representative Biophage Pharma 
isolates (Saa 4 and 5) and representative LSPQ isolates (Saa 30 and 226). Lanes marked with the 
number 1 contain primers for SCCmec I, II and Sa442, a positive control to confirm S. aureus 
strain. Lanes marked with the number 2 contain primers for SCCmec V, and mecA. Lanes 
marked with the number 3 contain primers for SCCmec III, and Sa442. Lane marked with the 
letter M contains the molecular marker. b) monoplex PCR for SCCmec IV typing for the Saa 30 
strain. Lanes marked with 1kb and 100 bp are molecular markers, while lanes marked with IVa, 
IVb, IVc and IVd contain primers for SCCmec IVa, IVb, IVc and IVd, respectively.  
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As previously noted, mecA resides in the large mobile genetic element, SCCmec. Methicillin 
resistance is known to be inducible, and the mecA gene, which codes for PBP2a, is under the 
control of the mecI and mecR1 regulatory genes. These genes encode, respectively, for a 
repressor and for a β-lactam sensing signal transducer. In an antibiotic-free environment, mecI 
represses the transcription of mecA and mecR1. However, when β-lactams are introduced, mecR1 
is cleaved, thus freeing the metalloprotease domain and inducing mecA transcription[232]. The 
presence of mecA and the production of PBP2a provide methicillin resistance in S. aureus. Thus, 
testing with both SCCmec and mecA gene markers provides conclusive proof of resistance in 
MRSA. 
We arbitrarily selected Saa 4 as a representative strain for HA-MRSA, Saa 5 for MSSA, Saa 30 
for CA-MRSA and Saa 226 for BORSA to carry on biosensing studies. Amplification of the 
mecA gene and SCCmec types for selective S. aureus isolates included in Table 6.2 are shown in 
Figure 6-1. MSSA and BORSA strains (Saa 5 and 226) were negative for the 162-bp internal 
fragment of the mecA gene, while Saa 4 and Saa 30 were positive, confirming that these strains 
are MRSA . The Saa 4 strain showed resistance to oxacillin, cefazolin, ceftriaxone, ciprofloxacin, 
and ampicillin (MIC > 32 µg/ml for all antibiotics tested), but was susceptible to vancomycin 
(MIC = 2 µg/ml). PCR SCCmec typing showed that it was type II, making it a HA-MRSA strain. 
Saa 5 was chosen as representative of MSSA strains, with susceptibility to all antibiotics tested 
(MIC≤ 1 µg/ml); it was also negative for all SCCmecs and mecA genes tested. Saa30 was chosen 
as representative of CA-MRSA, as it was resistant to β-lactams, positive for mecA, positive for 
PVL, and was a SCCmec IV. For BORSA, Saa 226 was chosen, as it was negative for mecA and 
SCCmecs but showed borderline susceptibility to oxacillin (MIC = 8 µg/ml).  
Although PCR, spa typing, and SCCmec subtyping are suitable for epidemiological studies, risk 
assessment and surveillance, there is still a paramount need for a highly discriminatory, 
inexpensive, and rapid technology for point-of-care diagnosis.   
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6.4.2 Expression of protein PBP2a 
 
Currently, the reported mechanism of methicillin resistance in S. aureus is the production of a 
distinctive cell wall protein, PBP2a, which exhibits low affinity toward β-lactams[17]. In 
contrast, susceptible strains of S. aureus have normal PBPs that function as transpeptidases, 
endopepitdases or carboxypeptidases in the crosslinking of macromolecules in the cell wall 
during cell division. MRSA PBP2a has a slightly different molecular size than PBP, and is 
controlled by a repressor gene also confined within the mec gene. Various other PBPs can be 
found in both resistant and susceptible strains of S .aureus, but only PBP2a remains active in the 
presence of high concentrations of β-lactams. On the other hand, BORSA strains do not exhibit 
PBP2a in their cell wall membranes but appear to produce large amounts of staphylococcal 
penicillinase that slowly degrades methicillin and oxacillin[233]. 
Due to the fact that multiple genes are involved in cell-wall precursor formation, regulation, 
transport and signal transduction, different MRSA strains appear to be heterogeneous in their 
level of resistance[232]. Thus, different strains of MRSA may not only manifest a wide range of 
resistance to β-lactams, but also different concentrations of PBP2a in the cell wall membranes. 
The inset of Figure 6-2 shows SDS-PAGE of total cell lysate protein (10 µg) derived from Saa 4, 
5, 30 and 226.  
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Figure 6-2: PBP2a protein expression in S. aureus. Expression of PBP2a from membranes of Saa 
4 (HA-MRSA), Saa 5 (MSSA), Saa 30 (CA-MRSA) and Saa 226 (BORSA). Significant 
heterogeneous expression of PBP2a was found for Saa 4 MRSA strains compared to Saa 30 
(P<0.01, N=3). The inset shows SDS-PAGE of total membranous protein expression of S. aureus 
lysates. The arrow indicates PBP2a expression (82kDa).  
 
 
In this experiment, membranous proteins were extracted from 2.0x1010 CFU/mL of freshly 
cultured bacteria (Saa4, 5, 30, and 226) in order to determine the PBP2a concentration in 
different S. aureus strains. The normalized PBP2a concentrations were found to be 89.4 ±0.2 % 
for HA-MRSA Saa 4 strain, 6.9±1.7 % for MSSA Saa5, 17.9±1.3 % for CA-MRSA strain Saa 30, 
and 0.3±0.1 % for BORSA strain Saa 226, respectively. As expected, no significant PBP2a 
expression was found in the MSSA and BORSA strains, whereas MRSA strains (Saa4 and Saa 
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30) expressed heterogeneous amounts of PBP2a (P<0.01, N=3). In fact there is approximately 5 
times more PBP2a in Saa 4 than in Saa 30.  
Resistance levels in MRSA depend on PBP2a production, which is regulated by chromosomal 
factors and is dependent on controlled cell wall synthesis and chemical structure of the 
peptidoglycan precursor. The regulation of genes that govern resistant levels may, in turn, be 
contingent on control by global regulators whose fine-tuning may vary from strain to strain.   
Thus, resistance levels in different MRSA strains range from phenotypically susceptible to highly 
resistant. In the following section, we propose an SPR assay, which can prove efficient at 
determining the level of membranous PBP2a in different MRSA strains.  
 
6.4.3 Differential detection of MRSA, MSSA and BORSA 
 
One of the major objectives of our work is to develop a rapid and sensitive technique, using a 
SPR biosensor, to specifically detect and differentiate between MRSA, BORSA and MSSA 
strains. To meet this objective, we used a home-built biosensor, with anti-PBP2a antibodies as 
specific recognition elements, to detect low concentrations of methicillin-resistant bacteria. A 
PBS solution was injected onto the gold chip for 10 minutes, followed by a 20 minute injection of 
a PBS solution containing different concentrations of S. aureus Saa4 and Saa5 strains. PBS was 
then injected to wash away the unbound bacteria (Figure 6-3a). Results are shown in pixel units, 
with one pixel corresponding to 0.005 angle units. All experiments were carried out at room 
temperature and were performed in triplicates. The SPR responses for Saa 4 were 26.1± 1.2 
pixels for 102 CFU/mL and 6.4± 0.9 pixels for 10 CFU/mL (inset of Figure 6-3). Noticeably a 
small, but measurable, response was noted for 104 CFU/mL Saa 5 (1.1± 1.1 pixels). These results 
confirm the specificity of the antibody to PBP2a and the presence of the PBP2a protein on the 
membranes of MRSA strains (Saa4) and not on the antibiotic susceptible strain (Saa 5). 
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a) 
 
b) 
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Figure 6-3: Detection of MRSA, using anti-PBP2a antibodies, immobilized on the gold sensor 
chip. A baseline was created by injecting PBS buffer for 10 minutes. PBS was used as negative 
control.  a) Known concentrations of HA-MRSA (Saa 4) diluted in PBS were flowed onto the 
sensor surface. MSSA (Saa 5), at a concentration of 104 CFU/mL, was also tested, and 
manifested the high specificity of the anti-PBP2a antibody for MRSA detection. For detection of 
Saa4 MRSA strain, a dose-response curve is shown, in inset, for values taken after 20 minutes. b) 
Known concentrations of CA-MRSA (Saa 30), diluted in PBS, were flowed onto the sensor 
surface. Surface plasmon responses for MRSA strains (Saa 30) showed the high specificity of the 
antibody for PBP2a. On the contrary, BORSA strains (Saa 226), at a concentration of 104 
CFU/mL, did not show any significant SPR response. For detection of Saa30 MRSA strain, a 
dose-response curve is shown, in inset. 
 
 
The same experiment was repeated to establish the possibility of detecting CA-MRSA (Saa 30) 
bacteria using PBP2a antibody. All slides were previously coated with anti-PBP2a antibody and 
BSA, to prevent non-specific adhesion. The controls consisted of a solution of 106 CFU/mL of 
BORSA (Saa 226), injected on an anti-PBP2a-coated slide (Figure 6-3b). SPR responses for 
predetermined concentrations of Saa 30 were 6.4± 1.0 pixels for 102 CFU/mL and 2.9±0.3 for 10 
CFU/mL. A concentration of 106 CFU/mL of Saa 226 produced a noticeably small, but 
measurable, response (0.4±0.3 pixels). As anticipated, because MSSA and BORSA do not exhibit 
PBP2a on their cell wall membranes, we did not observe a significant change in SPR response. 
Any surface plasmon response difference between the PBS baseline and the non-specific 
adsorption of MSSA was determined to be due to noise. Using the criterion of S/N ›3, the limit of 
detection is found to be 10 CFU/mL (inset of Figure 6-3b). Moreover, the SPR responses for Saa 
30 were 5 times lower than those of Saa 4, which is consistent with the SDS-PAGE results, 
where PBP2a expression was found to be approximately 5 times greater in Saa 4 than in Saa 30 
strains. This shows that the SPR assay can effectively assess the amount of PBP2a in MRSA cell 
walls.  
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Our results demonstrate that, when the SPR biosensor assay was used to test S. aureus samples, it 
could effectively differentiate among MRSA, MSSA, and BORSA strains. The methicillin 
resistance measured was in total agreement with standard microbiological approaches. The 
chemical and optical components of the biosensing surface have excellent sensitivity, as 
evidenced by a detection limit of 10 CFU/mL, when MRSA strain response was compared to that 
of BORSA strains. This analytical limit of sensitivity is adequate to detect the numbers of 
organisms in positive isolates. Furthermore, the surface configuration is designed to be 
chemically inert, thereby limiting nonspecific interactions. The SPR assay was able to 
differentiate among S. aureus strains without the need for a culture step, target amplification, or 
PCR products. Thus, this approach has the advantages of being simple and rapid, allowing for 
identification of resistant strains of Staphylococcus aureus up to 48 hours earlier than 
conventional microbiological techniques. This method could have a significant impact on 
hospital costs, effective infection control, and patient mortality.  
 
6.5 Conclusions 
 
Our proposed SPR assay allows rapid and accurate detection of MRSA, eliminating the necessity 
for specialized reference laboratories. This assay is easy to perform, can accurately differentiate 
MRSA from BORSA and MSSA isolates, and provides a rapid (less than 20 min) alternative for 
the detection of methicillin resistance in S. aureus in clinical laboratories, especially when mecA 
PCR gene detection is unavailable. This will permit clinicians to more effectively manage 
patients and to control the spread of MRSA. This new test shows great promise in providing 
rapid, sensitive and specific alternatives, when neither PCR nor DNA hybridization for the mecA 
gene is available. 
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CHAPTER 7 ARTICLE 6 : X-RAY PHOTOELECTRON 
SPECTROSCOPIC AND TRANSMISSION ELECTRON 
MICROSCOPIC CHARACTERIZATIONS OF BACTERIOPHAGE-
NANOPARTICLE COMPLEXES FOR PATHOGEN DETECTION 
 
 
The need for a more flexible, reliable and sensitive targeting of pathogens has directed our 
research towards the synthesis of bacteriophage-nanoparticles systems. The unique properties of 
NPs may increase the sensitivity of pathogen detection, while opening up new possibilities for 
point-of-care, multiplexed devices. Moreover, these nano-bio hybrids hold great promise for 
further applications, such as in other sensing systems, imaging and therapy.  
 
In this article, we take advantage of the previous knowledge we acquired, about functionalization 
chemistries and conventional SPR detection, to design a sensing platform where gold NPs were 
functionalized and bioconjugated to bacteriophages, and studied with XPS and TEM.  
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7.1 Abstract 
We report the synthesis and characterization of gold-bacteriophage hybrids for biodetection 
purposes. The physical and optical properties of gold nanoparticles (AuNPs) and the biological 
features of the phages offer a multifunctional scaffold with great potential for 
nanotechnologically based biomedical applications. AuNPs stabilized (PEGylated) using 
heterobifunctional polyethylene glycol (PEG), were coupled to methicillin-resistant S. aureus-
specific phages. The PEG ligands contain a thiol group for stable anchoring to the gold surface, 
and a terminal carboxylic acid group for further coupling to the outside of the PEG shell by 
carbodiimide chemistry. Transmission electron microscopic analysis showed that the NP-phage 
bioconjugates are highly stable, with a median diameter of 90 nm. X-ray photoelectron 
spectroscopy was used to chemically characterize the surfaces of the PEG-functionalized AuNPs, 
the bacteriophages, and the gold-phage hybrids. The role of the interface and the covalent 
coupling chemistry employed to attach the phages to the AuNPs have been delineated. Successful 
attachment of phages to AuNPs was confirmed by the presence of amide between the primary 
amines of the phage and the carboxylic acid terminal groups of the NPs and by the presence of 
carboxyl and amine species, which form hydrogen bonds. 
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Figure 7-1: Graphical Abstract : Nanoparticle-Bacteriophage interaction for LSPR applications 
7.2  Introduction  
 
Conventional microbiological techniques for the detection of harmful bacteria, such as 
methicillin-resistant Staphylococcus aureus (MRSA), often require up to two days[234] to obtain 
results. Many groups have devoted significant efforts toward the development of rapid, sensitive, 
and specific methods for the detection of such pathogens[9, 126, 185, 191, 235-240]. The past 
few decades have seen the advent of biosensors, based on surface plasmon resonance (SPR), for 
the study of the chemical and biological reactions that occur at the interface of a metal and its 
biochemical environment[3, 107, 241, 242]. A surface plasmon (SP) is a charge density 
oscillation, propagating along the boundary between a dielectric and a metal[94, 100, 243]. 
However, the requirement for detection by attenuated total reflectance requires a rather complex 
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optical setup. Here we use localized surface plasmon resonance (LSPR), where the plasmon is 
produced by metal nanoparticles (NPs). In accordance with the Mie theory, the movement of 
electrons through the internal metal framework of the NPs is confined in three dimensions[244]. 
When the frequency of the incident light matches that of the resonance of the collectively 
oscillating electrons, the energy of the incident photons is absorbed, corresponding to a peak in 
the absorbance spectrum. The use of localized SPs permits increased resolution and sensitivity of 
the optical probes and therefore the amplification of the detection signal[245].  
In the case of LSPR for bacterial detection, recent findings show that the contact area between a 
bacterial cell and a single NP may be too small to result in a detectable plasmon peak shift[245]. 
This prompted us to explore the possibility of attaching numerous NPs to a single bacterial cell 
by exploiting the specificity of bacteriophage-bacteria interactions. Bacteriophages are among the 
most promising candidates for biosensing scaffolds due to their specificity, robustness and unique 
display system. Au–phage fractal networks have previously been shown to effectively integrate 
the unique signal-reporting properties of AuNPs while preserving the biological properties of 
phages[6]. Moreover, the use of these NP-phage hybrids can be extended to the targeted 
separation of specific bacteria from heterogeneous samples as well as a wide range of 
biotechnological applications, such as labels for enhanced fluorescence and dark-field 
microscopy and surface-enhanced Raman scattering detection[6].  
In a previous paper, using bacteriophages immobilized on planar gold surfaces, we studied the 
bacteriophage-MRSA specificity[3].  The phages were covalently attached to the gold through 
amide bonds via a mixed self-assembled monolayer of L-cysteine and 11-mercaptoundecanoic 
acid[107]. We present here a novel method to immobilize phages on AuNPs that are 
functionalized with heterobifunctional PEG molecules, consisting of a thiol anchor group on one 
end and a carboxylic acid group on the other end, for further reaction.  
The use of these PEG linkers has the dual functions of readily substituting weakly adsorbed 
surface molecules and stabilizing the NPs during synthesis. The linker is there to provide a high 
density of docking sites for bacteriophages through carbodiimide amidization reactions between 
the carboxy terminal of PEG and the amine groups at the phage surface.  
Together with the NP shape and size and the specificity of the bacteriophage, the immobilization 
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chemistry of the nanohybrid defines the performance and stability of the system. Although self-
assembled monolayer (SAM) characterization on gold platforms has been extensively 
studied[149, 152, 159, 163], a detailed quantitative characterization of PEG-functionalized 
AuNPs is lacking[246]. Furthermore, a detailed physicochemical analysis for the reliable 
interpretation of observed biointerfacial interactions of NPs and lytic phage conjugates has not 
been published. The characterization of such intentionally designed nanohybrids is a crucial step 
in the development of novel nanomaterials.  
X-ray photoelectron spectroscopy (XPS) and transmission electron microscopy (TEM) are widely 
used techniques for the characterization of nanobiomaterials[247].  TEM was used to determine 
the morphology of PEG-AuNPs, and XPS was used to determine surface chemistries of the PEG-
AuNPs, MRSA-specific bacteriophages, and phage-AuNPs nanohybrids. 
 
7.3 Materials and Methods 
 
7.3.1 Chemicals 
 
1-(3-dimethylaminopropyl) ethylcarbodiimide hydrochloride (EDC), N-hydroxy-succinimide 
(NHS), glutaraldehyde, sodium chloride, magnesium sulfate, and gelatin were purchased from 
Sigma-Aldrich. Luria-Bertani (LB) medium was purchased from Quelabs (Montréal, Québec, 
Canada). Phosphate-buffered saline (PBS) was purchased from Fisher Scientific (Nepean, 
Ontario, Canada). Sixty nanometer diameter heterobifunctional PEG-AuNPs  (cat # CGC3K-60-
25) were provided by Cytodiagnostics (Burlington, Ontario, Canada). MRSA bacteria and 
bacteriophages were provided by Biophage Pharma (Montréal, Québec, Canada). Uranyl acetate 
(UA) was purchased from Canemco Inc. (Lakefield, Québec, Canada). 
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7.3.2  Bacterial culture 
 
MRSA bacteria were isolated by Biophage Pharma and were grown in an incubator-shaker at 
37°C in 4 mL of LB medium for 3h. The bacteria were then centrifuged at 2500 g (Sorvall RT7, 
3500 rpm) for 20 min. The supernatant was discarded, and the bacteria were washed twice and 
resuspended in water. Their concentration was determined by plate count technique and 
expressed in colony forming units per milliliter (CFU/mL). 
 
7.3.3  Bacteriophage preparation 
 
 
Bacteriophages were isolated by Biophage Pharma and amplified by pipetting 100 µL of a 
suspension of 106 PFU/mL of bacteriophages into a solution containing 1 mL of 106 CFU/mL of 
freshly prepared bacteria. The bacteriophage concentration was determined by plate count 
technique and expressed in plaque forming units per milliliter (PFU/mL).  After 15 minutes of 
incubation at room temperature, the infection mix was added to an Erlenmeyer flask containing 
250 mL LB medium and incubated for 6 hours, at 37°C, in an incubator-shaker.  The infected 
culture was then centrifuged at 2500 g for 20 minutes, filtered (0.22 µm) and titrated. For XPS 
and TEM, the bacteriophages were further centrifuged for 60 minutes, the supernatant was 
removed, and the phages were washed 3 times and resuspended in water.  
7.3.4 Preparation of phage-AuNPs hybrids 
 
One milliliter of nanoparticle stock solution (9.80 x 1011 particles/ml, 50 OD) was mixed with 49 
mL of a solution consisting of 1 mol L-1 EDC and 0.1 mol L-1 NHS, for 15 min. The PEGylated 
NPs were then added to the phage solution (1.2 x 106 PFU/mL) and mixed overnight in an 
incubator shaker at 37°C. Gold-phage hybrids slowly precipitated, sank to the bottom of the tube, 
and were centrifuged at 10 000 g for 1 min.  The pellet was resuspended in 1 mL of water. 
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7.3.5 Transmission electron microscopy  
The TEM employed was a Hitachi H-7100, operating at 75 kV. Copper grids (200 mesh), coated 
with a layer of Formvar and an overlayer of evaporated amorphous carbon, were used. A 10 μL 
drop of sample was deposited onto the grid by the reverse drop method: a drop of sample was 
deposited on Parafilm for 5 min, then the grid was deposited on top of the Parafilm, and excess 
liquid was removed with filter paper.  The grid was then dipped, for 5 minutes, in a drop of 2% 
gluteraldehyde. The excess solution was again wicked from the edge of the grid with filter paper, 
and the specimen was washed twice with water. A drop of 1% UA was applied to the grid for 1 
min, and excess was removed with the edge of a filter paper. The grid was allowed to dry before 
the sample was used for TEM analysis.  
 
7.3.6 X-ray photoelectron spectroscopy  
The XPS apparatus was a VG ESCALAB 3 Mark II using a non-monochromated Mg Kα X-ray 
source (1253.6 eV) at a base pressure below 10-10 Torr. For sample preparation, drops of the 
colloidal solution were placed on undoped, undiced, polished, Piranha-cleaned silicon wafers and 
dried overnight in a pumped desiccator. High-resolution spectra were obtained at a perpendicular 
takeoff angle using a pass energy of 20 eV and 0.05 eV steps. Spectral peaks were separated 
using the VG Avantage software; the peak widths used were those established in our laboratory, 
and are held constant for any element. The components were separated after a Shirley 
background was subtracted. The energy was calibrated by setting the major C1s peak, attributed 
to hydrocarbon, to 285.0 eV. 
7.3.7 DNA sequence analysis and bioinformatics 
Open reading frame identification was performed using GeneMark.hmm [195]. Similarity 
searches, for nucleotide sequences and for the deduced amino acid sequences, were performed 
using the FASTA [196], BLAST [197], and PARALIGN [198] programs available on the Online 
Analysis Tools website (http://molbio-tools.ca/). 
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7.4 Results and Discussion 
 
7.4.1 Silicon wafer characterization 
All samples were deposited onto a silicon wafer. As can be seen from Figure 7-1, where the XPS 
survey scan of a silicon wafer is presented, the surface has, in addition to silicon (22.55%), the 
expected presence of natural oxide (67.33 %) and lower but significant amounts of carbon (8.92 
%) and fluorine (1.20%). The presence of carbon indicates the existence of organic contaminants, 
arising from the ambient atmosphere and perhaps human handling. Fluorine contamination is 
certainly due to the etching process[248] used in the original cleaning of the silicon wafer 
surface. The presence of silicon was not detected in further experiments due to the thicknesses of 
the phages, NPs and phage-NP hybrid layers and will not be discussed. 
 
Figure 7-2: XPS survey spectrum of the silicon wafer 
  121 
 
7.4.2 Bacteriophage characterization 
Taking into account that a typical layer thickness measured by XPS ranges from around 4 to 5 
nm (three times the attenuation length) for C, N and O,  we expected to see the chemical 
constituents of the outer layer of the phage capsid, primarily composed of amino acids. Figure 7-
2a shows a bacteriophage survey spectrum. A molecular characterization [3] of the podoviral 
bacteriophages virulent for S. aureus revealed the open reading frame six (ORF 6) codes for the 
major coat proteins containing 30 amino acids (MEKIYTAVLLYNVSINEIYEHEIEQFEKNK).  
Major XPS peaks account for the presence of C1s, O1s, and N1s, at 62.22, 23.26, and 14.45%, 
respectively.  A minor S2p peak (163.66 eV) is found, at 0.06%, corresponding to sulfur present 
in methionine. No Si was detected, indicating that the wafer was thickly covered with 
bacteriophages.  
 
Figure 7-3: XPS spectra of MRSA-specific bacteriophage (a) XPS survey spectrum of 
bacteriophages showing carbon, nitrogen and oxygen species. (b) C1s high-resolution spectrum. 
(c) N1s high-resolution spectrum. (d) O1s high-resolution spectrum. 
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Table 7.1 presents the binding energies of the component peaks. The high resolution C1s 
spectrum was separated into five peaks (Figure 7-2b). The first, at 284.99 eV, is attributed to 
aliphatic carbon present in all amino acids, bound only to carbon or hydrogen[249-251]. The 
second, at 285.91 eV, is attributed to carbon singly bound to nitrogen (C-N)[251, 252], present in 
all amino acids, as well as carbon singly bound to sulfur (C-S)[253], present in methionine. The 
third, at 286.98 eV, is attributed to C-OH[252, 254] present in serine and threonine residues. The 
fourth, at 288.14 eV, is attributed to carbonyl carbon (O=C-C, O=C-N)[250, 252]. The highest 
binding energy component in the C1s spectra, at 289.29 eV, is attributed to carboxylate or 
carboxylic acid groups (R-COO- ; HO-C=O)[250, 255].   
 
Table 7.1: C1s, N1s and O1s peaks detected for bacteriophage samples 
 
Name               Peak BE 
(eV) 
FWHM 
(eV) 
At. % 
(%) 
Suggested attributions 
C 1s      284.99 1.60 9.87 Aliphatic carbon 
285.91  19.63 C-N; C-S 
286.98  13.68 C-OH 
288.14  10.21 O=C-N; O=C-C 
289.29  6.79 
 
COOH 
N 1s      400.24 1.70 1.88 Amine 
401.55  4.16 Amide 
402.67  6.00 Protonated nitrogen 
403.85  3.62 Oxidized nitrogen 
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Name               Peak BE 
(eV) 
FWHM 
(eV) 
At. % 
(%) 
Suggested attributions 
 
O 1s      531.69 1.80 8.32 Oxidized nitrogen 
532.92  12.37 Carbonyl 
534.26  3.45 Hydroxyl 
 
High-resolution N1s spectra, obtained from the sample, are found in Figure 7-2c.  The spectra 
were separated into four peaks, representing contributions from neutral nitrogen, mainly amines, 
at 400.24 eV[256], and amides from asparagine and glutamine, at 401.55 eV[257].  The peak at 
402.67 eV is attributed to protonated amino acid residues[256].  This is in agreement with 
Helgstrand et al. [258], where some amino acids of the major capsid proteins involved in the 
formation of the icosahedral capsid of phages are in a highly polar region and are protonated, 
forming hydrogen bonds with carboxylate groups. The fourth peak, at 403.85 eV, is due to a 
higher oxidation state, such as an amine N-oxide [255] .  
Finally, the O1s spectrum was separated into three peaks (Figure 7-2d).  The first, at 531.69 eV, 
is attributed to oxidized nitrogen. The second (532.92 eV) is attributed to carbonyl groups and the 
third, at 534.26 eV, is attributed to hydroxyl groups. 
From the TEM image in Figure 7-3, the MRSA-specific bacteriophage is seen to be very similar 
to other S. aureus phages, such as the 44AHDJ virus, and is most probably from the Podoviridae 
family. As seen in Figure 7-3, it possesses a small isometric head, measuring 42 nm and, at its 
lower left a short, non-contractile tail, measuring 25 nm; the tail is responsible for its ability to 
adhere to and infect its bacterial host. The length of the phage (recognition element) is of critical 
importance to LSPR and will be discussed later. 
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Figure 7-4: TEM photomicrograph of an MRSA bacteriophage 
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7.4.3 Heterobifunctional PEG-functionalized gold nanoparticles 
Previous studies showed that the chemical synthesis of the gold NPs, through the reduction of a 
precursor salt by a reducing agent, often leads to surface contamination [259]. An XPS survey of 
the 60 nm PEGylated nanoparticles shows, as expected, the presence of gold, sulfur, carbon and 
oxygen (Figure 7-4a). The relative concentrations were, respectively, 26.04, 2.46, 37.87, and 
23.26%. Silicon was not detected, indicating a thick, homogenous coverage of the wafer. No 
other contaminants, such as chlorine, fluorine or sodium were detected.  
Our XPS resultsshow that the PEG linker is composed of seven repeat units, which is not in 
accordance with the manufacturer [260], who claims that the PEG functional group has a 
molecular weight of 3000 Da (~70 repeat units). We can still see the gold through the PEG 
surface layer; because XPS can probe up to 4.5 nm (three times the attenuation length of Au, 
15Å), the PEG  surface layer must be < 4.5 nm in thickness.  For S-(O-C-C)n-COOH with n=7, 
we should have 15 times the amount of carbon relative to that of sulfur (i.e. 36.9%) and nine 
times the amount of oxygen (i.e. 22.14%).  A comparison with what we found experimentally 
leads us to believe that there is very little, if any, carbon and oxygen contamination.  
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Figure 7-5: XPS spectra of heterobifunctionalized PEGylated gold nanoparticles. a) XPS survey 
spectrum. b) Au 4f high-resolution spectrum. c) S2p high-resolution spectrum. d) C1s high-
resolution spectrum. e) O1s high-resolution spectrum. 
A detailed chemical analysis of the high-resolution Au4f spectrum showed that the NPs may be 
partially oxidized by the oxygen present in solution (Figure 7-4b).  High-resolution gold spectra 
are characterized by three pairs of peaks contained in the Au4f7/2 and Au4f5/2 doublet. The 
positions of the first and most important pair (BEs of 83.83 and 87.5 eV) are due to elemental 
gold (Au0); those of the other pairs are due to Au-S (BE 84.22 and 87.89 eV), and oxidized gold 
(Au-O) (BEs of 85.63 and 89.30 eV) (Table 7.2). Our results clearly indicate that gold is present 
at the interface in several oxidation states, explaining the low energy O1s components of O-Au 
species. On the basis of relative peak areas, their respective atomic percentages were estimated as 
18.94% for Au
0
, 7.04% for Au-S, and 0.52% for Au-O.  
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Table 7.2: Au 4f, S2p, C1s and O1s peaks detected for PEGylated nanoparticle samples 
  
Name Peak BE 
(eV) 
FWHM 
(eV) 
At. % 
(%) 
 Suggested attributions 
Au 4f doublets 83.83 – 87.50 0.95 18.94  Au0 
 84.22 – 87.89  7.04  Au-S 
 85.63 – 89.30  0.52  Au-O 
S2p doublets 162.24 – 163.42 1.75 4.15  S-Au 
 165.71 – 166.89  1.14  S-O-C 
C 1s 285.02 1.60 5.67  Hydrocarbon 
 286.42  21.01  O-C-C 
 287.86  3.12  S-O-C 
 289.53  1.82  COOH 
O 1s 532.87 1.80 5.86  Au-O 
 533.82  22.85  Carbonyl 
 534.92  7.87  Hydroxyl 
 
  128 
 
 
The S2p high-resolution spectrum (Figure 7-4c) consists of two pair of peaks, attributed to S-Au 
(BEs 162.24 and 163.42 eV) and S-O-C (BEs 165.71 and 166.89 eV), with respective atomic 
percentages of 4.15  and 1.14.  
The high-resolution C1s spectrum (Figure7- 4d) consists of four peaks attributed to hydrocarbon 
(285.02 eV), (O-C)n (286.42 eV), S-O-C (287.86 eV), and COOH (289.53 eV). Respective 
atomic percentages were found to be 5.67, 21.01, 3.12, and 1.82 of the total.  
The high-resolution O1s spectrum (Figure 7-4e) contains three peaks attributed to Au-O (532.87 
eV), carbonyl (BE 533.95 eV), and hydroxyl components of PEG (534.92 eV). Respective atomic 
percentages were found to be 5.86, 22.85, and 7.87. 
From Figure 7-5, it can be seen that the Au NPs are approximately cuboctahedral and reasonably 
monodisperse. From the TEM images, we obtain an average particle diameter and standard 
deviation of 62 ± 6 nm. The size of the NPs is of critical importance for biodetection purposes 
using LSPR and will be further discussed in the following section.  
 
 
 
Figure 7-6: TEM photomicrograph of heterobifunctional PEG-functionalized gold nanoparticles. 
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7.4.4 Bacteriophage-gold nanoparticle nanohybrids 
We recently investigated several coupling strategies aimed at attaching lytic bacteriophages to 
gold surfaces[107].  It is of paramount importance that phages retain their native conformation 
and binding activity while being stably immobilized to a sensor surface.  Thus, an understanding 
of the interface between the gold surface and the systems to be studied is fundamental to all 
surface-sensitive sensor systems.  
Phages were coupled to heterobifunctional PEGylated NPs using carbodiimide chemistry through 
reaction of the phage amino groups with EDC/NHS and the carboxylic acid terminations of the 
PEG deposited onto the gold NP surfaces. Chemical alterations of the sample surfaces, leading to 
the formation of an amide bond between the bacteriophages and the AuNPs, were studied by 
XPS. An elemental survey of the samples shows the presence of carbon, oxygen and nitrogen, 
contributed by the presence of phages as well as small but detectable amounts of gold and sulfur, 
contributed by the PEGylated NPs (Figure 7-6a). The low atomic percentages of gold (0.32) and 
sulfur (0.77) indicate that Au NPs were densely covered by phages. Thus, we expect relatively 
similar carbon, nitrogen, and oxygen percentages for phage-NPs hybrids when compared to 
phages. The atomic percentages of carbon were 60.72 for phage-NPs hybrids, compared to 60.18 
for phages. Similarly, the nitrogen and oxygen contributions remained very similar, at 15.4 and 
22.82%, respectively, for phage-NPs hybrids, compared to 15.60 and 24.16 % for phage species. 
There was, however, an increase in sulfur components (0.77%) for phage-NP when compared to 
phages alone (0.06%) due to the presence of thiolated heterobifunctional PEG nanoparticles. 
A detailed chemical analysis of the high resolution Au4f spectrum showed a component 
composition pattern similar to that of the PEGylated NPs (Figure 7-6b).  Gold was characterized 
by three Au4f7/2 and Au4f5/2 doublets. The relative atomic percentage of elemental gold (Au0) 
(0.10%, BEs 83.88 and 87.55 eV)  as well as Au-S (0.12%, BEs 84.86 and 88.53 eV) diminished 
when compared to PEGylated NPs .  This is due to the high density coverage of the NPs with 
phages, lowering the relative atomic percentage of the gold species, compared to the C, N and O 
contributions of the phages.  The presence of Au-O species (BEs of 85.71 and 89.38 eV) was also 
detectable (0.08%). The S2p high-resolution spectra again consisted of two pair of S2p3/2 and 
S2p1/2 doublets (Figure 7-6c).  The first pair, attributed to S-Au (0.53% BEs 162.56 and 163.74 
eV), is derived from PEG attachment to NPs; the second peak, less electronegative than that 
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reported for S-O-C component of PEGylated AuNPs, is attributed to oxidized sulfur at 0.28 % 
with BEs of  163.72 and 164.90 eV.  
High-resolution C1s spectra (Figure 7-6d), showed a decrease of the relative atomic percentage 
of aliphatic carbons in phage-NPs hybrids (6.38%, BE 284.99 eV), compared to phages (9.87%). 
This decrease was also noted for the peak attributed to C-N and C-S (15.77%, BE 285.98 eV) 
compared with 19.63% in phages. There was an increase in the relative atomic percentages of C-
OH (16.82%, BE 286.95 eV), when compared to phages (13.68%). The peak attributed to the 
amide contribution (288.79 eV) showed a slight increase (12.52%, compared with 10.20% for 
phages), due to bond formation between the NP and the phage surface amines. The peak 
corresponding to the carboxylic acid components of phages remained stable (6.85%, 289.31 eV).  
A sixth peak appeared at BE 290.54 eV, at 2.37%.  This peak may be due to the EDC/NHS 
complex used to form active ester functionalities with carboxylate groups.  
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Figure 7-7: XPS spectra of phage-NPs hybrids. a) XPS survey spectrum. b) Au 4f high-resolution 
spectrum. c) S2p high-resolution spectrum. d) C1s high-resolution spectrum. e) N1s high-
resolution spectrum. f) O1s high-resolution spectrum. 
 
Although the relative percentages of the N1s, O1s and C1s components remained the same in 
phage-NPs samples compared with phages, high resolution N1s spectra were different, with only 
three peaks for phage-NPs compared to four for phages (Figure 7-6e). Moreover, we see an 
increase in amine concentration (6.28%, 400.20 eV) and amide groups (6.86%, 401.18 eV) when 
compared with phages (1.88 and 4.16%, respectively), reflecting the formation of a peptide bond 
between the PEGylated gold and the phage.  Our N1s XPS results reveal the presence of both 
amine (-NH2) and ammonium ion (-NH3+) in phage samples. However, following the covalent 
attachment of phages to AuNPs, N1s spectra show a marked decrease in protonated amine (2.27 
%, 402.10 eV, compared to 6.00% in phage samples) and a complete disappearance of the peak 
attributed to N-oxides compared with 3.62% for the phage samples. This indicates that the -NH2 
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covalently binds to the AuNPs, while the -NH3+ electrostatically binds to the negatively charged 
silicon surface. These results are consistent with previously published work [259]: although 
amines do not generally react with bulk Au, they do react with nanosized Au, in solution, to form 
a weak covalent bond [261, 262]. Moreover, amine oxides are very reactive and can be readily 
converted to amine, in the presence of reducing agents, such as NHS.  We note the presence of –
NH2 species at 400.20 eV, while –NH3+ species are present at 402.10 eV;–COO- are found at 
lower binding energy (531.93 eV) than –COOH groups (533.99 eV).  These are consistent with 
recent findings, where core level shifts larger than 1 eV in the N1s and O1s spectra are induced 
by the formation of strong intermolecular H bonds with opposite sign for the proton donor and 
the proton acceptor[263].  Positions and atomic percentages for the high-resolution peaks of the 
O1s spectrum remained essentially the same (Figure 7-6f).  
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Table 7.3: Au4f, S2p, C1s, N1s and O1s peaks detected for bacteriophage-NP hybrids 
 
Name  Peak BE FWHM eV At. %  Suggested attributions 
Au 4f doublets 83.88 – 87.55 0.95 0.10 Au0 
 84.86 – 88.53  0.12 Au-S 
 85.71 – 89.38  0.08 Au-O 
S 2p doublets 162.56 – 163.74 1.75 0.53 S-Au 
 163.72 – 164.90  0.28 S-O-C 
C 1s 284.99 1.60 6.38 Aliphatic carbon 
 285.98  15.77 C-N; C-S 
 286.95  16.82 C-OH 
 288.07  12.51 O=C-N;  
O-C-C 
 289.31  6.85 COOH 
 290.54  2.37 Carbonate 
N 1s 400.20 1.70 6.28 Amine 
 401.18  6.85 Amide 
 402.10  2.27 Protonated nitrogen 
O 1s 531.93 1.80 7.63 COO- 
 532.97  10.94 Carbonyl 
 533.99  4.25 Carboxyl 
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TEM was used it to directly visualize the nanohybrid complex at high resolution (Figure 7-7).  
Negative staining was required to verify the presence of the bacteria and bacteriophages.  To 
date, very few studies have investigated negative staining factors affecting these types of 
complexes. Recent studies show that phosphotungstic acid (PTA) solution interrupts the 
interactions between Au NPs and phage particles, resulting in the detachment of the NPs from 
phages [246]. To avoid this, we used a 2% UA solution.  Although the NP-phage hybrids were 
darkened, lytic bacteriophages are still recognizable.  Moreover, phage-nanoparticle hybrids can 
be seen to still adhere to their host bacterium, implying that the phage remains active.  Further 
studies are needed to confirm this. 
 
 
Figure 7-8: TEM photomicrograph of phage-NP nanohybrids adhering to MRSA bacteria 
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We have used a finite-element model that solves for Maxwell’s equations in the time-harmonic 
regime[264] to support our views and to estimate the optimum size of NPs to be used for the field 
enhancement of LSPR in biodetection. The distribution of the amplification of the electric field in 
space was obtained by solving for the Helmholtz equation and using the dielectric function of 
gold given by Johnson and Christy[265]. Figure 7-8a presents the near-field enhancement (|E|2) 
around our 60 nm AuNPs suspended in a PBS solution (refractive index ≈1.334), following 
linearly polarized irradiation at 680 nm. Calculations (Figure 7-8b) show that the enhanced field 
intensity reaches well beyond the size of an average phage (≈ 42 nm[3])confirming the possibility 
of phage-NP hybrid-based biodetection. Varying the AuNPs diameter, Figure 7-8c also reveals 
the dependence of the enhanced near-field intensity, at the phage-bacterium interface, relative to 
the size of the NPs and shows that the greatest intensity is predicted for 150 nm NPs; 
unfortunately, this could not be verified because PEGylated Au NPs of this dimension are not 
available at the time. However, those NPs would be, as a consequence, the most promising 
candidates for the development of efficient phage-NP hybrids.     
 
 
Figure 7-9: a. Enhancement of the field intensity (|E|2) around a 60 nm diameter AuNPs 
suspended in PBS medium, on irradiation at 680 nm. The laser polarization direction is indicated 
on the figure. b. Enhancement of the field intensity along the horizontal axis. The NP-phage 
boundary is situated at 30nm, and the phage-bacteria boundary is at 72nm. An enlargement near 
the phage-bacteria boundary is shown in inset. c. Enhancement of the field intensity at the phage-
bacteria boundary as a function of AuNP diameter.  
 
  136 
 
7.5 Conclusion  
 
Gold nanoparticles, functionalized with a heterobifunctional PEG, were successfully coupled to 
lytic bacteriophages specific to MRSA, via carbodiimide chemistry, for biodetection purposes. 
XPS has been used to study the interface between the metal and the bacteriophage. XPS 
characterization of the lytic phage showed the presence of protonated nitrogen species attributed 
to the major capsid proteins. PEGylated gold nanoparticles were shown to efficiently bind to 
phages through the formation of amide bonds between the primary amines of the phage and the 
carboxylic acid terminal groups of the NP platforms. Our results also showed the formation of 
strong intermolecular hydrogen bonds between carboxyl and amine species, as shown by N1s and 
O1s core level shifts. 
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GENERAL DISCUSSION 
 
The ever-increasing incidence of multidrug-resistant infections has created a global public health 
crisis. It is difficult to go a week without hearing about the deteriorating state of health care. The 
CDC estimates that there are 1.7 million people infected by nosocomial bacteria in the US. This 
translates into excess health costs, reaching $20 billion, with 8 million days of additional hospital 
occupancy, and $35 billion in societal costs annually.  Of these nosocomial infections, MRSA is 
by far, the most important and constitutes one of the biggest therapeutic hurdles of our time.   
According to the CDC, more people in the US died from MRSA infections than from AIDS in 
2005.  The situation is alarming, and we need to find suitable ways to tackle this problem. The 
pressing need for novel technologies to detect and, thus, better treat these infections, has paved 
the way for a worldwide effort in biosensor research and development. The significant number of 
publications and patents, presenting improvements in sensor performance in terms of selectivity 
and sensitivity, suggests a continuing interest for biosensing technologies targeting health, drug 
discovery, agro-food industries and homeland security. The world market for in vitro diagnostics 
was estimated to be about $17 billion in 2003, with the biosensor market expected to reach $8.2 
billion by 2009 [266]. Nonetheless, the commercialization of biosensor technology is lagging 
behind research efforts. The technology transfer to a clinical setting seems to be circumvented by 
cost, sensitivity, and reliability considerations.   In order to respond to these limitations, we 
turned our attention to bacteriophages whose multivalent, fast and specific interaction with target 
bacteria, combined with their low production costs, make them a promising alternative to 
antibodies in a biosensing scheme. 
One of the key steps in the construction of a sensing platform is to select a pertinent method for 
the immobilization of the recognition element to the surface. We chose to study the self-assembly 
of thiols to generate functionalized surfaces which selectively attach bacteriophages to gold.  
Although alkanethiol SAMs are commonly used in biosensing technologies, little is known about 
their real-time assembly. In particular, the monolayer formation of amino acids, such as L-
cysteine, has been largely overlooked.  The importance of L-cysteine resides in the fact that the 
molecules have both carboxyl and amino terminal endgroups that confer broader possibilities for 
metal-molecule and molecule-molecule interactions. Moreover, its zwitterionic state results in 
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various intermolecular forces governing its interaction with the metal surface. We chose to use 
SPR to determine the binding mechanisms of both L-cysteine and MUA on gold, and introduced 
numerical models to describe the assembly of both higher and lower concentrations of the 
thiolated molecules. Our results were deemed necessary to improve strategies for the attachment 
of recognition elements, such as bacteriophages, to the functionalized surface.   
The self-assembly technique offers an interesting perspective in developing a sensitive sensor. It 
is widely accepted that generating functionalized surfaces, through modification of thiols, permits 
the attachment of biomolecules onto gold. However, there is a lack of systematic investigation of 
the relationship between the immobilization conditions and the resulting orientation and 
bioactivity of adhered bacteriophages.  Our SPR investigations relating to bacteriophage 
attachment to gold using various chemistries, including physisorption, gluteraldehyde fixation, 
and L-cysteine, combined with MUA and EDC/NHS, show that it is possible to attach 
bacteriophages with a reasonable density for all methods.  However, high phage coverage did not 
necessarily translate into preserved phage lytic activity. These results suggest that density of 
immobilized phages cannot solely account for an increased binding of host bacteria or a better 
sensitivity of detection. To circumvent the problem of steric hindrance, we prepared a mixed 
SAM consisting of a long chain alkanethiol (MUA) combined with a shorter-chain amino acid 
(L-cysteine). AFM results show the resulting formation of a more uniform surface with vacancy 
cavities permitting the oriented positioning of bacteriophages.  This correlates with increased 
binding affinities of the phages immobilized with this method, suggesting a tail-up deposition and 
availability of their caudal proteins to the external medium containing the host bacteria. The 
results of the present study confirm that oriented immobilization of phages allow for the capture 
and detection of their host bacteria with high sensitivity.  
Market viability and applicability of a biosensor in a clinical setup depends on its cost, which is 
related to its shelf life and stability. Most biosensors cannot fulfill this requirement due to the 
fragility of the biorecognition element (i.e. antibodies). Moreover, the biosensor should 
accurately assay a biological sample in less than a few minutes.  Most devices presently available 
have analysis times ranging from hours to several days.  We successfully report on the detection 
of E. coli (Gram negative) and MRSA (Gram positive), using a phage-based SPR sensor, for 
bacterial concentrations of 103 CFU/mL in less than 20 minutes.  What is more, bacteriophages 
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are extremely stable and can survive at room temperature for more than a month. The proposed 
biodetection approach could be extended further to other phages targeting different types of 
bacteria of particular interest for health care, food, and homeland security.  
The failed technology transfer of biosensors can be attributed in part by their inadequacy to 
effectively probe clinical samples; biosensors are usually tested under controlled environments, 
and only subjected to the evaluation of pristine, homogeneous laboratory samples.  Moreover, 
successful biosensors must be versatile enough to support interchangeable biorecognition 
elements. We evaluated 250 clinical samples, provided by the LSPQ, for their susceptibility to 
antibodies. We found that these samples displayed a wide range of antimicrobial resistance or 
susceptibility.  We then modified our SPR assay in order to selectively detect and differentiate 
between MSSA, CA-MRSA, HA-MRSA and BORSA strains, by targeting PBP2a proteins 
exclusive to MRSA, but present in different concentrations on the membranes of community or 
hospital acquired strains. We found that the system permits the label-free, real time, specific 
detection of pathogens for concentrations as low as 10 CFU/mL, in less than 20 minutes.  We 
found that the highest sensitivity of detection was achieved by using antibodies as recognition 
elements owing to their smaller size when compared to that bacteriophage. Smaller recognition 
elements tend to increase the sensitivity of the platform due to the fact that the probing depth of 
the evanescent field is approximately 300nm in the direction perpendicular to the detection 
surface. This system promises to become a diagnostic tool for bacterial pathogens in clinical 
settings and should be further tested for clinical samples in biological fluids, such as serum. 
Nanoparticles have been reported to significantly enhance detections sensitivities of SPR sensors.  
Recent advances in nanofabrication have prompted us to immobilize bacteriophages to 
heterobifunctional nanoparticles. The chemical functionalization of nanomaterials and the 
subsequent attachment of phages are expected to pave the way for improved biosensing assays. 
We used XPS and TEM to delineate the role of the interface and covalent coupling chemistry to 
attach phages to gold nanoparticles. This study is of interest for LSPR biosensing and can be 
extended to other applications, such as targeted separation of bacteria from heterogeneous 
samples, dark-field microscopy and surface-enhanced Raman scattering detection.  
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CONCLUSIONS 
 
 
Pathogen detection is of utmost importance in many sectors, such as in the food industry, 
environmental quality control, clinical diagnostics, bio-defence and counter-terrorism. Failure to 
appropriately, and specifically, detect pathogenic bacteria can lead to serious consequences, and 
may ultimately be lethal. Public safety, new legislation, recent outbreaks in food contamination, 
and the ever-increasing prevalence of multidrug-resistant infections have fostered a worldwide 
research effort targeting novel biosensing strategies. Phage-based SPR biosensors could become 
a powerful diagnostic tool for the detection of emerging infectious diseases in a clinical setting. 
 
We have developed a phage-based biosensing SPR system suited to the specific and sensitive 
detection of bacterial pathogens in a rapid and inexpensive fashion. The first part of this work 
was devoted to deciphering the self-assembly of L-cysteine and MUA and derive better strategies 
for the oriented immobilization of the phages to the gold sensing platform. A mixed self-
assembled layer of these two molecules permitted a favorable positioning of the phages where the 
caudal recognition proteins are facing the surrounding medium containg the bacterial pathogens. 
Optimization of surface immobilization chemistry and finding bacteriophage candidates suitable 
for SPR permitted the detection of low concentrations of pathogens in real time for 
concentrations < 103 CFU/mL in 20 minutes, without prior labeling or enrichment steps. Clinical 
applicability of the sensor was demonstrated by investigating 250 clinical S. aureus samples 
displaying a large spectrum of resistance. Finally, phages were immobilized to heterobifunctional 
nanoparticles with the intent of improving the sensitivity of biodectection, as well as extending 
their use to a wide range of biotechnological applications. 
 
Although this body of work reports on the development of a fast, easy to use, specific and 
inexpensive biosensor, many important challenges remain before it can be efficiently used in a 
point of care setting. Of these challenges, the biosensor should include an apparatus for sample 
collection, which is compatible with blood serum and other heterogeneous environmental 
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samples.  Moreover, the system should be miniaturized to allow for a wireless, handheld 
apparatus.  
 
In conclusion, phage-based SPR sensing offers many promising features and has a great potential 
for pathogen detection. A multidisciplinary research effort is of essence to bring about the 
commercialization and introduction of this system in a clinical setting.  
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